pdb,description,method,datapath,github,protein,virus,hasRerefinement,Molprobity_score
6xez,"EM structure of SARS-CoV-2 replication transcription complex bound to nsp13 helicase-RTC together with product and template RNA. Hetero octamer, RNA polymerase with one chain, NSP8 and helicase with two chains each and NSP7 and RNAs with one chain each. Structure suggests that the nsp13 helicase could act in the 5' > 3' direction on the tRNA to disrupt stable RNA.",ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/6xez,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/6xez,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
6acg,"Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1.  Part of a series of studies on the conformational landscape of spike in complex with ACE2",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6acg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6acg,surface_glycoprotein,SARS-CoV,0,2.0
6acj,"Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2.  Part of a series of studies on the conformational landscape of spike in complex with ACE2",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6acj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6acj,surface_glycoprotein,SARS-CoV,0,2.0
6ack,"Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3.  Part of a series of studies on the conformational landscape of spike in complex with ACE2",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6ack,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6ack,surface_glycoprotein,SARS-CoV,0,3.0
6cs2,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6cs2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6cs2,surface_glycoprotein,SARS-CoV,0,0.0
6m17,Receptor binding domain in complex with full lenght ACE2 and amino acid transporter B0AT1. Study highlight the entry mechanism of SARS-CoV-2 in cells.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6m17,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6m17,surface_glycoprotein,SARS-CoV-2,1,0.0
6m18,Receptor binding domain in complex with full lenght ACE2 and amino acid transporter B0AT1. Study highlight the entry mechanism of SARS-CoV-2 in cells.,ELECTRON MICROSCOPY,../pdb\human_interaction_partners\ACE2\6m18,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6m18,..,pdb\human_interaction_partners\ACE2,0,0.0
6m1d,Receptor binding domain in complex with full lenght ACE2 and amino acid transporter B0AT1. Study highlight the entry mechanism of SARS-CoV-2 in cells.,ELECTRON MICROSCOPY,../pdb\human_interaction_partners\ACE2\6m1d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6m1d,..,pdb\human_interaction_partners\ACE2,0,0.0
6agf,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6agf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6agf,..,pdb\human_interaction_partners\TCP2,0,2.59
6du8,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6du8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6du8,..,pdb\human_interaction_partners\TCP2,0,2.59
6j8e,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6j8e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6j8e,..,pdb\human_interaction_partners\TCP2,0,2.59
6j8g,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6j8g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6j8g,..,pdb\human_interaction_partners\TCP2,0,2.59
6j8h,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6j8h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6j8h,..,pdb\human_interaction_partners\TCP2,0,2.59
6j8i,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6j8i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6j8i,..,pdb\human_interaction_partners\TCP2,0,2.59
6j8j,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6j8j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6j8j,..,pdb\human_interaction_partners\TCP2,0,2.59
6kzo,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6kzo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6kzo,..,pdb\human_interaction_partners\TCP2,0,2.59
6kzp,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6kzp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6kzp,..,pdb\human_interaction_partners\TCP2,0,2.59
6n4q,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6n4q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6n4q,..,pdb\human_interaction_partners\TCP2,0,2.37
6n4r,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6n4r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6n4r,..,pdb\human_interaction_partners\TCP2,0,2.37
6nq0,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6nq0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6nq0,..,pdb\human_interaction_partners\TCP2,0,2.37
6nq1,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6nq1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6nq1,..,pdb\human_interaction_partners\TCP2,0,2.37
6nq2,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6nq2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6nq2,..,pdb\human_interaction_partners\TCP2,0,2.37
6nt3,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6nt3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6nt3,..,pdb\human_interaction_partners\TCP2,0,2.37
6nt4,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",ELECTRON MICROSCOPY,../pdb\human_interaction_partners\TCP2\6nt4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6nt4,..,pdb\human_interaction_partners\TCP2,0,2.37
6zlw,"Electron Microscopy. Structure of nsp1 (""leader-protein) of SARS-CoV-2, bound to the human 40S ribosomal subunit.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zlw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zlw,leader_protein,SARS-CoV-2,0,0.0
6zm7,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex human CCDC124-80S-EBP1 ribosome. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zm7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zm7,leader_protein,SARS-CoV-2,1,0.0
6zme,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with human CCDC124-80S-eERF1 ribosome and rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zme,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zme,leader_protein,SARS-CoV-2,0,0.0
6zmi,"Electron Microscopy. Structure of nsp1 (""leader-protein) of SARS-CoV-2, bound to the human LYAR-80S ribosome complex.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zmi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zmi,leader_protein,SARS-CoV-2,0,1.0
6zmo,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with human LYAR-80S-eEF1a ribosome and rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zmo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zmo,leader_protein,SARS-CoV-2,0,0.0
6zmt,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with human pre-40S-like ribosome and rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zmt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zmt,leader_protein,SARS-CoV-2,0,0.0
6zn5,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with human pre-40S-like ribosome state 2 and rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zn5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zn5,leader_protein,SARS-CoV-2,0,0.0
6zoj,"Electron Microscopy. Structure of nsp1 (""leader-protein) of SARS-CoV-2, in complex with 40S ribosomal subunit.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zoj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zoj,leader_protein,SARS-CoV-2,0,0.0
6zok,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with the human ribosomal 40S subunit and 18s rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zok,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zok,leader_protein,SARS-CoV-2,0,0.0
6zon,"Electron Microscopy. Structure of nsp1 (""leader-protein) of SARS-CoV-2, bound to the human 43S preinitiation ribosome complex - state 1.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zon,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zon,leader_protein,SARS-CoV-2,0,0.0
6zp4,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex human 43S preinitiation ribosome state 2 and 18s rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zp4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zp4,leader_protein,SARS-CoV-2,0,0.0
7k5i,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with the human ribosomal 40S subunit and rRNA but with worse percentile ranks than 6zol. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/7k5i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7k5i,leader_protein,SARS-CoV-2,0,1134.0
6xdc,,ELECTRON MICROSCOPY,pdb/orf3a_protein/SARS-CoV-2/6xdc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf3a_protein/SARS-CoV-2/6xdc,orf3a_protein,SARS-CoV-2,0,0.0
7kjr,Cryo-EM structure of SARS-CoV-2 ORF3a in dimerized form. The structure consists of two ORF3a chains dimerized and two peripher alpha-helices from membrane scaffold proteins from the lipid nanodiscs.,ELECTRON MICROSCOPY,pdb/orf3a_protein/SARS-CoV-2/7kjr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf3a_protein/SARS-CoV-2/7kjr,orf3a_protein,SARS-CoV-2,0,0.0
7kdt,Electron microscopy structure of human Tom70 (mitochondrial import receptor subunit) in complex with SARS CoV2 Orf9b.,ELECTRON MICROSCOPY,pdb/orf9b/SARS-CoV-2/7kdt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf9b/SARS-CoV-2/7kdt,orf9b,SARS-CoV-2,0,0.0
6xrz,,ELECTRON MICROSCOPY,pdb/rna/SARS-CoV-2/6xrz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/6xrz,rna,SARS-CoV-2,0,0.0
6nur,SARS-CoV RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 3.1Å resolution and was published alongside PDB entry 6nus.The NSP12 & NSP8 chains have some N-terminal truncations & NSP7 is full length. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV/6nur,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV/6nur,nsp7-nsp8-rna_polymerase,SARS-CoV,1,0.0
6m71,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 2.9Å resolution and was published alongside PDB entry 7btf. The NSP7 chain is almost full length & NSP8 & NSP12 chains have N-terminus missing as well as some loops. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/6m71,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/6m71,nsp8,SARS-CoV-2,0,0.0
6x2g,Structure of SARS-CoV-2 RdRp/RNA complex at 3.4 Angstroms resolution. Hetero 4-mer - A1B1C1D1 measured by electron microscopy.,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6x2g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6x2g,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
6xqb,Structure of SARS-CoV-2 RdRp/RNA complex at 3.4 Angstroms resolution. Hetero 4-mer - A1B1C1D1 measured by electron microscopy.,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6xqb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6xqb,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
6yyt,SARS-CoV2 RNA Polymerase (NSP12) with NSP7 & two NSP8 co-factors bound with RNA during replication. This electron microscopy model has 2.9Å resolution. NSP12 has some missing loops & all other chains are almost full length. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6yyt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/6yyt,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
7aap,"Electron microscopy structure of SARS-CoV2 RNA-dependent RNA polymerase (Rdrp with subunits Nsp7-Nsp8-Nsp12) in complex with template:primer dsRNA and favipiravir-RTP. Structure of favipiravir ribonucleoside triphosphate (favipiravir-RTP) in complex with the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) bound to a template:primer RNA duplex, determined by electron cryomicroscopy (cryoEM) to a resolution of 2.5 Å. EM structure of SARS-CoV-2 RNA polymerase in complex with dsRNA and favipiravir-RTP. Hetero hexamer, NSP8 with two chains, RNA polymerase, NSP7 and the two RNAs with one chain each. Favipiravir-RTP is an inefficient substrate for the viral RdRp in primer extension assays.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7aap,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7aap,nsp8,SARS-CoV-2,0,0.0
7btf,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 2.95Å resolution and was published alongside PDB entry 6m71. The NSP12 & NSP7 chains are almost full length & NSP8 chains have some N-terminal truncations. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7btf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7btf,nsp8,SARS-CoV-2,0,0.0
7bv1,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 2.8Å resolution and was published alongside PDB entry 7bv2. The NSP12 & NSP7 chains are almost full length & NSP8 chains have some N-terminal truncations.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7bv1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7bv1,nsp8,SARS-CoV-2,0,0.0
7bv2,"SARS-CoV2 RNA Polymerase (NSP12) with NSP7 & a single NSP8 co-factor, RNA & a triphosphate form of Remdesivir. This electron microscopy model has 2.5Å resolution and was published alongside PDB entry 7bv1. NSP12 & NSP7 have some sequence missing from their chains & NSP 8 has an N-terminal truncation.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7bv2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7bv2,nsp8,SARS-CoV-2,0,0.0
7bw4,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 3.7Å resolution. The NSP12 chain has several sections missing. The NSP8 chains have large N-terminal truncations & NSP7 has a small C-terminal section missing. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7bw4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7bw4,nsp8,SARS-CoV-2,0,1.0
7bzf,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 3.26Å resolution and was published alongside PDB entry 7c2k. The NSP12 & NSP7 chains have small C-terminal sections missing & NSP8 chains have large N-terminal truncations. Structure has RNA bound & is in a post-translocation state.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7bzf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7bzf,nsp8,SARS-CoV-2,0,0.0
7c2k,SARS-CoV2 RNA Polymerase (NSP12) bound with NSP7 & two NSP8 co-factors. This electron microscopy model has 2.93Å resolution and was published alongside PDB entry 7bzf. The NSP12 & NSP7 chains are almost full length & NSP8 chains have some N-terminal truncations. Structure has RNA bound & is in a pre-translocation state.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7c2k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7c2k,nsp8,SARS-CoV-2,0,0.0
7ctt,Cryo-EM structure of Favipiravir bound to replicating polymerase complex of SARS-CoV-2 in the pre-catalytic state.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7ctt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7ctt,nsp8,SARS-CoV-2,0,0.0
7cxm,"Atomic structure of a SARS-CoV-2 mini RTC, assembled by viral RNA-dependent RNA polymerase (RdRp, nsp12) with a template-primer RNA, nsp7 and nsp8, and two helicase molecules (nsp13-1 and nsp13-2), by cryo-electron microscopy.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7cxm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7cxm,nsp8,SARS-CoV-2,0,80.0
7cxn,"Atomic structure of a SARS-CoV-2 mini RTC, assembled by viral RNA-dependent RNA polymerase (RdRp, nsp12) with a template-primer RNA, nsp7 and nsp8, and two helicase molecules (nsp13-1 and nsp13-2), by cryo-electron microscopy.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7cxn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7cxn,nsp8,SARS-CoV-2,0,22.0
7d4f,Structure of COVID-19 RNA-dependent RNA polymerase bound to suramin. Hetero 4-mer - A2B1C1 measured by electron microscopy.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7d4f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7d4f,nsp8,SARS-CoV-2,0,0.0
6nus,SARS-CoV RNA Polymerase (NSP12) bound with a single NSP8 co-factor. This electron microscopy model has 3.5Å resolution and was published alongside PDB entry 6nur. The NSP12 chain is truncated at the N & C-terminus with some loops missing. The NSP8 chain has a large N-terminal truncation. The NSP12-NSP7-NSP8 complex replicates viral RNA.,ELECTRON MICROSCOPY,pdb/nsp8-rna_polymerase/SARS-CoV-2/6nus,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8-rna_polymerase/SARS-CoV-2/6nus,nsp8-rna_polymerase,SARS-CoV-2,0,0.0
5wrg,"The spike receptor-binding domain (RBD) attaches the virus to ACE2. The homo trimer is a 3 chain structure. The conformation determined at 4.3 A resolution is three-fold symmetric and has the three RBD 1 (CTD1s) of S1 in down-positions. The binding to ACE2 is not possible, suggesting that it represents a receptor-binding inactive state.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/5wrg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5wrg,surface_glycoprotein,SARS-CoV,0,0.0
5x58,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The homo trimer is a 3 chain structure of spike glycoprotein, Conformation 1 in its pre-fusion conformation. It shows, that HR1 region and the central helix are potential targets for eliciting broadly neutralizing antibodies.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/5x58,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5x58,surface_glycoprotein,SARS-CoV,0,0.0
5x5b,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The homo trimer is a 3 chain structure of spike glycoprotein, Conformation 2 in its pre-fusion conformation. It shows, that HR1 region and the central helix are potential targets for eliciting broadly neutralizing antibodies.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/5x5b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5x5b,surface_glycoprotein,SARS-CoV,0,0.0
5xlr,The spike receptor-binding domain (RBD) attaches the virus to ACE2. The homo trimer is a 3 chain structure Electron Microscopy 3.8 A resolution. It describes the up-position and exposes the rbd for ACE2 engagement? Compare to 5wrg! It shows new insights into the intermediate states of coronavirus pre-fusion spike trimer during infection.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/5xlr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5xlr,surface_glycoprotein,SARS-CoV,0,0.0
6acc,Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein with three RBD in down conformation. Part of a series of studies on the conformational landscape of spike in complex with ACE2,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6acc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6acc,surface_glycoprotein,SARS-CoV,0,1.0
6acd,Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein with one RBD in up conformation. Part of a series of studies on the conformational landscape of spike in complex with ACE2 ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6acd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6acd,surface_glycoprotein,SARS-CoV,0,0.0
6crv,"SARS Spike Glycoprotein, Stabilized variant, C3 symmetry",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6crv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6crv,surface_glycoprotein,SARS-CoV,0,0.0
6crw,"SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6crw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6crw,surface_glycoprotein,SARS-CoV,0,0.0
6crx,"SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation. This study reveal that stabilized spikes resist conformational changes induced by receptor.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6crx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6crx,surface_glycoprotein,SARS-CoV,0,1.0
6crz,"SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry. This study reveal that stabilized spikes resist conformational changes induced by receptor.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6crz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6crz,surface_glycoprotein,SARS-CoV,0,0.0
6cs0,"SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation. This study reveal that stabilized spikes resist conformational changes induced by receptor.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6cs0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6cs0,surface_glycoprotein,SARS-CoV,0,0.0
6cs1,"SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation. This study reveal that stabilized spikes resist conformational changes induced by receptor.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6cs1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6cs1,surface_glycoprotein,SARS-CoV,0,0.0
6nb6,SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1). This study reveal that stabilized spikes resist conformational changes induced by receptor.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6nb6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6nb6,surface_glycoprotein,SARS-CoV,0,4.0
6nb7,SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2). This study reveal that stabilized spikes resist conformational changes induced by receptor.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6nb7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6nb7,surface_glycoprotein,SARS-CoV,0,1.0
6vsb,The EM sturcture of spike glycoprotein shows a single receptor-binding domain up,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6vsb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6vsb,surface_glycoprotein,SARS-CoV-2,0,0.0
6vsj,Cryo-electron microscopy structure of mouse coronavirus spike protein complexed with its murine receptor,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6vsj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6vsj,surface_glycoprotein,SARS-CoV-2,0,0.0
6vxx,"EM structure of the SARS-CoV-2 spike glycoprotein in its closed state. As other entries of the closed spike, this presents all the three RBD in the down position.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6vxx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6vxx,surface_glycoprotein,SARS-CoV-2,1,0.0
6vyb,SARS-CoV-2 spike in the open conformation. One of the RBDs is open. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6vyb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6vyb,surface_glycoprotein,SARS-CoV-2,1,1.0
6wps,Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment. The fragment binds the external surface of the RBD near Val80. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6wps,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6wps,surface_glycoprotein,SARS-CoV-2,0,0.0
6wpt,Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state). The fragment binds the external surface of the RBD near Val80. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6wpt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6wpt,surface_glycoprotein,SARS-CoV-2,0,0.0
6x29,Em structure of a spike glycoprotein mutant forced into its closed state.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x29,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x29,surface_glycoprotein,SARS-CoV-2,0,0.0
6x2a,Em structure of a spike glycoprotein mutant forced into its open state. 1 RBD open.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x2a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x2a,surface_glycoprotein,SARS-CoV-2,0,0.0
6x2b,Em structure of a spike glycoprotein mutant forced into its open state. 2 RBD open.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x2b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x2b,surface_glycoprotein,SARS-CoV-2,0,0.0
6x2c,Em structure of a spike glycoprotein mutant in its closed state.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x2c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x2c,surface_glycoprotein,SARS-CoV-2,0,0.0
6x6p,Cryo-EM structure of SARS-CoV-2 spike glycoprotein recombinant version of S protein termed OptSpike 1 used for a characterization. Homo trimer with 3 chains.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x6p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x6p,surface_glycoprotein,SARS-CoV-2,0,0.0
6x79,"EM structure of a prefusion SARS-CoV-2 ectodomain trimer stabilize in the closed conformation. Homo trimer with three chains. Prefusion spike covalently stabilized by a disulfide bond in the closed conformation, good strategy to stabilize ?-coronaviruses. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6x79,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x79,surface_glycoprotein,SARS-CoV-2,0,0.0
6xcm,EM Structure of a spike glycoprotein in a complex with two antibodies of C105 fabs (one heavy and one light chain in state 1). Non-polymer only heptamer with 7 chains. The crystallographic structure of C105 Fab has been deposited (PDB 6cxa). The state 2 of the same molecules is deposited as 6xcn.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xcm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xcm,surface_glycoprotein,SARS-CoV-2,0,15.37
6xcn,"EM structure of the SARS-CoV-2 spike glycoprotein in complex with the neutralizing antibody C105 fab fragment, symmetric trimer with three RBDs in up conformation. Non polymer only nonamer, spike protein with three chains, antibody with a heavy and a light chain with three chains each. There are two states of C105 this one is state 2 state 1 is in the structure 6xcm. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xcn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xcn,surface_glycoprotein,SARS-CoV-2,0,14.77
6xdg,Cryo-EM Structure of SARS-CoV-2 spike glycoprotein receptor binding domain in complex with the antibody fab fragments of REGN 10933 (one heavy and one light chain) and REGN 10987 (also one heavy and one light chain). Non-polymer only pentamer with 5 chains. The structure shows that the antibodies can synchronously bind to distinct regions of the RBD. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xdg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xdg,surface_glycoprotein,SARS-CoV-2,0,18.92
6xey,"Cryo EM structure of SARS-CoV-2 spike glycoprotein bound to the antibody fab 2-4. Non polymer only nonamer, spike protein with three chains and antibody three chains on the heavy and the light chain each. Fab 2-4 binds the spike protein near the apex, with all RBDs in the down orientation.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xey,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xey,surface_glycoprotein,SARS-CoV-2,0,1.0
6xf5,Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state with RBDs down. Homo trimer with three chains. Biotin labeled probes comprising specific regions of the SARS-CoV-2 spike are helpful in the isolation and characterization of antibodies. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xf5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xf5,surface_glycoprotein,SARS-CoV-2,0,1.0
6xf6,Cryo EM structure of a biotinylated SARS-CoV-2 spike probe in a prefusion state with one RBD up. Homo trimer with three chains. Biotin labeled probes comprising specific regions of the SARS-CoV-2 spike are helpful in the isolation and characterization of antibodies. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xf6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xf6,surface_glycoprotein,SARS-CoV-2,0,0.0
6xkl,EM structure of SARS-CoV-2 S variant HexaPro with one RBD up. Homo trimer with three chains. HexaPro retains the prefusion conformation and withstands heating and freezing. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xkl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xkl,surface_glycoprotein,SARS-CoV-2,0,0.0
6xlu,"EM structure of SARS-CoV-2 spike protein at pH 4.0. Homo trimer with three chains. Related structure to 6xm0, 6xm3, 6xm4 and 6xm5. Structures where used to test a pH dependent mechanism of conformational masking. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xlu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xlu,surface_glycoprotein,SARS-CoV-2,0,0.0
6xm0,"EM structure of SARS-CoV-2 spike protein at pH 5.5 used as a consensus sequence. Homo trimer with three chains. Related to the structures, 6xm3, 6xm4 and 6xm5. This structures tested a pH dependent mechanism of conformational masking. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xm0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xm0,surface_glycoprotein,SARS-CoV-2,0,1.0
6xm3,EM structure of a SARS-CoV-2 spike protein at pH 5.5 with a single RBD up in conformation 1. Homo trimer with three chains. Spikes maybe evade potential neutralizing antibodies through a pH dependent mechanism of conformational masking. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xm3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xm3,surface_glycoprotein,SARS-CoV-2,0,3.0
6xm4,EM structure of a SARS-CoV-2 spike protein at pH 5.5 with a single RBD up in conformation 2. Homo trimer with three chains. Spikes maybe evade potential neutralizing antibodies through a pH dependent mechanism of conformational masking. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xm4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xm4,surface_glycoprotein,SARS-CoV-2,0,0.0
6xm5,EM structure of a SARS-CoV-2 spike protein at pH 5.5 with all RBDs down. Homo trimer with three chains. Spikes maybe evade potential neutralizing antibodies through a pH dependent mechanism of conformational masking. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xm5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xm5,surface_glycoprotein,SARS-CoV-2,0,0.0
6xr8,"Cryo-EM structure of a SARS-CoV-2 trimeric spike glycoprotein in its prefusion conformation. Three receptor-binding domains are clamped down by a segment adjacent to the fusion peptide. The S1 fragment domains, NTD, RBD, CTD1 and CTD2 are wrapped around the three-fold axis, covering the S2 fragment underneath. The furin cleavage site at the S1/S2 boundary is in a surface-exposed and disordered loop.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xr8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xr8,surface_glycoprotein,SARS-CoV-2,0,1.0
6xra,"EM structure of the S2 trimer in the postfusion conformation. Homo trimer with three chains. The S1/S2-2' fragment is an integral part of the postfusion structure. Five glycans are positioned along the axis, if these glycosylation sites are fully occupied by branched sugars they max shield most surfaces.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xra,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xra,surface_glycoprotein,SARS-CoV-2,1,18.0
6xs6,EM structure of SARS-CoV-2 spike protein with the D614G mutation and without the RBD. Homo trimer with three chains. The S2 subunit of D614G overlapped with the published structures of D614 and a deviation with the S1 subunit. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6xs6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xs6,surface_glycoprotein,SARS-CoV-2,0,0.0
6yor,Crystallographic structure of the SARS-CoV-2 RBD S1 subunit in complex with the antibody CR3022 Fab,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6yor,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6yor,surface_glycoprotein,SARS-CoV-2,0,0.0
6z43,Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with the H11-D4 nanobody. Non-polymer only hexamer with 6 chains. The H11-D4 nanobody shows neutralising activity for the SARS-CoV-2 virus. Another relevant structure is 6yz5 which is the H11-D4 nanobody in complex with the SARS-CoV-2 receptor binding domain. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6z43,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6z43,surface_glycoprotein,SARS-CoV-2,0,0.0
6z97,EM structure of the prefusion SARS-CoV-2 spike glycoprotein. Homo trimer with 3 chains. It is suspected that the destruction of the prefusion spike will lead to the neutralization of the SARS-CoV-2 Virus. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6z97,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6z97,surface_glycoprotein,SARS-CoV-2,0,4.94
6zb4,A SARS-CoV-2 spike protein in closed conformation with a C1 symmetry. A homo trimer with three chains. The precence of linoleic acid in all three binding pockets of the S trimer was confirmed for this structure. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zb4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zb4,surface_glycoprotein,SARS-CoV-2,0,0.0
6zb5,A SARS-CoV-2 spike protein in closed conformation with a C3 symmetry. Homo trimer with three chains. The model revealed additional density in the RBDs. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zb5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zb5,surface_glycoprotein,SARS-CoV-2,0,1.0
6zdg,"EM structure of the dimeric and trimeric complexes of the largely structurally disordered spike ectodomain bound with the antibody EY6A. Non polymer only nonamer, spike with three chains and antibody with a heavy and a light chain with three chains each. The EY6A antibody mimics S2 binding ot the RBD and spikes lose structural integrity. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zdg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zdg,surface_glycoprotein,SARS-CoV-2,0,0.0
6zdh,"EM structure of SARS-CoV-2 spike glycoprotein in complex with the neutralizing antibody EY6A Fab. Non polymer only nonamer, spike with three chains and antibody with a heavy and a light chain with three chains each. The antibody is a candidate therapeutic for COVID-19 and binds to the RBD. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zdh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zdh,surface_glycoprotein,SARS-CoV-2,0,4.55
6zfo,EM structure of an association of two complexes SARS-CoV-2 disordered spike ectodomain with the antibody EY6A fab. Non-polymer only trimer with 6 chains. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zfo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zfo,surface_glycoprotein,SARS-CoV-2,0,0.0
6zge,EM structure of an uncleavable spike glycoprotein of SARS-CoV-2 in closed conformation. Homo trimer with 3 chains. Homo trimer with 3 chains. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zge,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zge,surface_glycoprotein,SARS-CoV-2,0,2.22
6zgg,A cleaved spike glycoprotein precursor by furin-like cellular proteases for SARS-CoV-2. It is a homo trimer molecule with 3 chains. The structure is reported with one receptor binding domain erected. Two other relevant structures are 6zgi and 6zgh which are also furin cleaved spike proteins. 6zgi is in a closed conformation and 6zgh is in an intermediate conformation. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zgg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zgg,surface_glycoprotein,SARS-CoV-2,0,0.0
6zgh,EM structure of a furin cleaved spike protein of SARS-CoV-2 in Intermediate conformation. Homo trimer with three chains. Structure was used for a comparison with the closely related bat virus RaTG13. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zgh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zgh,surface_glycoprotein,SARS-CoV-2,0,0.0
6zgi,EM structure of a furin cleaved spike protein of SARS-CoV-2 in a closed conformation. Homo trimer with three chains. Structure was used for a comparison between SARS-CoV-2 and bat RatG13 structures. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zgi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zgi,surface_glycoprotein,SARS-CoV-2,0,1.66
6zhd,"EM structure of SARS-CoV-2 Spike protein bound to the Nanobody H11-H4. Non polymer only hexamer, spike with three chains and Nanobody with three chains. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zhd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zhd,surface_glycoprotein,SARS-CoV-2,0,10.0
6zow,"Cryo-EM structure of a trimeric spike glycoprotein in prefusion state. For a flexibility analysis of the prefusion state, prior cryo-EM data were re-analyzed (6VSB; 6ZOW). Glycan chains on the S2 fusion unit could be extended compared to former structures. Flexibility analysis revealed a concerted motion involving the RBD, N-terminal domain (NTD) and subdomain 1 and 2 (SD1 & SD2) around the 1-RBD-up state.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zow,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zow,surface_glycoprotein,SARS-CoV-2,0,0.0
6zox,"Cryo-EM structure of a disulfide-stabilized SARS-CoV-2 spike protein trimer containing two disulfide-bond mutants (G413C; V987C) and a single Arg S1/S2 cleavage site. The disulfide-bonded spike protein is trapped in a closed, prefusion state. Related PDB Structures are 6ZOX, 6ZOZ, 6ZOY, 6ZP1, 6ZP0, 6ZP2 referring to disulfide-bonded and non-disulfide-bonded spike structures.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zox,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zox,surface_glycoprotein,SARS-CoV-2,0,18.0
6zoy,"EM structure SARS-CoV-2 spike protein trimer disulphide stabilized, disulphide bond mutant in closed state. Homo trimer with three chains. Structures of disulfide stabilized proteins reveal distinct closed and locked conformations.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zoy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zoy,surface_glycoprotein,SARS-CoV-2,0,0.0
6zoz,"EM structure SARS-CoV-2 spike protein trimer disulphide stabilized, disulphide bond mutant in locked state. Homo trimer with three chains. Structures of disulfide stabilized proteins reveal distinct closed and locked conformations.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zoz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zoz,surface_glycoprotein,SARS-CoV-2,0,6.0
6zp0,"Cryo-EM structure of a SARS-CoV-2 trimeric spike protein with a single Arg S1/S2 cleavage site in a closed state. Negatively charged residues D427 and D428 in the RBD, in proximity to positively charged K986 may electrostatically stabilize the closed form. Related PDB Structures are 6ZOX, 6ZOZ, 6ZOY, 6ZP1, 6ZP0, 6ZP2 referring to disulfide-bonded and non-disulfide-bonded spike structures. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zp0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zp0,surface_glycoprotein,SARS-CoV-2,0,9.0
6zp1,"Cryo-EM structure of SARS-CoV-2 spike protein trimer in the closed state with a single Arg S1/S2 cleavage site and two mutated stabilizing prolines (K986P, V987P). Related PDB Structures are 6ZOX, 6ZOZ, 6ZOY, 6ZP1, 6ZP0, 6ZP2 referring to disulfide-bonded and non-disulfide-bonded spike structures",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zp1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zp1,surface_glycoprotein,SARS-CoV-2,0,9.0
6zp2,"Cryo-EM structure of SARS-CoV-2 Spike protein trimer with two mutated stabilizing prolines (K986P, V987P) and a single Arg S1/S2 cleavage site in the locked state. Related PDB structures are 6ZOX, 6ZOZ, 6ZOY, 6ZP1, 6ZP0, 6ZP2 referring to disulphide-bonded and non-disulfide-bonded spike structures",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zp2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zp2,surface_glycoprotein,SARS-CoV-2,0,3.0
6zp5,"Cryo-EM structure of a trimeric spike glycoprotein in a prefusion closed conformation state with 1-receptor-binding domain (RBD) up. For a flexibility analysis of the prefusion state, prior cryo-EM data were re-analyzed (6VSB; 6ZOW). Analysis revealed a concerted motion involving the RBD, N-terminal domain (NTD) and subdomain 1 and 2 (SD1 & SD2) around the 1-RBD-up state.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zp5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zp5,surface_glycoprotein,SARS-CoV-2,0,0.0
6zp7,EM structure of SARS-CoV-2 spike protein in prefusion state with one open up conformation. Homo trimer with three chains. Structure was used for a flexibility analysis. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zp7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zp7,surface_glycoprotein,SARS-CoV-2,0,0.0
6zwv,"Cryo EM structure of the SARS-CoV-2 spike protein on intact virions, 3 Closed RBDs. Homo trimer with three chains. Structure reveals the conformations of the spike protein on the virions. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zwv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zwv,surface_glycoprotein,SARS-CoV-2,0,2.97
6zxn,"Cryo EM structure of the SARS-CoV-2 spike protein bound to the neutralizing nanobodies Ty1. Non polymer only hexamer, spike protein with three chains and nanobody Ty1 with three chains. The alpaca derived single domain antibody fragment Ty1 specifically targets the RBD of the SARS-CoV-2 spike preventing ACE2 engagement. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/6zxn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zxn,surface_glycoprotein,SARS-CoV-2,0,0.0
7a29,"EM structure of SARS-CoV-2 spike protein bound to neutralizing nanobodies (Sb23)with a 1up conformation of the RBD. A non-polymer only hexamer structure, spike and Sb23 both have 3 chains each. Sb23 binds competitively in the ACE2 binding site. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a29,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a29,surface_glycoprotein,SARS-CoV-2,0,0.0
7a4n,"Cyro EM structure of a prefusion SARS-CoV-2 Spike protein stabilized with the point mutations, D614N, R682S, R685G, A892P, A942P and V987P. Homo trimer with three chains.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a4n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a4n,surface_glycoprotein,SARS-CoV-2,0,1.0
7a5r,"EM structure of SARS-CoV-2 spike protein in complex with the antibody CR3022 Fab. Non polymer only hexamer, spike with two chains and antibody with a heavy and a light chain with two chains each. Antibody that was prepared for SARS-CoV-1 it binds to SARS-CoV-2 but does not neutralize it. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a5r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a5r,surface_glycoprotein,SARS-CoV-2,0,0.0
7a5s,"EM structure of SARS-CoV-2 spike protein in complex with the antibody CR3022. Non polymer only hexamer, spike protein with two chains. Antibody with two heavy and two light chains. Antibody selected from a group of SARS-CoV monoclonal antibodies with the ability to bind to the ectodomain of the SARS-CoV-2 spike protein. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a5s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a5s,surface_glycoprotein,SARS-CoV-2,0,4.0
7a91,"The dissociated S1 domain of the SARS-CoV-2 spike protein bound to the cell-surface receptor ACE2. A non-polymer only dimer the spike and the receptor both have one chain each. The interaction between S1 domain and ACE2 is important for the fusion of viral and host membranes. Another important structure is 7a92, it shows the same structure with a different refinement. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a91,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a91,surface_glycoprotein,SARS-CoV-2,0,0.0
7a92,Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement). Binding of ACE2 to the furin-cleaved form of the SARS-CoV-2 spike protein using cryo-electron microscopy.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a92,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a92,surface_glycoprotein,SARS-CoV-2,0,0.0
7a93,"EM structure of the SARS-CoV-2 spike glycoprotein with two erect RBDs. Homo trimer with three chains. Structure is part of a graphic that shows the sequential steps in ACE2 binding, related Structures to this graphic are 7a98, 7a97, 7a92, 7a91, 7a94, 7a95 and 7a96. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a93,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a93,surface_glycoprotein,SARS-CoV-2,0,0.0
7a94,"EM structure of a SARS-CoV-2 spike glycoprotein bound to one cell-surface receptor ACE2. Non-polymer only tetramer, the spike protein have three chains and the receptor one. An SARS-CoV-2 infection is initiated by virus binding to ACE2.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a94,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a94,surface_glycoprotein,SARS-CoV-2,0,3.0
7a95,"EM structure of SARS-CoV-2 spike glycoprotein bound to one ACE2 and one RBD in clockwise direction. Non polymer only tetramer, spike protein with three chains and ACE2 with one chain. SARS-CoV-2 infections are initiated by virus binding to ACE2 cell surface receptors. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a95,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a95,surface_glycoprotein,SARS-CoV-2,0,2.0
7a96,"EM structure of SARS-CoV-2 spike glycoprotein bound to one ACE2 with one RBD erect in anticlockwise direction. Non Polymer only tetramer, spike with three chains and ACE2 with one chain. Structure is part of a graphic that shows the sequential steps in ACE2 binding. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a96,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a96,surface_glycoprotein,SARS-CoV-2,0,1.0
7a97,"EM structure of a SARS-CoV-2 spike glycoprotein bound to two cell-surface receptor ACE2. Non-polymer only tetramer, the spike protein have three chains and the receptor one. An SARS-CoV-2 infection is initiated by virus binding to ACE2.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a97,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a97,surface_glycoprotein,SARS-CoV-2,0,1.0
7a98,"EM structure of a SARS-CoV-2 spike glycoprotein bound to three cell-surface receptor ACE2. Non-polymer only tetramer, the spike protein have three chains and the receptor one. An SARS-CoV-2 infection is initiated by virus binding to ACE2.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a98,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a98,surface_glycoprotein,SARS-CoV-2,0,0.0
7ad1,"Cyro EM structure of a prefusion SARS-CoV-2 Spike protein, one up trimer stabilized with the point mutations, D614N, R682S, R685G, A892P, A942P and V987P. Homo trimer with three chains.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ad1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ad1,surface_glycoprotein,SARS-CoV-2,0,0.0
7byr,EM structure of SARS-CoV-2 spike ectodomain trimer in complex with the antibody BD-23-Fab (heavy and light chain). Non-polymer only pentamer with 5 chains. The BD-23-Fab antibody overlaps with the ACE2 binding site. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7byr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7byr,surface_glycoprotein,SARS-CoV-2,0,0.0
7c2l,Cryo-EM structure of a trimeric spike glycoprotein of SARS-CoV-2 in complex with a monoclonal antibody named 4A8. The monoclonal antibody binds the N-terminal domain (NTD) of the spike protein with potent neutralizing activity. The structure was solved with a resolution of 3.1 Å.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7c2l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c2l,surface_glycoprotein,SARS-CoV-2,0,0.0
7c8d,"Cryo EM structure of SARS-CoV-2 receptor binding domain with the cat ACE2. Non polymer only dimer, spike protein with one chain and cat ACE2 with one chain. The ACE2 from various species could bind to SARS-COV-2 RBD, the cat ACE2 showed a similar binding mode as the human one. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7c8d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c8d,surface_glycoprotein,SARS-CoV-2,0,0.0
7cah,"EM structure of SARS-CoV-2 spike protein bound to the interface of a humanized monoclonal antibody H014 fab. Non polymer only trimer, spike protein with one Chain and antibody with one heavy and one light chain. The antibody H014 prevents attachment of SARS-CoV-2 to its host cell receptors by engaging the RBD. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cah,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cah,surface_glycoprotein,SARS-CoV-2,0,0.0
7cai,"EM structure of SARS-CoV-2 spike trimer with two RBDs in open state in complex with two H014 antibodies. Non polymer only heptamer, spike with three chains, antibodies with one light chain and one heavy chain each. The humanized monoclonal antibody H014 neutralizes SARS-CoV-2 by engaging the S RBD it also reduced SARS-CoV-2 titers in the infected lungs. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cai,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cai,surface_glycoprotein,SARS-CoV-2,0,0.0
7cak,"EM structure of SARS-CoV-2 S trimer with three RBDs in the open state in a complex with three H014 Fab. Non polymer only nonamer, spike with three chains and antibodies with a light and a heavy chain with three chains each. The antibody H014 prevents attachment of SARS-CoV-2 to its host cell receptors by engaging the RBD. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cak,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cak,surface_glycoprotein,SARS-CoV-2,0,3.0
7chh,"Cryo EM structure of SARS-CoV-2 S-6P in complex with the antibody BD-368-2. Non polymer only nonamer, spike with three chains, antibody with heavy and light chain with three chains each. BD-368-2 fully blocks ACE2 recognition. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7chh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chh,surface_glycoprotein,SARS-CoV-2,0,0.0
7cn9,"Cyro-EM structure of the SARS-CoV-2 spike ectodomain. A homo trimer with three chains. Structure was used to test the binding affinity of the lectin FRIL to the SARS-CoV-2 S protein, the affinitiy is stronger with N-glycans. FRIL has anti-influenza and anti SARS-CoV-2 activity. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cn9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cn9,surface_glycoprotein,SARS-CoV-2,0,0.0
7ct5,"EM structure of SARS-CoV-2 spike protein in complex with T-ACE2. Hetero hexamer, spike with three chains and ACE2 witch three chains. Engineered trimeric ACE2 (T-ACE2) binds to the spike and locks it in Three up conformation.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ct5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ct5,surface_glycoprotein,SARS-CoV-2,0,0.0
7jji,EM structure of SARS-CoV-2 3Q-2P full lenght spike vaccine candidate prefusion spike trimer in C3 symmetry. Homo trimer with three chains. This protein was engineered from the full length SARS-CoV-2 spike gene and modified at the S1/S2 polybasic cleavage site. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jji,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jji,surface_glycoprotein,SARS-CoV-2,0,0.0
7jjj,EM structure of SARS-CoV-2-3Q-2P full length dimers of spike trimers. Homo hexamer with six chains. 3Q-2P-spike is a vaccine candidate that was engineered from the full lenght SARS-CoV-2 spike gene. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jjj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jjj,surface_glycoprotein,SARS-CoV-2,0,0.0
7jv2,"EM structure of SARS-CoV-2 spike protein in complex with the S2H13 neutralizing antibody Fab fragment. A non-polymer only trimer structure the fab fragment has a heavy and a light chain, the spike has one chain. This structures helps to understand the neutralization process of SARS-CoV. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jv2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jv2,surface_glycoprotein,SARS-CoV-2,0,0.0
7jv4,"EM structure of SARS-CoV-2 spike protein (open RBD) in complex with the S2H13 neutralizing antibody Fab fragment. A non-polymer only trimer structure the fab fragment has a heavy and a light chain, the spike has one chain. This structures helps to understand the neutralization process of SARS-CoV. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jv4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jv4,surface_glycoprotein,SARS-CoV-2,0,1.0
7jv6,"EM structure of SARS-CoV-2 spike protein in complex with the S2H13 neutralizing antibody Fab fragment in a closed conformation. A non-polymer only nonamer structure the fab fragment has a heavy and a light chain with 3 chains each, the spike has three chain. This structures helps to understand the neutralization process of SARS-CoV. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jv6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jv6,surface_glycoprotein,SARS-CoV-2,0,0.0
7jva,"EM structure of SARS-CoV-2 spike protein in complex with the S2A4 neutralizing antibody fab fragment (local refinement). Non polymer only trimer, spike with three chains, antibody with a heavy and a light chain with three chains each. Structure is related to 7jvc which shows also this antibody in complex with the SARS-CoV-2 spike. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jva,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jva,surface_glycoprotein,SARS-CoV-2,0,0.0
7jvc,"EM structure of SARS-CoV-2 spike protein in complex with the S2A4 neutralizing antibody fab fragment. Non polymer only nonamer, spike with three chains, antibody with a heavy and a light chain with three chains each. The antibody have a weak neutralizing effect on SARS-CoV-2 by competing with the ACE2 for binding to the RBD. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jvc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jvc,surface_glycoprotein,SARS-CoV-2,0,0.0
7jw0,"EM structure of SARS-CoV-2 spike protein in complex with the neutralizing antibody Fab fragment S304. Non polymer only nonamer, spike with three Chains and antibody with a light and a heavy chain with three chains each. Antibody with a cross reaction with the antibodies S2A4, S2X35 and CR3022. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jw0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jw0,surface_glycoprotein,SARS-CoV-2,0,6.0
7jwb,"EM structure of SARS-CoV-2 spike domain with engineered trimerized variable heavy binder. Non polymer only tetramer, spike protein with three chains, human heavy variable domain with one chain. Variable heavy domain binders are neutralizing SARS-CoV-2 by binding an RBD at the ACE2 binding site. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jwb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jwb,surface_glycoprotein,SARS-CoV-2,0,3.0
7jzl,"EM structure of SARS-CoV-2 spike protein 2 RBDs open in complex with the miniprotein inhibitor LCB1. Hetero hexamer, spike protein with three chains and LCB1 with three chains. The mini-inhibitors show advantages over antibodies as potential therapeutics in terms of storage and production.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jzl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jzl,surface_glycoprotein,SARS-CoV-2,0,0.0
7jzm,"EM structure of SARS-CoV-2 spike protein in complex with the mini inhibitor LCB3. Non polymer only dimer, spike and mini inhibitor have one chain each. The mini inhibitor LCB3 binds to the RBD but with a lower affinity then 7jzu. Another related structure is 7jzn it shows the same complex but with two open RBDs. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jzm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jzm,surface_glycoprotein,SARS-CoV-2,0,0.0
7jzn,"SARS-CoV-2 spike in complex with LCB3 (2RBDs open), interaction between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and the human angiotensin-converting enzyme 2 (ACE2).",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jzn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jzn,surface_glycoprotein,SARS-CoV-2,0,1.0
7jzu,"EM structure of SARS-CoV-2 spike protein in complex with a designed miniprotein inhibitor LCB1. Non polymer only dimer, spike protein and mini inhibitor have both one chain each. LCB1 binds with a high affinity to the RBD in a competed manner with ACE2. A related structure is 7jzl it shows the same complex with 2 RBDs open. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jzu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jzu,surface_glycoprotein,SARS-CoV-2,0,0.0
7k43,"EM structure of SARS-CoV-2 spike protein in complex with the S2M11 neutralizing antibody Fab fragment. Non polymer only nonamer, spike with three chains and antibody with a heavy and a light chain with three chains each. S2M11 competitively blocks ACE2 attachment and it locks the spike in a closed conformation. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k43,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k43,surface_glycoprotein,SARS-CoV-2,0,12.0
7k45,"SARS-CoV-2 spike protein in complex with the S2E12 neutralizing antibody Fab fragment. Non polymer only trimer, antibody with one heavy and one light chain. Spike glycoprotein with one chain. S2E12 traps the spike in a conformation that cannot bind ACE2. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k45,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k45,surface_glycoprotein,SARS-CoV-2,0,0.0
7k4n,"SARS-CoV-2 spike protein in complex with the S2E12 neutralizing antibody Fab fragment. Non polymer only nonamer, antibody with three heavy and three light chain. Spike glycoprotein with three chains. S2E12 traps the spike in a conformation that cannot bind ACE2. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k4n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k4n,surface_glycoprotein,SARS-CoV-2,0,0.0
7k8s,"EM structure of SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment C002 (state 1). Non polymer only nonamer, spike protein with three chains and antibody with a heavy and a light chain with three chains each. Antibody has a similar S binding orientation as the antibody C144 which shows an unusual binding characteristic. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8s,surface_glycoprotein,SARS-CoV-2,0,5.0
7k8t,"Structure of SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment C002 (State2). Non polymer only nonamer, spike protein with three chains and antibody with a heavy and a light chain with three chains each. Antibody has a similar S binding orientation as the antibody C144 which shows an unusual binding characteristic. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8t,surface_glycoprotein,SARS-CoV-2,0,3.0
7k8u,"EM structure of SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment C104. Non polymer only pentamer, spike protein with three chains and antibody with one heavy and one light chain. Antibody has a similar S binding orientation as the antibody C144 which shows an unusual binding characteristic. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8u,surface_glycoprotein,SARS-CoV-2,0,2.0
7k8v,"EM structure of SARS-CoV-2 2S 2P trimer in complex with the human neutralizing antibody Fab fragment C110. Non polymer only heptamer, spike with three chains and antibody with a heavy and a light chain with two chains each. C110 epitiope showed similarities with class3 and class2 Nabs, it binds distal to the ACE2-binding motif and could potentially steric interfere with ACE2. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8v,surface_glycoprotein,SARS-CoV-2,0,0.0
7k8w,"EM structure of SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment C119. Non polymer only heptamer, spike with three chains and antibody with a heavy and a light chain with two chains each. Antibody has a similar S binding orientation as the antibody C144 which shows an unusual binding characteristic. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8w,surface_glycoprotein,SARS-CoV-2,0,2.0
7k8x,"Structure of SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment C121 in state 1. Non polymer only heptamer, spike with three chains and antibody with a heavy and a light chain with two chains each.  Antibody has a similar S binding orientation as the antibody C144 which shows an unusual binding characteristic. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8x,surface_glycoprotein,SARS-CoV-2,0,0.0
7k8y,"EM structure of SARS-CoV-2 spike protein 2P trimer in complex with the human antibody Fab fragment C121 in state 2. Non polymer only pentamer, spike protein with three chains. Antibody with one heavy and one light chain. The antibody binds to the RBD and prevents ACE2 interactions. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8y,surface_glycoprotein,SARS-CoV-2,0,0.0
7k8z,"EM structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment C135. Non polymer only heptamer, spike with three chains and antibody with a heavy and a light chain with two chains each. The antibody is a potent NAb that showed distinct binding properties from class 1, 2 and 4 NAbs. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k8z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8z,surface_glycoprotein,SARS-CoV-2,0,0.0
7k90,"EM structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment C144. Non polymer only nonamer, spike protein with three chains and antibody with a heavy and a light chain with three chains each. The antibody has a different binding mode then other class 1 NAbs. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k90,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k90,surface_glycoprotein,SARS-CoV-2,0,11.0
7kdg,"Em structure of SARS-CoV-2 spike protein trimer, RBD down with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdg,surface_glycoprotein,SARS-CoV-2,0,3.0
7kdh,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, without the P986-987 mutation. A homo trimer with three chains. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdh,surface_glycoprotein,SARS-CoV-2,0,3.0
7kdi,"Em structure of SARS-CoV-2 spike protein trimer, three RBD down fully cleaved by furin, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdi,surface_glycoprotein,SARS-CoV-2,0,2.0
7kdj,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdj,surface_glycoprotein,SARS-CoV-2,0,1.0
7kdk,"Em structure of SARS-CoV-2 spike protein trimer, RBD down, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdk,surface_glycoprotein,SARS-CoV-2,0,8.0
7kdl,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kdl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kdl,surface_glycoprotein,SARS-CoV-2,0,2.0
7ke4,"Em structure of SARS-CoV-2 spike protein trimer, RBD down, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ke4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ke4,surface_glycoprotein,SARS-CoV-2,0,8.0
7ke6,"Em structure of SARS-CoV-2 spike protein trimer, three RBDs down, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ke6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ke6,surface_glycoprotein,SARS-CoV-2,0,4.0
7ke7,"Em structure of SARS-CoV-2 spike protein trimer, RBD down, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ke7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ke7,surface_glycoprotein,SARS-CoV-2,0,5.0
7ke8,"Em structure of SARS-CoV-2 spike protein trimer, one RBD down without the P986-987 mutation. A homo trimer with three chains. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ke8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ke8,surface_glycoprotein,SARS-CoV-2,0,5.0
7ke9,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ke9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ke9,surface_glycoprotein,SARS-CoV-2,0,0.0
7kea,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kea,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kea,surface_glycoprotein,SARS-CoV-2,0,6.0
7keb,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7keb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7keb,surface_glycoprotein,SARS-CoV-2,0,4.0
7kec,"Em structure of SARS-CoV-2 spike protein trimer, RBD up, with the D614G mutation and without the P986-987 mutation. A homo trimer with three chains. The D614G mutation alters the spike conformation in SARS-CoV-2 and the protease cleavage susceptibility at the S1/S2 junction. The P986-987 mutation has a stabilizing effect but the paper shows that even without the mutation the protein is stable. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kec,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kec,surface_glycoprotein,SARS-CoV-2,0,0.0
7kj2,"EM structure of a SARS-CoV-2 spike glycoprotein bound to one cell-surface receptors ACE2. Non polymer only pentamer, spike protein with three chains ACE2 with two chains. Paper suggest that engineered trimeric ACE2 may be a anti SARS-CoV-2 agent. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kj2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kj2,surface_glycoprotein,SARS-CoV-2,0,11.0
7kj3,"EM structure of a SARS-CoV-2 spike glycoprotein bound to two cell-surface receptors ACE2. Non polymer only pentamer, spike protein with three chains ACE2 with two chains. Paper suggest that engineered trimeric ACE2 may be a anti SARS-CoV-2 agent. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kj3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kj3,surface_glycoprotein,SARS-CoV-2,0,11.0
7kj4,"EM structure of a SARS-CoV-2 spike glycoprotein bound to three cell-surface receptors ACE2. Non polymer only pentamer, spike protein with three chains ACE2 with two chains. Paper suggest that engineered trimeric ACE2 may be a anti SARS-CoV-2 agent. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kj4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kj4,surface_glycoprotein,SARS-CoV-2,0,14.0
7kj5,EM structure of the SARS-CoV-2 spike glycoprotein prefusion with one RBD in up conformation. Homo trimer with three chains. ,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kj5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kj5,surface_glycoprotein,SARS-CoV-2,0,10.0
7kkk,"EM structure of SARS-CoV-2 spike protein in complex with the neutralizing synthetic nanobody Nb6. Non polymer only hexamer, spike with three chains and nanobody with three chains. Nb6 binds spikes in a fully inactive conformation so they are incapable of binding ACE2. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kkk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kkk,surface_glycoprotein,SARS-CoV-2,0,3.0
7kkl,"EM structure of SARS-CoV-2 spike protein in complex with the neutralizing nanobody mNb6. Non polymer only hexamer, spike with three chains and nanobody with three chains. mNb6 is a mutated form of Nb6 (7kkk) which binds with an increased affinity.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kkl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kkl,surface_glycoprotein,SARS-CoV-2,0,0.0
7kl9,"EM structure of SARS-CoV-2 spike 6P trimer in complex with an ACE2 decoy protein CTC-445.2 in state 4. A non-polymer only hexamer, spike protein with three chains and the CTC-445.2 inhibitor protein with three chains. CTC-445.2 is a promising decoy for neutralizing pathogens like SARS-CoV-2. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kl9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kl9,surface_glycoprotein,SARS-CoV-2,0,2.0
7k0r,Nsp15 bound to uridine-5'-monophosphate and phosphate ions.,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7k0r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7k0r,endornase,SARS-CoV-2,0,0.0
7cyq,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity. EM structure of SARS-CoV-2 extended RTC assembled by nsp7-nsp8­-nsp12-nsp13-RNA and a single RNA-binding protein, nsp9. Hetero nonamer, Helicase and NSP8 with two chains each and RNA polymerase, NSP7, NSP9 and both RNAs with one chain each. NSP9 binds tightly to NSP12 NiRAN, allowing NSP9 N-terminus to insert into the catalytic center of NSP12 which inhibits activity.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7cyq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7cyq,nsp8,SARS-CoV-2,0,61.0
6zol,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with the human ribosomal 40S subunit and 18s rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/6zol,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/6zol,leader_protein,SARS-CoV-2,0,0.0
7jqb,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with the 40S subunit of rabbit ribosome and rRNA. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/7jqb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7jqb,leader_protein,SARS-CoV-2,0,0.0
7jqc,"This electron microscopy structure shows the SARS-CoV-2 leader protein (Nsp1) in a complex with CrPV IRES and rabbit 40S ribosome. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",ELECTRON MICROSCOPY,pdb/leader_protein/SARS-CoV-2/7jqc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7jqc,leader_protein,SARS-CoV-2,0,0.0
7b3b,Electron microscopy structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase (Rdrp) with Remdesivir at position -3 (structure 1). Structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase with Remdesivir at position -3 (structure 1). Cryo-electron microscopy is used to establish the molecular mechanism of remdesivir-induced RdRp stalling.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7b3b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7b3b,nsp8,SARS-CoV-2,0,0.0
7b3c,Electron microscopy structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase (Rdrp) with Remdesivir at position -4 (structure 2). Structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase with Remdesivir at position -4 (structure 2). Cryo-electron microscopy is used to establish the molecular mechanism of remdesivir-induced RdRp stalling.,ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7b3c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7b3c,nsp8,SARS-CoV-2,0,0.0
7b3d,"Electron microscopy structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase (Rdrp) with AMP at position -4 (structure 3). Structure of elongating SARS-CoV-2 RNA-dependent RNA polymerase with AMP at position -4 (structure 3). Cryo-electron microscopy is used to establish the molecular mechanism of remdesivir-induced RdRp stalling. EM structure of SARS-CoV-2 RNA dependent RNA polymerase with AMP at position -4. Hetero pentamer, five macromolecules with one chain each. This structure together with 7b3c and 7b3b is part of a study to analyse the mechanism of the drug Remdesivir.",ELECTRON MICROSCOPY,pdb/nsp8/SARS-CoV-2/7b3d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7b3d,nsp8,SARS-CoV-2,0,0.0
7l1f,The SARS-CoV-2 RNA-dependent RNA polymerase with nsp7 and nsp8 in complex with 4 Remdesivir monophosphate.,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7l1f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7l1f,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,3.0
6m3w,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/6m3w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6m3w,surface_glycoprotein,SARS-CoV,0,0.0
7a25,"EM structure of a SARS-CoV-2 spike protein bound to the neutralizing sybodies Sb23. Hetero hexamer, spike protein with three chains and Sybody with three chains. Sb23 competes with ACE2 for RBD binding of the spike protein.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7a25,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7a25,surface_glycoprotein,SARS-CoV-2,0,0.0
7b17,This electron microscopy structure shows the SARS-CoV spike RBD bound to two neutralizing nanobodies. Nanobodies have size and cost advantages over conventional antibodies. This structure shows an in vitro generated multivalent neutralizing nanobody that targets the receptor-binding domain of the SARS-CoV-2 spike protein.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7b17,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b17,surface_glycoprotein,SARS-CoV-2,0,0.0
7bh9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7bh9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bh9,surface_glycoprotein,SARS-CoV-2,0,0.0
7bnm,"Closed conformation of D614G SARS-CoV-2 spike protein. In the D614 spike""closed"",  conformation, RBD is partly buried and cannot bind to the human ACE2 receptor. The D614G substitution promotes""opening"",  of the spike, priming it for binding to the receptor ACE2",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7bnm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bnm,surface_glycoprotein,SARS-CoV-2,0,9.08
7bnn,"EM structure of SARS-CoV-2 spike with 1 erect RBD and the D614G substitution. Homo trimer, spike protein with three chains. The substitution has a greater conformational flexibility and a more open conformation wich may results in the exposure of epitopes for additional neutralizing antibodies. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7bnn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bnn,surface_glycoprotein,SARS-CoV-2,0,0.0
7bno,"EM structure of SARS-CoV-2 spike protein with the D614G substitution with 2 erect RBDs. Homo trimer, spike with three chains. The substitution has a greater conformational flexibility and a more open conformation wich may results in the exposure of epitopes for additional neutralizing antibodies.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7bno,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bno,surface_glycoprotein,SARS-CoV-2,0,0.0
7cab,"This electron microscopy structure shows the SARS-CoV-2 spike protein bound to the potent therapeutic antibody 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose. Cryo-electron microscopy characterization of the SARS-CoV-2 S trimer in complex with the H014 Fab fragment unveiled a previously uncharacterized conformational epitope, which was only accessible when the RBD was in an open conformation.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cab,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cab,surface_glycoprotein,SARS-CoV-2,0,0.0
7cac,"EM structure of SARS-CoV-2 S trimer with one RBD open state in complex with one H014 Fab. Hetero pentamer, spike protein with three chains and Fab with one heavy and one light chain. H014 reduces SARS-CoV-2 titers in infected lungs and prevent pulmonary pathology in a human ACE2 mouse model.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cac,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cac,surface_glycoprotein,SARS-CoV-2,0,0.0
7cwl,"EM structure of SARS-CoV-2 spike protein RBD in close state in complex with the P17 fab. Hetero nonamer, fab P17 with a heavy and a light chain with three chains each, spike with three chains. The fab can together with S309 and H014 form a neutralization cluster on the RBD of trimeric S.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwl,surface_glycoprotein,SARS-CoV-2,0,4.0
7cwm,"EM structure of SARS-CoV-2 spike protein one RBD in open state and two RBDs in closed state in complex with Fab P17. Hetero nonamer, spike with three chains and Fab with a heavy and a light chain with three chains each. P17 together with H014 revealed that neutralization was achieved by S1 shielding and conformational locking.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwm,surface_glycoprotein,SARS-CoV-2,0,2.0
7cwn,"EM structure of SARS-CoV-2 spike protein in complex with the antibodiy coctail P17-H014 Fab. Hetero pentadecamer, spike with three chains, P17 and H014 antibody with a heavy and a light chain with three chains each. P17 together with H014 revealed that neutralization was achieved by S1 shielding and conformational locking.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwn,surface_glycoprotein,SARS-CoV-2,0,8.0
7cwo,"Structure of SC2 spike protein receptor binding domain (RBD) and P17 fab complex. The study exploited antibody cooperativity to develop a therapeutic antibody cocktail against SC2.  SC2 spike in complex with H014 and P17 antibodies achieved synergistic neutralization by S1 shielding and conformational locking, blocking receptor attachment and viral membrane fusion, conferring high potency as well as robustness against viral mutation escape.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwo,surface_glycoprotein,SARS-CoV-2,0,0.0
7cws,SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail. Structure with 3.40 Å resolution from electron microscopy (Reconstruction Method: single particle).,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cws,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cws,surface_glycoprotein,SARS-CoV-2,0,10.0
7cwu,SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail. Structure with 3.50 Å resolution from electron microscopy (Reconstruction Method: single particle).,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwu,surface_glycoprotein,SARS-CoV-2,0,4.0
7czp,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czp,surface_glycoprotein,SARS-CoV-2,0,0.0
7czq,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czq,surface_glycoprotein,SARS-CoV-2,0,0.0
7czr,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czr,surface_glycoprotein,SARS-CoV-2,0,0.0
7czs,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czs,surface_glycoprotein,SARS-CoV-2,0,8.0
7czt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czt,surface_glycoprotein,SARS-CoV-2,0,0.0
7czu,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czu,surface_glycoprotein,SARS-CoV-2,0,0.0
7czv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czv,surface_glycoprotein,SARS-CoV-2,0,8.0
7czw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czw,surface_glycoprotein,SARS-CoV-2,0,0.0
7czx,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czx,surface_glycoprotein,SARS-CoV-2,0,1.0
7czy,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czy,surface_glycoprotein,SARS-CoV-2,0,0.0
7czz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7czz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7czz,surface_glycoprotein,SARS-CoV-2,0,8.0
7d00,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d00,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d00,surface_glycoprotein,SARS-CoV-2,0,0.0
7d03,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d03,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d03,surface_glycoprotein,SARS-CoV-2,0,1.0
7d0b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d0b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d0b,surface_glycoprotein,SARS-CoV-2,0,1.0
7d0c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d0c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d0c,surface_glycoprotein,SARS-CoV-2,0,0.0
7d0d,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d0d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d0d,surface_glycoprotein,SARS-CoV-2,0,0.0
7dcc,"EM structure of SARS-CoV-2 spike protein with three RBDs up each bound to a 3C1 Fab. Hetero nonamer, spike with three chains, Fab with three heavy and three light chains. 3C1 bind to RBD through adapting feasible orientation of 3C1 or coordinated conformational changes.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dcc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dcc,surface_glycoprotein,SARS-CoV-2,0,0.0
7dcx,"EM structure of SARS-CoV-2 spike protein with two RBDs up and one RBD down, each RBD is bound to a 3C1 fab. Hetero nonamer, spike with three chains, fab with three heavy and three light chains. 3C1 bind to RBD through adapting feasible orientation of 3C1 or coordinated conformational changes.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dcx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dcx,surface_glycoprotein,SARS-CoV-2,0,0.0
7dd2,"S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab. The study identifies and characterizes two groups of MAbs, 2H2 and 3C1 targeting RBD on the SC2 spike (S) protein. It reveals MAb-triggered stepwise allosteric rearrangements of the S trimer",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dd2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dd2,surface_glycoprotein,SARS-CoV-2,0,0.0
7dd8,"EM structure of SARS-CoV-2 spike protein with one RBD up and two RBDs down, the up RBD is bound with a 3c1 fab. Hetero pentamer, 3C1 with one heavy and one light chain, spike with three chains. The structure shows that the binding of the 3C1 fab could induce a further 32.3° outward tilt of the up RBD.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dd8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dd8,surface_glycoprotein,SARS-CoV-2,0,0.0
7ddd,SARS-CoV-2 Spike protein at close state. Identification and characterization of two groups of mouse neutralizing monoclonal antibodies (MAbs) targeting the receptor-binding domain (RBD) on the SARS-CoV-2 spike (S) protein. MAbs 2H2 and 3C1 bind distinct epitopes and are compatible in formulating a noncompeting antibody cocktail.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ddd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ddd,surface_glycoprotein,SARS-CoV-2,0,0.0
7ddn,This electron microscopy structure shows the SARS-CoV-2 spike protein at open state.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ddn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ddn,surface_glycoprotein,SARS-CoV-2,0,0.0
7df3,EM structure of the spike gycloprotein S trimer in closed prefusion state. Homo trimer with three chains. The structure shows counterclockwise rotation with an RBD inward shift toward the central axis.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7df3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7df3,surface_glycoprotein,SARS-CoV-2,0,0.0
7df4,Structure of SC2 S-ACE2 complex. The SC2 trimeric spike (S) glycoprotein interacts with the human ACE2 receptor to mediate viral entry into host cells. The RBD T470-T478 loop and Y505 act as viral determinants for specific recognition of SC2 RBD by ACE2.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7df4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7df4,surface_glycoprotein,SARS-CoV-2,0,0.0
7dk3,"SARS-CoV-2 S trimer in S-open state. Cryo-EM structures of a tightly closed SARS-CoV-2 S-trimer with packed fusion peptide, and an ACE2-bound S-trimer at 2.7 Å and 3.8 Å resolution.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dk3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk3,surface_glycoprotein,SARS-CoV-2,0,0.0
7dk4,"This electron microscopy structure shows the SARS-CoV-2 spike protein in complex with 2H2-F3a fragments. Two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dk4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk4,surface_glycoprotein,SARS-CoV-2,0,0.0
7dk5,"Identification and characterization of two groups of mouse neutralizing monoclonal antibodies (MAbs) targeting the receptor-binding domain (RBD) on the SARS-CoV-2 spike (S) protein. S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dk5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk5,surface_glycoprotein,SARS-CoV-2,0,0.0
7dk6,"This electron microscopy structure shows the SARS-CoV-2 spike protein in complex with 2H2-Fab fragments. Two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dk6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk6,surface_glycoprotein,SARS-CoV-2,0,0.0
7dk7,"EM structure of SARS-CoV-2 spike with three RBDs up and each RBD binds with a 2H2 Fab. Hetero nonamer, spike with three chains, Fab with heavy and light chain with three chains each. 2H2 Fab is bound on the top of the RBD.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dk7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk7,surface_glycoprotein,SARS-CoV-2,0,0.0
7jwy,"This electron microscopy structure shows the SARS-CoV-2 spike homo trimer at pH 4.5. A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike. The SARS-CoV-2 spike has 10% the unfolding enthalpy of a globular protein at physiological pH, where it is recognized by antibodies and up to 10-times more unfolding enthalpy at endosomal pH, where it sheds such antibodies, suggesting that the spike evades potentially neutralizing antibody through a pH-dependent mechanism of conformational masking.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7jwy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jwy,surface_glycoprotein,SARS-CoV-2,0,0.0
7kmb,"EM structure of SARS-Cov-2 trimer spike bound to ACE2. Hetero dimer, ACE2 and spike with one chain each. RBD-ACE2 region in greater detail through focused refinement and particle expansion with C3 symmetry applied.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kmb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmb,surface_glycoprotein,SARS-CoV-2,0,0.0
7kmk,This electron microscopy structure shows the SARS-CoV-2 spike protein in complex with Fab 15033-7 bound to two RBDs.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kmk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmk,surface_glycoprotein,SARS-CoV-2,0,1.0
7kml,"Cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, with three RBDs bound.  protein engineering and modular design principles that have led to the development of synthetic bivalent and tetravalent nAbs against SARS-CoV-2.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kml,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kml,surface_glycoprotein,SARS-CoV-2,0,0.0
7kms,"EM structure of SARS-CoV-2 trimer spike bound to three ACE2 at pH 7,4. Hetero hexamer, ACE2 with three chains and spike with three chains. This structure is part of a study with reveals a pH-dependent switch to mediate endosomal positioning of RBDs.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kms,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kms,surface_glycoprotein,SARS-CoV-2,0,0.0
7kmz,"EM strucutre of SARS-CoV-2 trimer in complex with double ACE2 at pH 7,4. Hetero pentamer, ACE2 with two chains and the spike with three chains. This structure is part of a study with reveals a pH-dependent switch to mediate endosomal positioning of RBDs.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kmz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmz,surface_glycoprotein,SARS-CoV-2,0,0.0
7knb,"Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4, cryo-electron microscopy structures-at serological and endosomal pH-delineating spike recognition of up to three ACE2 molecules.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7knb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7knb,surface_glycoprotein,SARS-CoV-2,0,0.0
7kne,"EM structure of SARS-CoV-2 trimer spike in complex with ACE2 at pH 5,5. Hetero tetramer, spike with three chains ACE2 with one. This structure is part of a study with reveals a pH-dependent switch to mediate endosomal positioning of RBDs.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kne,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kne,surface_glycoprotein,SARS-CoV-2,0,0.0
7knh,This electron microscopy structure shows the SARS-CoV-2 Double ACE2-Bound Spike Trimer at pH 5.5. Cryo-EM Structures of SARS-CoV-2 Spike with and without ACE2 reveal a pH-dependent switch to mediate endosomal positioning of RBDs.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7knh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7knh,surface_glycoprotein,SARS-CoV-2,0,1.0
7kni,"EM structure of SARS-CoV-2 Trimer spike bound with Triple ACE2 at pH 5,5. Hetero hexamer, spike with three chains and ACE 2 with three chains. This structure is part of a study with reveals a pH-dependent switch to mediate endosomal positioning of RBDs.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kni,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kni,surface_glycoprotein,SARS-CoV-2,0,0.0
7ks9,Cryo-EM structure of prefusion SC2 spike glycoprotein in complex with 910-30 Fab. 910-30 Fab targets the SC2 ACE2 receptor binding site and binds to RBD in the up position. Bound to the SC2 spike trimer 910-30 recognizes a glycan-independent region. Native heavy:light chain pairings is important for ACE2 binding competition and for spike disassembly.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ks9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ks9,surface_glycoprotein,SARS-CoV-2,0,0.0
7ksg,"EM structure of SARS-CoV-2 spike protein in complex with Nanobodies E (not mentioned what nanobodies). Hetero hexamer, spike with three chains and nanobody with three chains.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ksg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ksg,surface_glycoprotein,SARS-CoV-2,0,1.0
7kxj,SARS-CoV-2 spike protein in complex with Fab 15033-7,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kxj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kxj,surface_glycoprotein,SARS-CoV-2,0,2.0
7kxk,"EM structure of SARS-CoV-2 spike protein RBD 2 up and 1 down conformation in complex with Fab 15033-7. Hetero nonamer, spike glycoprotein with three chains and Fab with heavy and light chain with three chains each. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kxk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kxk,surface_glycoprotein,SARS-CoV-2,0,3.0
7l02,This electron microscopy structure shows the SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12. A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l02,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l02,surface_glycoprotein,SARS-CoV-2,0,4.0
7l06,"EM structure of SARS-CoV-2 ectodomain bound to two copies of domain swapped antibody 2G12. Hetero undecamer, spike with three chains and antibody with heavy and light chain with four chains each. 2G12 revealed a quaternary glycan epitope on the spike S2 domain involving multiple protomers. ",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l06,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l06,surface_glycoprotein,SARS-CoV-2,0,2.0
7l09,"EM structure of SARS-CoV-2 2P S ectodomain bound to the domain swapped antibody 2G12 from masked 3D refinement. Hetero heptamer, spike with three chains and antobody with a heavy and a light chain with two chains each. Structure is part of a study which reveals a new epitope on the SARS-CoV-2 spike that can be targeted for vaccine design.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l09,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l09,surface_glycoprotein,SARS-CoV-2,0,4.0
7l3n,"EM structure of SARS-CoV-2 spike protein bound to the antibody LY-CoV555. Hetero pentamer, spike protein with three chains and antibody with one heavy and one light chain. Ly-CoV555 has a high affinity binding to the receptor binding domain and ACE2 binding inhibition.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l3n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l3n,surface_glycoprotein,SARS-CoV-2,0,0.0
7l7f,"Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1. Preclinical vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles. BNT162b1 encodes a soluble, secreted trimerized receptor-binding domain (known as the RBD-foldon).",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l7f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l7f,surface_glycoprotein,SARS-CoV-2,0,0.0
7l7k,"Cryo-EM structure of protein encoded by vaccine candidate BNT162b2. Preclinical development of two vaccine candidates (BNT162b1 and BNT162b2) that contain nucleoside-modified messenger RNA that encodes immunogens derived from the spike glycoprotein (S) of SARS-CoV-2, formulated in lipid nanoparticles. BNT162b2 encodes the full-length transmembrane S glycoprotein.",ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l7k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l7k,surface_glycoprotein,SARS-CoV-2,0,0.0
7laa,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7laa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7laa,surface_glycoprotein,SARS-CoV-2,0,9.0
7lab,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lab,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lab,surface_glycoprotein,SARS-CoV-2,0,4.0
7lcn,Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1. Isolated potent NAbs against the receptor-binding domain (RBD) and the N-terminal domain (NTD) of SARS-CoV-2 spike protein from individuals with acute or convalescent SARS-CoV-2 or a history of SARS-CoV-1 infection.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lcn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lcn,surface_glycoprotein,SARS-CoV-2,0,26.0
7ld1,This electron microscopy structure shows the SARS-CoV-2 Spike protein in complex with Receptor Binding Domain antibody DH1047.,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ld1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ld1,surface_glycoprotein,SARS-CoV-2,0,8.0
7ls9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ls9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ls9,surface_glycoprotein,SARS-CoV-2,0,9.0
7lss,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lss,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lss,surface_glycoprotein,SARS-CoV-2,0,2.0
7nd3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd3,surface_glycoprotein,SARS-CoV-2,0,0.0
7nd4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd4,surface_glycoprotein,SARS-CoV-2,0,3.0
7nd5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd5,surface_glycoprotein,SARS-CoV-2,0,0.0
7nd6,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd6,surface_glycoprotein,SARS-CoV-2,0,0.0
7nd7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd7,surface_glycoprotein,SARS-CoV-2,0,0.0
7nd8,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd8,surface_glycoprotein,SARS-CoV-2,0,0.0
7nd9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nd9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nd9,surface_glycoprotein,SARS-CoV-2,0,0.0
7nda,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nda,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nda,surface_glycoprotein,SARS-CoV-2,0,0.0
7ndb,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ndb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ndb,surface_glycoprotein,SARS-CoV-2,0,0.0
7ndc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ndc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ndc,surface_glycoprotein,SARS-CoV-2,0,0.0
7ndd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ndd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ndd,surface_glycoprotein,SARS-CoV-2,0,1.0
7msw,,ELECTRON MICROSCOPY,pdb/nsp2/SARS-CoV-2/7msw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp2/SARS-CoV-2/7msw,nsp2,SARS-CoV-2,0,0.0
7msx,,ELECTRON MICROSCOPY,pdb/nsp2/SARS-CoV-2/7msx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp2/SARS-CoV-2/7msx,nsp2,SARS-CoV-2,0,0.0
7opl,,ELECTRON MICROSCOPY,pdb/nsp1/SARS-CoV/7opl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp1/SARS-CoV/7opl,nsp1,SARS-CoV,0,18.01
7dfh,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dfh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dfh,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
7ozv,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7ozv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7ozv,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,8.35
7ozu,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7ozu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7ozu,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,6.34
7dte,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dte,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dte,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,7.87
7oyg,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7oyg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7oyg,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
7dfg,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dfg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dfg,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,4.22
7m4r,,ELECTRON MICROSCOPY,pdb/protein_e/SARS-CoV-2/7m4r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV-2/7m4r,protein_e,SARS-CoV-2,0,0.0
7krn,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7krn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7krn,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,9.24
7rdz,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdz,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,6.09
7re0,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re0,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,13.09
7re1,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re1,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,7.99
7re3,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re3,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,10.89
7rdy,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdy,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,8.09
7rdx,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7rdx,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,7.33
7kro,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7kro,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7kro,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
7re2,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7re2,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,8.77
7krp,,ELECTRON MICROSCOPY,pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7krp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase-nsp7-nsp8-rna_polymerase/SARS-CoV-2/7krp,helicase-nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,0.0
7o7z,,ELECTRON MICROSCOPY,pdb/rna/SARS-CoV-2/7o7z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7o7z,rna,SARS-CoV-2,0,0.0
7o7y,,ELECTRON MICROSCOPY,pdb/rna/SARS-CoV-2/7o7y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7o7y,rna,SARS-CoV-2,0,0.0
7o81,,ELECTRON MICROSCOPY,pdb/rna/SARS-CoV-2/7o81,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7o81,rna,SARS-CoV-2,0,0.0
7o80,,ELECTRON MICROSCOPY,pdb/rna/SARS-CoV-2/7o80,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7o80,rna,SARS-CoV-2,0,0.0
7n06,,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7n06,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n06,endornase,SARS-CoV-2,0,3.31
7me0,,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7me0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7me0,endornase,SARS-CoV-2,0,0.0
7n33,,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7n33,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n33,endornase,SARS-CoV-2,0,4.01
7rb2,,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7rb2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7rb2,endornase,SARS-CoV-2,0,7.71
7rb0,,ELECTRON MICROSCOPY,pdb/endornase/SARS-CoV-2/7rb0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7rb0,endornase,SARS-CoV-2,0,12.84
7n0d,,ELECTRON MICROSCOPY,pdb/exonuclease-nsp10/SARS-CoV-2/7n0d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7n0d,exonuclease-nsp10,SARS-CoV-2,0,4.17
7n0c,,ELECTRON MICROSCOPY,pdb/exonuclease-nsp10/SARS-CoV-2/7n0c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7n0c,exonuclease-nsp10,SARS-CoV-2,0,6.87
7n0b,,ELECTRON MICROSCOPY,pdb/exonuclease-nsp10/SARS-CoV-2/7n0b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7n0b,exonuclease-nsp10,SARS-CoV-2,0,8.42
7dwz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dwz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dwz,surface_glycoprotein,SARS-CoV-2,0,0.0
7mji,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mji,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mji,surface_glycoprotein,SARS-CoV-2,0,2.85
7lxy,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lxy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lxy,surface_glycoprotein,SARS-CoV-2,0,0.0
7e7d,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e7d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e7d,surface_glycoprotein,SARS-CoV-2,0,1.0
7e39,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e39,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e39,surface_glycoprotein,SARS-CoV-2,0,15.81
7vx1,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vx1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vx1,surface_glycoprotein,SARS-CoV-2,0,8.2
7ezv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ezv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ezv,surface_glycoprotein,SARS-CoV-2,0,14.56
7vx9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vx9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vx9,surface_glycoprotein,SARS-CoV-2,0,12.48
7krs,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7krs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7krs,surface_glycoprotein,SARS-CoV-2,0,7.0
7lyp,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyp,surface_glycoprotein,SARS-CoV-2,0,5.0
7mlz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mlz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mlz,surface_glycoprotein,SARS-CoV-2,0,17.71
7dzx,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dzx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dzx,surface_glycoprotein,SARS-CoV-2,0,0.0
7sod,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sod,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sod,surface_glycoprotein,SARS-CoV-2,0,0.0
7lwu,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwu,surface_glycoprotein,SARS-CoV-2,0,6.0
7b18,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7b18,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b18,surface_glycoprotein,SARS-CoV-2,0,12.94
7oan,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7oan,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oan,surface_glycoprotein,SARS-CoV-2,0,8.1
7eb5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eb5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eb5,surface_glycoprotein,SARS-CoV-2,0,7.54
7lqv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lqv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lqv,surface_glycoprotein,SARS-CoV-2,0,0.0
7dx1,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx1,surface_glycoprotein,SARS-CoV-2,0,0.0
7ej5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ej5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ej5,surface_glycoprotein,SARS-CoV-2,0,7.11
7lwp,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwp,surface_glycoprotein,SARS-CoV-2,0,9.0
7sob,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sob,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sob,surface_glycoprotein,SARS-CoV-2,0,12.0
7dx2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx2,surface_glycoprotein,SARS-CoV-2,0,0.0
7krq,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7krq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7krq,surface_glycoprotein,SARS-CoV-2,0,9.0
7e3l,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e3l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3l,surface_glycoprotein,SARS-CoV-2,0,9.05
7lwv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwv,surface_glycoprotein,SARS-CoV-2,0,6.0
7v8b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v8b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v8b,surface_glycoprotein,SARS-CoV-2,0,6.24
7lww,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lww,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lww,surface_glycoprotein,SARS-CoV-2,0,5.0
7v77,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v77,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v77,surface_glycoprotein,SARS-CoV-2,0,8.45
7n9c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n9c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n9c,surface_glycoprotein,SARS-CoV-2,0,11.0
7vx7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vx7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vx7,surface_glycoprotein,SARS-CoV-2,0,1.0
7m6g,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m6g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6g,surface_glycoprotein,SARS-CoV-2,0,6.57
7ey4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ey4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ey4,surface_glycoprotein,SARS-CoV-2,0,10.52
7k9i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k9i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k9i,surface_glycoprotein,SARS-CoV-2,0,12.23
7dx4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx4,surface_glycoprotein,SARS-CoV-2,0,0.0
7l56,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l56,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l56,surface_glycoprotein,SARS-CoV-2,0,1.0
7lyk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyk,surface_glycoprotein,SARS-CoV-2,0,5.0
7mjh,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mjh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mjh,surface_glycoprotein,SARS-CoV-2,0,3.39
7soa,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7soa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7soa,surface_glycoprotein,SARS-CoV-2,0,0.0
7m6i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m6i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6i,surface_glycoprotein,SARS-CoV-2,0,8.91
7dx5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx5,surface_glycoprotein,SARS-CoV-2,0,0.0
7mjj,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mjj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mjj,surface_glycoprotein,SARS-CoV-2,0,3.2
7r8n,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7r8n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r8n,surface_glycoprotein,SARS-CoV-2,0,12.54
7l2d,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l2d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l2d,surface_glycoprotein,SARS-CoV-2,0,5.0
7lqw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lqw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lqw,surface_glycoprotein,SARS-CoV-2,0,1.0
7lwl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwl,surface_glycoprotein,SARS-CoV-2,0,4.0
7d4g,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7d4g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d4g,surface_glycoprotein,SARS-CoV-2,0,1.0
7n01,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n01,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n01,surface_glycoprotein,SARS-CoV-2,0,25.0
7mkl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mkl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mkl,surface_glycoprotein,SARS-CoV-2,0,10.18
7ey5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ey5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ey5,surface_glycoprotein,SARS-CoV-2,0,0.0
7v88,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v88,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v88,surface_glycoprotein,SARS-CoV-2,0,11.88
7ljr,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ljr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ljr,surface_glycoprotein,SARS-CoV-2,0,9.0
7fg7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fg7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fg7,surface_glycoprotein,SARS-CoV-2,0,0.0
7e5s,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e5s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e5s,surface_glycoprotein,SARS-CoV-2,0,20.93
7vnd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vnd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vnd,surface_glycoprotein,SARS-CoV-2,0,9.03
7v89,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v89,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v89,surface_glycoprotein,SARS-CoV-2,0,8.9
7akd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7akd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7akd,surface_glycoprotein,SARS-CoV-2,0,0.0
7mdw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mdw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mdw,surface_glycoprotein,SARS-CoV-2,0,8.16
7v7r,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7r,surface_glycoprotein,SARS-CoV-2,0,6.26
7dwy,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dwy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dwy,surface_glycoprotein,SARS-CoV-2,0,0.0
7cyp,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cyp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cyp,surface_glycoprotein,SARS-CoV-2,0,32.12
7so9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7so9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7so9,surface_glycoprotein,SARS-CoV-2,0,0.0
7v7v,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7v,surface_glycoprotein,SARS-CoV-2,0,6.01
7mtd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mtd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mtd,surface_glycoprotein,SARS-CoV-2,0,2.25
7sof,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sof,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sof,surface_glycoprotein,SARS-CoV-2,0,1.0
7vxe,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxe,surface_glycoprotein,SARS-CoV-2,0,1.79
7v7e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7e,surface_glycoprotein,SARS-CoV-2,0,7.77
7n62,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n62,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n62,surface_glycoprotein,SARS-CoV-2,0,20.57
7lyq,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyq,surface_glycoprotein,SARS-CoV-2,0,3.0
7sbq,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbq,surface_glycoprotein,SARS-CoV-2,0,7.05
7v7h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7h,surface_glycoprotein,SARS-CoV-2,0,7.18
7edj,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7edj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7edj,surface_glycoprotein,SARS-CoV-2,0,8.5
7edi,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7edi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7edi,surface_glycoprotein,SARS-CoV-2,0,7.96
7v7o,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7o,surface_glycoprotein,SARS-CoV-2,0,6.99
7k9j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k9j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k9j,surface_glycoprotein,SARS-CoV-2,0,8.81
7v8c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v8c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v8c,surface_glycoprotein,SARS-CoV-2,0,10.77
7v7z,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7z,surface_glycoprotein,SARS-CoV-2,0,9.13
7l58,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l58,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l58,surface_glycoprotein,SARS-CoV-2,0,2.0
7lyo,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyo,surface_glycoprotein,SARS-CoV-2,0,6.0
7fdh,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fdh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fdh,surface_glycoprotein,SARS-CoV-2,0,12.96
7n1v,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1v,surface_glycoprotein,SARS-CoV-2,0,4.27
7n1y,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1y,surface_glycoprotein,SARS-CoV-2,0,10.61
7me7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7me7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7me7,surface_glycoprotein,SARS-CoV-2,0,3.62
7e7b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e7b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e7b,surface_glycoprotein,SARS-CoV-2,0,3.0
7sbs,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbs,surface_glycoprotein,SARS-CoV-2,0,7.2
7soe,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7soe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7soe,surface_glycoprotein,SARS-CoV-2,0,0.0
7e5r,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e5r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e5r,surface_glycoprotein,SARS-CoV-2,0,18.76
7v7p,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7p,surface_glycoprotein,SARS-CoV-2,0,5.56
7eb0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eb0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eb0,surface_glycoprotein,SARS-CoV-2,0,7.08
7lwq,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwq,surface_glycoprotein,SARS-CoV-2,0,6.0
7eaz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eaz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eaz,surface_glycoprotein,SARS-CoV-2,0,8.19
7e3c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e3c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3c,surface_glycoprotein,SARS-CoV-2,0,0.0
7r8m,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7r8m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r8m,surface_glycoprotein,SARS-CoV-2,0,15.77
7ly0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ly0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ly0,surface_glycoprotein,SARS-CoV-2,0,0.0
7n1w,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1w,surface_glycoprotein,SARS-CoV-2,0,6.08
7mtc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mtc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mtc,surface_glycoprotein,SARS-CoV-2,0,1.55
7f63,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7f63,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7f63,surface_glycoprotein,SARS-CoV-2,0,12.45
7krr,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7krr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7krr,surface_glycoprotein,SARS-CoV-2,0,18.0
7n9b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n9b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n9b,surface_glycoprotein,SARS-CoV-2,0,3.0
7e3b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e3b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3b,surface_glycoprotein,SARS-CoV-2,0,0.0
7rr0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7rr0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rr0,surface_glycoprotein,SARS-CoV-2,0,0.0
7vxd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxd,surface_glycoprotein,SARS-CoV-2,0,7.44
7my3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7my3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7my3,surface_glycoprotein,SARS-CoV-2,0,0.0
7mej,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mej,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mej,surface_glycoprotein,SARS-CoV-2,0,4.44
7lwk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwk,surface_glycoprotein,SARS-CoV-2,0,2.0
7n9e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n9e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n9e,surface_glycoprotein,SARS-CoV-2,0,3.0
7dzw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dzw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dzw,surface_glycoprotein,SARS-CoV-2,0,0.0
7rw2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7rw2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rw2,surface_glycoprotein,SARS-CoV-2,0,6.28
7vxf,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxf,surface_glycoprotein,SARS-CoV-2,0,7.45
7fg2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fg2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fg2,surface_glycoprotein,SARS-CoV-2,0,0.0
7vx5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vx5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vx5,surface_glycoprotein,SARS-CoV-2,0,7.35
7ej4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ej4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ej4,surface_glycoprotein,SARS-CoV-2,0,9.93
7lwn,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwn,surface_glycoprotein,SARS-CoV-2,0,6.0
7edf,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7edf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7edf,surface_glycoprotein,SARS-CoV-2,0,6.71
7e23,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e23,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e23,surface_glycoprotein,SARS-CoV-2,0,14.04
7s0c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7s0c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s0c,surface_glycoprotein,SARS-CoV-2,0,13.46
7mte,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mte,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mte,surface_glycoprotein,SARS-CoV-2,0,2.16
7e8c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e8c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e8c,surface_glycoprotein,SARS-CoV-2,0,13.58
7ey0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ey0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ey0,surface_glycoprotein,SARS-CoV-2,0,17.4
7v84,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v84,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v84,surface_glycoprotein,SARS-CoV-2,0,5.87
7nta,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nta,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nta,surface_glycoprotein,SARS-CoV-2,0,7.01
7lym,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lym,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lym,surface_glycoprotein,SARS-CoV-2,0,2.0
7lwt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwt,surface_glycoprotein,SARS-CoV-2,0,5.0
7p77,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p77,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p77,surface_glycoprotein,SARS-CoV-2,0,3.76
7lx5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lx5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lx5,surface_glycoprotein,SARS-CoV-2,0,0.0
7lrt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lrt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lrt,surface_glycoprotein,SARS-CoV-2,0,9.07
7ra8,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ra8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ra8,surface_glycoprotein,SARS-CoV-2,0,0.0
7k9k,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k9k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k9k,surface_glycoprotein,SARS-CoV-2,0,11.03
7lws,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lws,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lws,surface_glycoprotein,SARS-CoV-2,0,3.0
7p40,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p40,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p40,surface_glycoprotein,SARS-CoV-2,0,0.0
7v7i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7i,surface_glycoprotein,SARS-CoV-2,0,8.26
7dx7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx7,surface_glycoprotein,SARS-CoV-2,0,0.0
7m8j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m8j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m8j,surface_glycoprotein,SARS-CoV-2,0,0.0
7v8a,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v8a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v8a,surface_glycoprotein,SARS-CoV-2,0,9.96
7e9t,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e9t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e9t,surface_glycoprotein,SARS-CoV-2,0,28.44
7n0h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n0h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n0h,surface_glycoprotein,SARS-CoV-2,0,0.0
7v7f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7f,surface_glycoprotein,SARS-CoV-2,0,7.3
7sbt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbt,surface_glycoprotein,SARS-CoV-2,0,7.85
7v7j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7j,surface_glycoprotein,SARS-CoV-2,0,9.57
7v7t,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7t,surface_glycoprotein,SARS-CoV-2,0,6.76
7v7u,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7u,surface_glycoprotein,SARS-CoV-2,0,7.26
7sbo,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbo,surface_glycoprotein,SARS-CoV-2,0,8.87
7v79,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v79,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v79,surface_glycoprotein,SARS-CoV-2,0,7.47
7lwm,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwm,surface_glycoprotein,SARS-CoV-2,0,4.0
7phg,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7phg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7phg,surface_glycoprotein,SARS-CoV-2,0,0.0
7sbr,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbr,surface_glycoprotein,SARS-CoV-2,0,8.85
7ntc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ntc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ntc,surface_glycoprotein,SARS-CoV-2,0,7.53
7lyl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyl,surface_glycoprotein,SARS-CoV-2,0,4.0
7m6f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m6f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6f,surface_glycoprotein,SARS-CoV-2,0,10.44
7soc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7soc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7soc,surface_glycoprotein,SARS-CoV-2,0,0.0
7v7s,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7s,surface_glycoprotein,SARS-CoV-2,0,7.41
7dx0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx0,surface_glycoprotein,SARS-CoV-2,0,0.0
7m6h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m6h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6h,surface_glycoprotein,SARS-CoV-2,0,14.11
7v7q,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7q,surface_glycoprotein,SARS-CoV-2,0,6.08
7v7d,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7d,surface_glycoprotein,SARS-CoV-2,0,6.82
7lrs,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lrs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lrs,surface_glycoprotein,SARS-CoV-2,0,8.7
7ral,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ral,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ral,surface_glycoprotein,SARS-CoV-2,0,0.0
7vxa,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxa,surface_glycoprotein,SARS-CoV-2,0,12.94
7lxw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lxw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lxw,surface_glycoprotein,SARS-CoV-2,0,0.0
7dwx,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dwx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dwx,surface_glycoprotein,SARS-CoV-2,0,4.0
7n1x,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1x,surface_glycoprotein,SARS-CoV-2,0,9.75
7r7n,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7r7n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r7n,surface_glycoprotein,SARS-CoV-2,0,0.0
7v7g,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7g,surface_glycoprotein,SARS-CoV-2,0,7.69
7v7n,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7n,surface_glycoprotein,SARS-CoV-2,0,6.7
7kqe,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kqe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kqe,surface_glycoprotein,SARS-CoV-2,0,8.0
7fdi,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fdi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fdi,surface_glycoprotein,SARS-CoV-2,0,15.36
7l2f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l2f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l2f,surface_glycoprotein,SARS-CoV-2,0,1.0
7m42,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m42,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m42,surface_glycoprotein,SARS-CoV-2,0,6.71
7p78,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p78,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p78,surface_glycoprotein,SARS-CoV-2,0,4.55
7sbp,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbp,surface_glycoprotein,SARS-CoV-2,0,6.02
7v81,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v81,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v81,surface_glycoprotein,SARS-CoV-2,0,10.75
7vne,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vne,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vne,surface_glycoprotein,SARS-CoV-2,0,11.31
7dx3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx3,surface_glycoprotein,SARS-CoV-2,0,0.0
7p7b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p7b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p7b,surface_glycoprotein,SARS-CoV-2,0,3.09
7lwo,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwo,surface_glycoprotein,SARS-CoV-2,0,5.0
7p79,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p79,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p79,surface_glycoprotein,SARS-CoV-2,0,4.27
7eya,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eya,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eya,surface_glycoprotein,SARS-CoV-2,0,7.98
7v7a,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v7a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v7a,surface_glycoprotein,SARS-CoV-2,0,7.74
7cwt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cwt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cwt,surface_glycoprotein,SARS-CoV-2,0,16.0
7n1q,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1q,surface_glycoprotein,SARS-CoV-2,0,4.13
7dzy,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dzy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dzy,surface_glycoprotein,SARS-CoV-2,0,0.0
7v76,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v76,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v76,surface_glycoprotein,SARS-CoV-2,0,6.1
7mjg,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mjg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mjg,surface_glycoprotein,SARS-CoV-2,0,2.81
7v78,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v78,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v78,surface_glycoprotein,SARS-CoV-2,0,6.37
7dx9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx9,surface_glycoprotein,SARS-CoV-2,0,0.0
7p7a,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7p7a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p7a,surface_glycoprotein,SARS-CoV-2,0,4.69
7n1u,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1u,surface_glycoprotein,SARS-CoV-2,0,6.48
7vnc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vnc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vnc,surface_glycoprotein,SARS-CoV-2,0,9.83
7m71,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m71,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m71,surface_glycoprotein,SARS-CoV-2,0,5.0
7v26,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v26,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v26,surface_glycoprotein,SARS-CoV-2,0,7.32
7sbl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbl,surface_glycoprotein,SARS-CoV-2,0,8.27
7mjk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mjk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mjk,surface_glycoprotein,SARS-CoV-2,0,2.91
7sbk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sbk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sbk,surface_glycoprotein,SARS-CoV-2,0,6.3
7fg3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fg3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fg3,surface_glycoprotein,SARS-CoV-2,0,0.0
7dx8,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx8,surface_glycoprotein,SARS-CoV-2,0,0.0
7eh5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eh5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eh5,surface_glycoprotein,SARS-CoV-2,0,10.14
7lxx,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lxx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lxx,surface_glycoprotein,SARS-CoV-2,0,0.0
7lwi,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwi,surface_glycoprotein,SARS-CoV-2,0,4.0
7dx6,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dx6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dx6,surface_glycoprotein,SARS-CoV-2,0,0.0
7v85,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v85,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v85,surface_glycoprotein,SARS-CoV-2,0,12.71
7n8h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n8h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n8h,surface_glycoprotein,SARS-CoV-2,0,0.0
7v82,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v82,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v82,surface_glycoprotein,SARS-CoV-2,0,10.1
7n1t,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n1t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1t,surface_glycoprotein,SARS-CoV-2,0,5.92
7v80,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v80,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v80,surface_glycoprotein,SARS-CoV-2,0,8.68
7ly2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7ly2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ly2,surface_glycoprotein,SARS-CoV-2,0,3.0
7m7b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m7b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m7b,surface_glycoprotein,SARS-CoV-2,0,5.0
7fdk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fdk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fdk,surface_glycoprotein,SARS-CoV-2,0,17.73
7l2e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l2e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l2e,surface_glycoprotein,SARS-CoV-2,0,25.0
7my2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7my2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7my2,surface_glycoprotein,SARS-CoV-2,0,7.0
7lxz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lxz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lxz,surface_glycoprotein,SARS-CoV-2,0,0.0
7m8k,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m8k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m8k,surface_glycoprotein,SARS-CoV-2,0,0.0
7cyh,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7cyh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cyh,surface_glycoprotein,SARS-CoV-2,0,28.17
7fdg,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fdg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fdg,surface_glycoprotein,SARS-CoV-2,0,23.14
7vx4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vx4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vx4,surface_glycoprotein,SARS-CoV-2,0,7.42
7v87,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v87,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v87,surface_glycoprotein,SARS-CoV-2,0,6.35
7s0e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7s0e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s0e,surface_glycoprotein,SARS-CoV-2,0,21.42
7v2a,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v2a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v2a,surface_glycoprotein,SARS-CoV-2,0,25.31
7edg,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7edg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7edg,surface_glycoprotein,SARS-CoV-2,0,6.81
7b14,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7b14,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b14,surface_glycoprotein,SARS-CoV-2,0,8.6
7n0g,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n0g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n0g,surface_glycoprotein,SARS-CoV-2,0,7.78
7r8o,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7r8o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r8o,surface_glycoprotein,SARS-CoV-2,0,11.86
7n8i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n8i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n8i,surface_glycoprotein,SARS-CoV-2,0,0.0
7mkm,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mkm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mkm,surface_glycoprotein,SARS-CoV-2,0,8.33
7n9t,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n9t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n9t,surface_glycoprotein,SARS-CoV-2,0,4.49
7lyn,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lyn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lyn,surface_glycoprotein,SARS-CoV-2,0,7.0
7eb3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eb3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eb3,surface_glycoprotein,SARS-CoV-2,0,7.84
7v83,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v83,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v83,surface_glycoprotein,SARS-CoV-2,0,9.98
7v86,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7v86,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7v86,surface_glycoprotein,SARS-CoV-2,0,9.25
7l57,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7l57,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l57,surface_glycoprotein,SARS-CoV-2,0,6.0
7k9h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7k9h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k9h,surface_glycoprotein,SARS-CoV-2,0,10.09
7n9a,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n9a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n9a,surface_glycoprotein,SARS-CoV-2,0,0.0
7e3k,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e3k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3k,surface_glycoprotein,SARS-CoV-2,0,1.0
7n5h,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n5h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n5h,surface_glycoprotein,SARS-CoV-2,0,5.0
7kqb,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7kqb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kqb,surface_glycoprotein,SARS-CoV-2,0,14.0
7m6e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m6e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6e,surface_glycoprotein,SARS-CoV-2,0,6.28
7rxd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7rxd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rxd,surface_glycoprotein,SARS-CoV-2,0,9.3
7nt9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7nt9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nt9,surface_glycoprotein,SARS-CoV-2,0,6.27
7n64,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7n64,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n64,surface_glycoprotein,SARS-CoV-2,0,36.44
7lwj,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7lwj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lwj,surface_glycoprotein,SARS-CoV-2,0,5.0
7m0j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7m0j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m0j,surface_glycoprotein,SARS-CoV-2,0,1.0
7eb4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7eb4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eb4,surface_glycoprotein,SARS-CoV-2,0,7.15
7mjm,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mjm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mjm,surface_glycoprotein,SARS-CoV-2,0,2.97
7rkv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7rkv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rkv,surface_glycoprotein,SARS-CoV-2,0,13.97
7s0d,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7s0d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s0d,surface_glycoprotein,SARS-CoV-2,0,18.03
7edh,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7edh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7edh,surface_glycoprotein,SARS-CoV-2,0,6.97
7mm0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7mm0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mm0,surface_glycoprotein,SARS-CoV-2,0,7.07
7e8f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7e8f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e8f,surface_glycoprotein,SARS-CoV-2,0,8.95
7f62,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7f62,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7f62,surface_glycoprotein,SARS-CoV-2,0,19.27
7sg4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/7sg4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7sg4,surface_glycoprotein,SARS-CoV,0,30.0
7cn4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/7cn4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7cn4,surface_glycoprotein,SARS-CoV,0,2.0
7akj,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV/7akj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7akj,surface_glycoprotein,SARS-CoV,0,0.0
7eiz,,ELECTRON MICROSCOPY,pdb/exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase/SARS-CoV-2/7eiz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase/SARS-CoV-2/7eiz,exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase,SARS-CoV-2,0,37.55
7egq,,ELECTRON MICROSCOPY,pdb/exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase/SARS-CoV-2/7egq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase/SARS-CoV-2/7egq,exonuclease-helicase-nsp10-nsp7-nsp8-nsp9-rna_polymerase,SARS-CoV-2,0,23.25
7mjl,,ELECTRON MICROSCOPY,pdb/3c_like_proteinase/SARS-CoV-2/7mjl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mjl,3c_like_proteinase,SARS-CoV-2,0,2.77
7mjn,,ELECTRON MICROSCOPY,pdb/3c_like_proteinase/SARS-CoV-2/7mjn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mjn,3c_like_proteinase,SARS-CoV-2,0,3.22
7dok,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dok,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7dok,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,5.67
7doi,,ELECTRON MICROSCOPY,pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7doi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8-rna_polymerase/SARS-CoV-2/7doi,nsp7-nsp8-rna_polymerase,SARS-CoV-2,0,5.88
7sy4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy4,surface_glycoprotein,SARS-CoV-2,0,2.34
7sxv,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxv,surface_glycoprotein,SARS-CoV-2,0,2.53
7w94,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w94,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w94,surface_glycoprotein,SARS-CoV-2,0,0.0
7sxu,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxu,surface_glycoprotein,SARS-CoV-2,0,2.39
7w9b,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w9b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w9b,surface_glycoprotein,SARS-CoV-2,0,0.0
7q9k,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9k,surface_glycoprotein,SARS-CoV-2,0,5.52
7sxs,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxs,surface_glycoprotein,SARS-CoV-2,0,2.51
7sy0,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy0,surface_glycoprotein,SARS-CoV-2,0,2.34
7sxx,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxx,surface_glycoprotein,SARS-CoV-2,0,3.29
7vxk,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxk,surface_glycoprotein,SARS-CoV-2,0,7.48
7t9j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7t9j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7t9j,surface_glycoprotein,SARS-CoV-2,0,4.49
7wk2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wk2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wk2,surface_glycoprotein,SARS-CoV-2,0,
7w9f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w9f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w9f,surface_glycoprotein,SARS-CoV-2,0,0.0
7w9c,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w9c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w9c,surface_glycoprotein,SARS-CoV-2,0,0.0
7sxy,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxy,surface_glycoprotein,SARS-CoV-2,0,2.81
7wev,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wev,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wev,surface_glycoprotein,SARS-CoV-2,0,
7t9l,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7t9l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7t9l,surface_glycoprotein,SARS-CoV-2,0,3.89
7qo7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7qo7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7qo7,surface_glycoprotein,SARS-CoV-2,0,6.47
7q9j,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9j,surface_glycoprotein,SARS-CoV-2,0,6.19
7w9i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w9i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w9i,surface_glycoprotein,SARS-CoV-2,0,0.0
7faf,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7faf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7faf,surface_glycoprotein,SARS-CoV-2,0,37.0
7vxm,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxm,surface_glycoprotein,SARS-CoV-2,0,7.87
7dqa,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7dqa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dqa,surface_glycoprotein,SARS-CoV-2,0,18.07
7sxt,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxt,surface_glycoprotein,SARS-CoV-2,0,2.67
7wbl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wbl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wbl,surface_glycoprotein,SARS-CoV-2,0,6.79
7w92,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w92,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w92,surface_glycoprotein,SARS-CoV-2,0,0.0
7sy5,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy5,surface_glycoprotein,SARS-CoV-2,0,3.07
7fce,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fce,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fce,surface_glycoprotein,SARS-CoV-2,0,
7sy3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy3,surface_glycoprotein,SARS-CoV-2,0,2.65
7sxz,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxz,surface_glycoprotein,SARS-CoV-2,0,3.23
7w98,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w98,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w98,surface_glycoprotein,SARS-CoV-2,0,0.0
7sn2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sn2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sn2,surface_glycoprotein,SARS-CoV-2,0,7.74
7t9k,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7t9k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7t9k,surface_glycoprotein,SARS-CoV-2,0,3.85
7sn3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sn3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sn3,surface_glycoprotein,SARS-CoV-2,0,5.17
7sxw,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxw,surface_glycoprotein,SARS-CoV-2,0,2.29
7sy1,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy1,surface_glycoprotein,SARS-CoV-2,0,3.05
7sxr,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sxr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sxr,surface_glycoprotein,SARS-CoV-2,0,3.42
7od3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7od3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7od3,surface_glycoprotein,SARS-CoV-2,0,
7q9f,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9f,surface_glycoprotein,SARS-CoV-2,0,4.46
7fet,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fet,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fet,surface_glycoprotein,SARS-CoV-2,0,0.0
7w99,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w99,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w99,surface_glycoprotein,SARS-CoV-2,0,0.0
7q9m,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9m,surface_glycoprotein,SARS-CoV-2,0,4.18
7sy6,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy6,surface_glycoprotein,SARS-CoV-2,0,2.58
7w9e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7w9e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7w9e,surface_glycoprotein,SARS-CoV-2,0,0.0
7wka,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wka,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wka,surface_glycoprotein,SARS-CoV-2,0,
7vxc,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxc,surface_glycoprotein,SARS-CoV-2,0,12.41
7q9p,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9p,surface_glycoprotein,SARS-CoV-2,0,8.93
7tas,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7tas,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7tas,surface_glycoprotein,SARS-CoV-2,0,0.0
7fem,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fem,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fem,surface_glycoprotein,SARS-CoV-2,0,0.0
7sy8,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy8,surface_glycoprotein,SARS-CoV-2,0,2.74
7fcd,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fcd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fcd,surface_glycoprotein,SARS-CoV-2,0,
7sy2,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy2,surface_glycoprotein,SARS-CoV-2,0,2.03
7qo9,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7qo9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7qo9,surface_glycoprotein,SARS-CoV-2,0,
7tb4,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7tb4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7tb4,surface_glycoprotein,SARS-CoV-2,0,7.11
7wk8,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wk8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wk8,surface_glycoprotein,SARS-CoV-2,0,
7sy7,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7sy7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sy7,surface_glycoprotein,SARS-CoV-2,0,3.27
7q9g,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9g,surface_glycoprotein,SARS-CoV-2,0,4.01
7tat,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7tat,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7tat,surface_glycoprotein,SARS-CoV-2,0,1.0
7vxb,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxb,surface_glycoprotein,SARS-CoV-2,0,12.21
7odl,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7odl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7odl,surface_glycoprotein,SARS-CoV-2,0,
7q6e,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q6e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q6e,surface_glycoprotein,SARS-CoV-2,0,3.25
7fae,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7fae,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7fae,surface_glycoprotein,SARS-CoV-2,0,5.0
7vxi,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7vxi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vxi,surface_glycoprotein,SARS-CoV-2,0,2.98
7q9i,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7q9i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q9i,surface_glycoprotein,SARS-CoV-2,0,4.76
7wk3,,ELECTRON MICROSCOPY,pdb/surface_glycoprotein/SARS-CoV-2/7wk3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wk3,surface_glycoprotein,SARS-CoV-2,0,
7k3g,The pentameric structure of the SARS-CoV-2 envelope protein transmembrane domain. The structure was determined by solid-state NMR. The e protein is important for the virus pathogenicity.,SOLID-STATE NMR,pdb/protein_e/SARS-CoV-2/7k3g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV-2/7k3g,protein_e,SARS-CoV-2,0,9.88
2k7x,SARS-CoV main protease C-terminal domain. The structure is reported as a monomeric solution structure.,SOLUTION NMR,pdb/3c_like_proteinase/SARS-CoV/2k7x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2k7x,3c_like_proteinase,SARS-CoV,0,8.0
2liz,SARS-CoV main protease C-terminal domain. The structure is reported as a monomeric solution structure. Extra 2.5 M urea was added.,SOLUTION NMR,pdb/3c_like_proteinase/SARS-CoV/2liz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2liz,3c_like_proteinase,SARS-CoV,0,15.0
1yo4,"SARS Coronavirus ORF 7a coded X4 protein, also known as 7a, U122 or X4. Type-I transmembrane protein with immunoglobulin like beta-sandwich fold. Potential functions of X4 in virus replication and pathogenesis are discussed.",SOLUTION NMR,pdb/hypothetical_protein_sars7a/SARS-CoV/1yo4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/hypothetical_protein_sars7a/SARS-CoV/1yo4,hypothetical_protein_sars7a,SARS-CoV,0,16.91
2gdt,First structure of SARS-CoV NSP1 (leader protein). This NMR structure showed a previously unknown beta barrel fold. The protein has been shown to inihibit the host cell ribosome and change the cell chemistry in various ways. It mediates RNA cleavage. Consensus structure (ensemble deposited as 2HSX).,SOLUTION NMR,pdb/leader_protein/SARS-CoV/2gdt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV/2gdt,leader_protein,SARS-CoV,0,
2hsx,First structure of SARS-CoV NSP1 (leader protein). This NMR structure showed a previously unknown beta barrel fold. The protein has been shown to inihibit the host cell ribosome and change the cell chemistry in various ways. It mediates RNA cleavage. Ensemble of structures (consensus structure deposited as 2GDT).,SOLUTION NMR,pdb/leader_protein/SARS-CoV/2hsx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV/2hsx,leader_protein,SARS-CoV,0,1.0
2gri,NMR strcuture of the Ubl1 of SARS-CoV nsp3. Ubl1 exhibits a ubiquitin-like globular fold of residues 1 to 112 and a flexibly extended glutamic acid-rich domain of residues 113 to 183. The known functional roles of UBl1 in CoV are related to ssRNA binding and interacting with the N-protein.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2gri,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2gri,nsp3,SARS-CoV,0,
2idy,NMR strcuture of the Ubl1 of SARS-CoV nsp3. Ubl1 exhibits a ubiquitin-like globular fold of residues 1 to 112 and a flexibly extended glutamic acid-rich domain of residues 113 to 183. The known functional roles of UBl1 in CoV are related to ssRNA binding and interacting with the N-protein.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2idy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2idy,nsp3,SARS-CoV,0,0.0
2jzd,"The nuclear magnetic resonance (NMR) structure of a central segment of the SARS-CoV nsp3 Mac3 domain. Mac3(513-651) exhibits a macrodomain fold.This domains function is connected to RNA binding, preferentially binds oligo G.",SOLUTION NMR,pdb/nsp3/SARS-CoV/2jzd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2jzd,nsp3,SARS-CoV,0,
2jze,"The nuclear magnetic resonance (NMR) structure of a central segment of the SARS-CoV nsp3 Mac3 domain. Mac3(513-651) exhibits a macrodomain fold.This domains function is connected to RNA binding, preferentially binds oligo G.",SOLUTION NMR,pdb/nsp3/SARS-CoV/2jze,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2jze,nsp3,SARS-CoV,0,1.0
2jzf,"The nuclear magnetic resonance (NMR) structure of a central segment of the SARS-CoV nsp3 Mac3 domain. Mac3(513-651) exhibits a macrodomain fold.This domains function is connected to RNA binding, preferentially binds oligo G. Unlike Mac2 this domain is essential for the replication of the virus",SOLUTION NMR,pdb/nsp3/SARS-CoV/2jzf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2jzf,nsp3,SARS-CoV,0,1.0
2k87,The NMR structure of a globular domain of residues 1071 to 1178 within the previously annotated nucleic acid-binding region (NAB) of nsp3. This domain has been shown to bind ssRNA and to unwind dsDNA. This is the only structure of NAB to date.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2k87,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2k87,nsp3,SARS-CoV,0,
2kaf,NMR structure determinations of the DPUP domain. This domains exact function is unknown to this date.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2kaf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2kaf,nsp3,SARS-CoV,0,
2kqv,NMR structure determinations of the DPUP domain. This domains exact function is unknown to this date.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2kqv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2kqv,nsp3,SARS-CoV,0,
2kqw,NMR structure determinations of the DPUP domain. This domains exact function is unknown to this date.,SOLUTION NMR,pdb/nsp3/SARS-CoV/2kqw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2kqw,nsp3,SARS-CoV,0,
2rnk,"The NMR structure of a central segment of the Mac3 domain in SARS coronavirus nsp3. This domains function is connected to RNA binding, preferentially binds oligo G",SOLUTION NMR,pdb/nsp3/SARS-CoV/2rnk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2rnk,nsp3,SARS-CoV,0,36.0
1ysy,SARS-CoV NSP7 NMR structure showing the full length protein. The NSP12-NSP7-NSP8 complex replicates viral RNA.,SOLUTION NMR,pdb/nsp7/SARS-CoV/1ysy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7/SARS-CoV/1ysy,nsp7,SARS-CoV,0,
2kys,SARS-CoV NSP7 NMR structure showing the full length protein. The NSP12-NSP7-NSP8 complex replicates viral RNA.,SOLUTION NMR,pdb/nsp7/SARS-CoV/2kys,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7/SARS-CoV/2kys,nsp7,SARS-CoV,0,
1ssk,This NMR structure shows the N-terminal RNA-binding domain of SARS-CoV nucleocapsid protein (N). It is a monomer with a length of 158 amino acids and exhibits a five-stranded β-sheet. This structure binds single-stranded RNA to enable the packaging of the viral genome RNA into a helical ribonucleocapsid (RNP).,SOLUTION NMR,pdb/nucleocapsid_protein/SARS-CoV/1ssk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/1ssk,nucleocapsid_protein,SARS-CoV,0,21.5
2jw8,This SAIL-NMR structure shows the C-terminal dimerization domain of SARS-CoV nucleocapsid protein (N). The structure is a homodimer and was modeled by the stereo-array isotope labeling (SAIL) method to determine a high-quality solution structure. The selection criteria for this structure was the fact that it has the least restraint violations.,SOLUTION NMR,pdb/nucleocapsid_protein/SARS-CoV/2jw8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/2jw8,nucleocapsid_protein,SARS-CoV,0,
6yi3,This NMR structure shows the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein (N). The structure is a monomer of one chain. The N-terminal domain provides structural features for RNA binding. The selection criteria for this structure was the fact that it has the least restraint violations.,SOLUTION NMR,pdb/nucleocapsid_protein/SARS-CoV-2/6yi3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6yi3,nucleocapsid_protein,SARS-CoV-2,0,
7acs,N-terminal RNA-binding domain of SARS-CoV-2 nucleocapsid protein. It is in complex with 7mer dsRNA and was solved via NMR.,SOLUTION NMR,pdb/nucleocapsid_protein/SARS-CoV-2/7acs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7acs,nucleocapsid_protein,SARS-CoV-2,0,
7act,N-terminal RNA-binding domain of SARS-CoV-2 nucleocapsid protein. It is in complex with 10mer ssRNA. It was solved with NMR and demonstrates the binding capability of the charged binding groove.,SOLUTION NMR,pdb/nucleocapsid_protein/SARS-CoV-2/7act,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7act,nucleocapsid_protein,SARS-CoV-2,0,55.0
2mm4,"This NMR structure is a monomer of the SARS-CoV envelope protein (E). It completely covers the transmembrane domain and the C- and N-terminus partly. The structure is involved in membrane curvature, membrane scission, and viral assembly.",SOLUTION NMR,pdb/protein_e/SARS-CoV/2mm4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV/2mm4,protein_e,SARS-CoV,0,0.0
5x29,This NMR structure is an oligomer of the envelope protein (E) of SARS-CoV. The structure is a pentamer of five identical monomers. It covers the transmembrane domain and the C- and N-terminus partly. This structure functions as a membrane-anchored ion channel.,SOLUTION NMR,pdb/protein_e/SARS-CoV/5x29,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV/5x29,protein_e,SARS-CoV,0,0.0
5xer,This NMR structure exhibits a short part of the monomeric envelope protein (E) of SARS-CoV. The structure covers 9 residues of the short α-helix in the C-terminus. It is proposed to be in dynamic equilibrium with an β-coil-β-motif and may work as a Golgi targeting signal.,SOLUTION NMR,pdb/protein_e/SARS-CoV/5xer,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV/5xer,protein_e,SARS-CoV,0,
5xes,This NMR structure exhibits a short part of the monomeric envelope protein (E) of SARS-CoV. The structure covers 9 residues of the short α-helix in the C-terminus. It  is proposed to be in dynamic equilibrium with an β-coil-β-motif and may work as a Golgi targeting signal.  5xes has a better overall quality than 5xer,SOLUTION NMR,pdb/protein_e/SARS-CoV/5xes,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV/5xes,protein_e,SARS-CoV,0,
2fxp,The spike glycoprotein S2 is a membrane protein with two heptad repeat domains (HR1&HR2). The homo trimer is a 3 chain solution structure of the S2-HR2 domain. It is the first example of the prefusion form of coronavirus envelope. It gives insight into the design of structure-based antagonists.,SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV/2fxp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2fxp,surface_glycoprotein,SARS-CoV,0,50.41
2rum,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The S2 protein has at least three conformational states. The monomeric is a 1 chain solution structure of fusion peptide. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.",SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV/2rum,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2rum,surface_glycoprotein,SARS-CoV,0,
2run,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The S2 protein has at least three conformational states. The monomeric is a 1 chain solution structure of pre transmembrane domain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.",SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV/2run,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2run,surface_glycoprotein,SARS-CoV,0,
5xjk,The spike receptor-binding domain S attaches the virus its host. The monomeric is a 1 chain NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion a 64-residue long fusion peptide or LFP in DPC detergent micelles. It provides insights toward fusion mechanism.,SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV/5xjk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5xjk,surface_glycoprotein,SARS-CoV,0,0.0
7lc8,,SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV-2/7lc8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lc8,surface_glycoprotein,SARS-CoV-2,0,
7my8,,SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV-2/7my8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7my8,surface_glycoprotein,SARS-CoV-2,0,84.0
7r95,,SOLUTION NMR,pdb/surface_glycoprotein/SARS-CoV-2/7r95,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r95,surface_glycoprotein,SARS-CoV-2,0,0.0
7pku,,SOLUTION NMR,pdb/nsp3-nucleocapsid_protein/SARS-CoV-2/7pku,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3-nucleocapsid_protein/SARS-CoV-2/7pku,nsp3-nucleocapsid_protein,SARS-CoV-2,0,0.0
1q2w,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. This is one of the first deposited main protease structures.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1q2w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1q2w,3c_like_proteinase,SARS-CoV,0,2.05
1uj1,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 6.0,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1uj1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1uj1,3c_like_proteinase,SARS-CoV,0,2.78
1uk2,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 8.0,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1uk2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1uk2,3c_like_proteinase,SARS-CoV,0,3.11
1uk3,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 7.6,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1uk3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1uk3,3c_like_proteinase,SARS-CoV,0,3.05
1uk4,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a specific inhibitor, hexapeptidyl chloromethyl ketone",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1uk4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1uk4,3c_like_proteinase,SARS-CoV,0,2.94
1wof,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an optimized Michael acceptor inhibitor, [N1](https://www.rcsb.org/ligand/I12)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1wof,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1wof,3c_like_proteinase,SARS-CoV,0,2.04
1z1i,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure reported here contains additional N- and C-terminal segments of the polyprotein sequences that undergo autoprocessing and yields the mature protease in vitro.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1z1i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1z1i,3c_like_proteinase,SARS-CoV,0,2.21
1z1j,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure reported here contains additional N-terminal segments of the polyprotein sequences that undergo autoprocessing and yields the mature protease in vitro.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/1z1j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/1z1j,3c_like_proteinase,SARS-CoV,0,1.36
2a5a,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in the so-called """"unbound",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2a5a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2a5a,3c_like_proteinase,SARS-CoV,0,2.92
2a5i,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in complex with an irreversible inhibition, aza-peptide epoxide. ",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2a5i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2a5i,3c_like_proteinase,SARS-CoV,0,2.85
2a5k,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported with an Ala added to the N-terminal and in complex with an irreversible inhibition, aza-peptide epoxide. The structure is in the space group P212121",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2a5k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2a5k,3c_like_proteinase,SARS-CoV,0,2.82
2alv,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a lead Inhibitor, [4](https://www.rcsb.org/ligand/CY6)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2alv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2alv,3c_like_proteinase,SARS-CoV,0,2.68
2amd,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an optimized Michael acceptor inhibitor, [N9](https://www.rcsb.org/ligand/9IN)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2amd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2amd,3c_like_proteinase,SARS-CoV,0,2.16
2amq,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an optimized Michael acceptor inhibitor, [N3](https://www.rcsb.org/ligand/PRD_002214)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2amq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2amq,3c_like_proteinase,SARS-CoV,0,2.54
2bx3,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 5.9 and in the pace group P 43 21 2.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2bx3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2bx3,3c_like_proteinase,SARS-CoV,0,2.3
2bx4,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 6.5 and in the pace group P 21 21 2.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2bx4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2bx4,3c_like_proteinase,SARS-CoV,0,1.92
2c3s,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 6.5 and in the space group P 21 21 2,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2c3s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2c3s,3c_like_proteinase,SARS-CoV,0,2.35
2d2d,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an optimized Michael acceptor inhibitor, [I2](https://www.rcsb.org/ligand/ENB)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2d2d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2d2d,3c_like_proteinase,SARS-CoV,0,3.18
2duc,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a so-called """"mature",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2duc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2duc,3c_like_proteinase,SARS-CoV,0,1.66
2gt7,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported at a pH value of 6.5 and in the pace group P21.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gt7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gt7,3c_like_proteinase,SARS-CoV,0,1.99
2gt8,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported with an Ala added to the N-terminal and in the space group P 43 21 2,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gt8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gt8,3c_like_proteinase,SARS-CoV,0,1.92
2gtb,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported with an Ala added to the N-terminal and in complex with an irreversible inhibition, aza-peptide epoxide. The structure is in the space group P 43 21 2",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gtb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gtb,3c_like_proteinase,SARS-CoV,0,2.57
2gx4,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a specific inhibitor, [TG-0205221](https://www.rcsb.org/ligand/NOL)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gx4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gx4,3c_like_proteinase,SARS-CoV,0,1.68
2gz7,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a nonpeptide inhibitor, [D3F](https://www.rcsb.org/ligand/D3F)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gz7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gz7,3c_like_proteinase,SARS-CoV,0,2.07
2gz8,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a nonpeptide inhibitor, [F3F](https://www.rcsb.org/ligand/F3F)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gz8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gz8,3c_like_proteinase,SARS-CoV,0,1.8
2gz9,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a native form and in the pace group C121.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2gz9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2gz9,3c_like_proteinase,SARS-CoV,0,1.98
2h2z,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported with authentic N and C termini (GST tag removed).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2h2z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2h2z,3c_like_proteinase,SARS-CoV,0,1.36
2hob,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported with authentic N and C termini (GST tag removed) and in a mode complexed with an optimized Michael acceptor inhibitor, [N3](https://www.rcsb.org/ligand/PRD_002214)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2hob,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2hob,3c_like_proteinase,SARS-CoV,0,1.4
2op9,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an irreversible inhibitor, an alpha,beta-epoxyketone [WR1](https://www.rcsb.org/ligand/WR1)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2op9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2op9,3c_like_proteinase,SARS-CoV,0,2.02
2pwx,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is a G11A mutant in which the mutation of the dimer-interface residue Gly-11 to alanine abolishes the activity of the protease,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2pwx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2pwx,3c_like_proteinase,SARS-CoV,0,2.89
2q6g,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is an active site knockout mutant, H41A and is reported in complex with its natural N-terminal autocleavage substrate.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2q6g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2q6g,3c_like_proteinase,SARS-CoV,0,2.79
2qc2,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is an Asn214Ala mutant.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2qc2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2qc2,3c_like_proteinase,SARS-CoV,0,3.28
2qcy,SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is a R298A mutant and is reported in an inactive monomeric form.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2qcy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2qcy,3c_like_proteinase,SARS-CoV,0,1.98
2qiq,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an active-site Cys145 inhibitor, [CYV](https://www.rcsb.org/ligand/CYV)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2qiq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2qiq,3c_like_proteinase,SARS-CoV,0,2.24
2v6n,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an irreversible inhibitor, 1-(Benzoyloxy)-Benzotriazole. This structure differs from 2vj1 in that the benzoyloxy moiety covers the S1 specificity pocket.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2v6n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2v6n,3c_like_proteinase,SARS-CoV,0,1.24
2vj1,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with an irreversible inhibitor, 1-(4-Dimethylaminobenzoyloxy)- Benzotriazole. This structure differs from 2v6n in that the dimethylamino group enters the S2-binding site.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2vj1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2vj1,3c_like_proteinase,SARS-CoV,0,2.76
2z3c,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a phthalhydrazide-charged peptidyl inhibitor, [an episulfide](https://www.rcsb.org/ligand/PRD_000250). This structure differs from 2z3e in that the complex was obtained through co-crystallized.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z3c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z3c,3c_like_proteinase,SARS-CoV,0,1.95
2z3d,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a phthalhydrazide-charged peptidyl inhibitor, [an episulfide](https://www.rcsb.org/ligand/PRD_000235)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z3d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z3d,3c_like_proteinase,SARS-CoV,0,2.25
2z3e,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a phthalhydrazide-charged peptidyl inhibitor, [an episulfide](https://www.rcsb.org/ligand/PRD_000250). This structure differs from 2z3c in that the complex was obtained via soaking.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z3e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z3e,3c_like_proteinase,SARS-CoV,0,2.5
2z94,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a metal-conjugated inhibitors inhibitor, [TDT](https://www.rcsb.org/ligand/TLD)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z94,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z94,3c_like_proteinase,SARS-CoV,0,1.99
2z9g,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a metal-conjugated inhibitors inhibitor, [PMA](https://www.rcsb.org/ligand/PMA)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z9g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z9g,3c_like_proteinase,SARS-CoV,0,1.69
2z9j,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a metal-conjugated inhibitors inhibitor, [EPDTC](https://www.rcsb.org/ligand/DTZ)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z9j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z9j,3c_like_proteinase,SARS-CoV,0,2.33
2z9k,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a metal-conjugated inhibitors inhibitor, [JMF1600](https://www.rcsb.org/ligand/DOZ)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z9k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z9k,3c_like_proteinase,SARS-CoV,0,2.28
2z9l,"SARS-CoV main protease: a three domain protein with two antiparallel beta-2-barrels in which the substrate binding site is located and one alpha helical. It cleaves the C-terminus of replicase polyprotein at 11 sites as a functional homodimer. The structure is reported in a mode complexed with a metal-conjugated inhibitors inhibitor, [JMF1586](https://www.rcsb.org/ligand/DAZ)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2z9l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2z9l,3c_like_proteinase,SARS-CoV,0,2.54
2zu4,Full length 3C-like protease from SARS-CoV with a peptide like enzyme inhibitor (TG-0204998) in the active site. This X-ray crystal structure was phased using PDB entry 1z1i for molecular replacement & has data to a resolution of 1.93Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2zu4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2zu4,3c_like_proteinase,SARS-CoV,0,2.72
2zu5,Full length 3C-like protease from SARS-CoV with a peptide like enzyme inhibitor (TG-0205486) in the active site. This X-ray crystal structure was phased using PDB entry 1z1i for molecular replacement & has data to a resolution of 1.65Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/2zu5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/2zu5,3c_like_proteinase,SARS-CoV,0,1.71
3atw,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2ZU5 for molecular replacement & has data to a resolution of 2.36Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3atw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3atw,3c_like_proteinase,SARS-CoV,0,1.39
3avz,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2ZU5 for molecular replacement & has data to a resolution of 2.46Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3avz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3avz,3c_like_proteinase,SARS-CoV,0,3.0
3aw0,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2ZU5 for molecular replacement & has data to a resolution of 2.3Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3aw0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3aw0,3c_like_proteinase,SARS-CoV,0,2.51
3aw1,Full length 3C-like protease from SARS-CoV forming a dimer. This protein was mutated to be resistant to auto-proteolysis. This X-ray crystal structure was phased using PDB entry 2ZU5 for molecular replacement & has data to a resolution of 2.0Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3aw1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3aw1,3c_like_proteinase,SARS-CoV,0,2.24
3d62,Full length 3C-like protease from SARS-CoV forming a monomer with benzyl(2-oxopropyl)carbamate in the active site. This X-ray crystal structure has data to a resolution of 2.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3d62,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3d62,3c_like_proteinase,SARS-CoV,0,2.79
3e91,"Full length 3C-like protease from SARS-CoV forming a dimer. This protein has been mutated at S284A, T285A & I286A to modify activity. This X-ray crystal structure was phased using molecular replacement & has data to a resolution of 2.55Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3e91,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3e91,3c_like_proteinase,SARS-CoV,0,2.79
3ea7,"Full length 3C-like protease from SARS-CoV forming a dimer. This protein has been mutated at S284A, T285A & I286A to modify activity. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.65Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3ea7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3ea7,3c_like_proteinase,SARS-CoV,0,2.84
3ea8,"Full length 3C-like protease from SARS-CoV forming a monomer. This protein has been mutated at S284A, T285A & I286A to modify activity. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.25Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3ea8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3ea8,3c_like_proteinase,SARS-CoV,0,2.14
3ea9,"Full length 3C-like protease from SARS-CoV forming a monomer. This protein has been mutated at S284A, T285A, I286A & F291A to modify activity. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.4Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3ea9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3ea9,3c_like_proteinase,SARS-CoV,0,2.92
3eaj,"Full length 3C-like protease from SARS-CoV forming a dimer. This protein has been mutated at S284A, T285A, I286A & F291A to modify activity. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.7Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3eaj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3eaj,3c_like_proteinase,SARS-CoV,0,2.89
3ebn,C-terminal domain of 3C-like protease from SARS-CoV forming an unusual dimer. This X-ray crystal structure was phased using PDB entry 1uk2 for molecular replacement & has data to a resolution of 2.4Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3ebn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3ebn,3c_like_proteinase,SARS-CoV,0,2.56
3f9e,Full length 3C-like protease from SARS-CoV forming a monomer with an S139A mutation. This X-ray crystal structure has data to a resolution of 2.5Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3f9e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3f9e,3c_like_proteinase,SARS-CoV,0,2.41
3f9f,Full length 3C-like protease from SARS-CoV forming a dimer with an F140A mutation. This X-ray crystal structure has data to a resolution of 2.3Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3f9f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3f9f,3c_like_proteinase,SARS-CoV,0,1.79
3f9g,Full length 3C-like protease from SARS-CoV forming a dimer with an F140A mutation. This X-ray crystal structure has data to a resolution of 2.6Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3f9g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3f9g,3c_like_proteinase,SARS-CoV,0,2.09
3f9h,Full length 3C-like protease from SARS-CoV forming a dimer with an F140A mutation. This X-ray crystal structure has data to a resolution of 2.9Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3f9h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3f9h,3c_like_proteinase,SARS-CoV,0,2.46
3fzd,Full length 3C-like protease from SARS-CoV forming a monomer with an N28A mutation that blocks dimerization inhibits enzyme activity. This X-ray crystal structure was phased using PDB entry 2bx4 for molecular replacement & has data to a resolution of 2.35Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3fzd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3fzd,3c_like_proteinase,SARS-CoV,0,2.07
3iwm,Full length 3C-like protease from SARS-CoV forming an octomer with a peptide like enzyme inhibitor in the active site and an unusual dimerisation interaction similar to PDB entry 3ebn. This X-ray crystal structure was phased using PDB entry 2hob for molecular replacement & has data to a resolution of 3.2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3iwm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3iwm,3c_like_proteinase,SARS-CoV,0,3.97
3m3s,Full length 3C-like protease from SARS-CoV forming a dimer with an N214A mutation. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.3Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3m3s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3m3s,3c_like_proteinase,SARS-CoV,0,2.45
3m3t,Full length 3C-like protease from SARS-CoV forming a monomer with an R298A mutation. This X-ray crystal structure was phased using PDB entry 2h2z for molecular replacement & has data to a resolution of 2.9Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3m3t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3m3t,3c_like_proteinase,SARS-CoV,0,2.68
3m3v,"Full length 3C-like protease from SARS-CoV forming a dimer with three mutations S284A, T285A & I285A. This X-ray crystal structure was phased using PDB entry 1uj1 for molecular replacement & has data to a resolution of 2.7Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3m3v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3m3v,3c_like_proteinase,SARS-CoV,0,3.17
3sn8,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.99Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3sn8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3sn8,3c_like_proteinase,SARS-CoV,0,2.26
3sna,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure has data to a resolution of 3.05Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3sna,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3sna,3c_like_proteinase,SARS-CoV,0,3.31
3snb,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure has data to a resolution of 2.4Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3snb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3snb,3c_like_proteinase,SARS-CoV,0,2.36
3snc,Full length 3C-like protease from SARS-CoV forming a monomer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure has data to a resolution of 2.58Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3snc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3snc,3c_like_proteinase,SARS-CoV,0,3.09
3snd,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.89Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3snd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3snd,3c_like_proteinase,SARS-CoV,0,1.96
3sne,"Full length 3C-like protease from SARS-CoV forming a monomer with an alpha, beta-unsaturated ethyl ester SG75 in the active site. This X-ray crystal structure has data to a resolution of 2.6Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3sne,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3sne,3c_like_proteinase,SARS-CoV,0,2.45
3szn,"Full length 3C-like protease from SARS-CoV forming a monomer with an alpha, beta-unsaturated ethyl ester SG75 in the active site. This X-ray crystal structure has data to a resolution of 1.69Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3szn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3szn,3c_like_proteinase,SARS-CoV,0,1.22
3tit,"Full length 3C-like protease from SARS-CoV forming a monomer with an alpha, beta-unsaturated ethyl ester SG81 in the active site. This X-ray crystal structure has data to a resolution of 1.99Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3tit,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3tit,3c_like_proteinase,SARS-CoV,0,1.34
3tiu,Full length 3C-like protease from SARS-CoV forming a monomer with a peptidic unsaturated ester in the active site. This X-ray crystal has data to a resolution of 2.08Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3tiu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3tiu,3c_like_proteinase,SARS-CoV,0,1.58
3tns,Full length 3C-like protease from SARS-CoV forming a monomer with a peptidic unsaturated ester in the active site. This X-ray crystal has data to a resolution of 1.99Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3tns,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3tns,3c_like_proteinase,SARS-CoV,0,1.56
3tnt,"Full length 3C-like protease from SARS-CoV forming a monomer with an alpha, beta-unsaturated ethyl ester SG81 in the active site. This X-ray crystal structure has data to a resolution of 1.59Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3tnt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3tnt,3c_like_proteinase,SARS-CoV,0,1.06
3v3m,Full length 3C-like protease from SARS-CoV forming a monomer with a small molecule inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.96Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3v3m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3v3m,3c_like_proteinase,SARS-CoV,0,1.88
3vb3,Full length 3C-like protease from SARS-CoV forming a dimer. This X-ray crystal structure was phased using PDB entry 2q6g for molecular replacement & has data to a resolution of 2.2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3vb3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3vb3,3c_like_proteinase,SARS-CoV,0,1.81
3vb4,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2q6g for molecular replacement & has data to a resolution of 2.2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3vb4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3vb4,3c_like_proteinase,SARS-CoV,0,1.71
3vb5,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2q6g for molecular replacement & has data to a resolution of 1.95Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3vb5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3vb5,3c_like_proteinase,SARS-CoV,0,2.03
3vb6,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2q6g for molecular replacement & has data to a resolution of 2.5Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3vb6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3vb6,3c_like_proteinase,SARS-CoV,0,2.31
3vb7,Full length 3C-like protease from SARS-CoV forming a dimer with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2q6g for molecular replacement & has data to a resolution of 1.95Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/3vb7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/3vb7,3c_like_proteinase,SARS-CoV,0,1.72
4hi3,Full length 3C-like protease from SARS-CoV forming a dimer. This X-ray crystal structure was phased using PDB entry 1uk4 for molecular replacement & has data to a resolution of 2.09Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/4hi3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/4hi3,3c_like_proteinase,SARS-CoV,0,2.21
4mds,Full length 3C-like protease from SARS-CoV forming a monomer with with a small molecule inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.598Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/4mds,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/4mds,3c_like_proteinase,SARS-CoV,0,1.58
4tww,"Full length 3C-like protease from SARS-CoV forming a dimer with a bromobenzoyl (S,R)-N-decalin type inhibitor in the active site. This X-ray crystal structure has data to a resolution of 2.42Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/4tww,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/4tww,3c_like_proteinase,SARS-CoV,0,1.73
4twy,"Full length 3C-like protease from SARS-CoV forming a monomer with a phenylbenzoyl (S,R)-N-decalin type inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 3atw for molecular replacement & has data to a resolution of 1.6Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/4twy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/4twy,3c_like_proteinase,SARS-CoV,0,1.65
4wy3,"Full length 3C-like protease from SARS-CoV forming a monomer with a phenylbenzoyl (R,S)-N-decalin type inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 3atw for molecular replacement & has data to a resolution of 1.89Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/4wy3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/4wy3,3c_like_proteinase,SARS-CoV,0,1.63
5b6o,Full length 3C-like protease from SARS-CoV forming a dimer. This X-ray crystal structure was phased using PDB entries 2duc & 1uj1 for molecular replacement & has data to a resolution of 2.202Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/5b6o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/5b6o,3c_like_proteinase,SARS-CoV,0,1.95
5c5n,"Full length 3C-like protease from SARS-CoV forming a monomer with a phenyl-beta-alanyl (R,S)-N-decalin type inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.69Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/5c5n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/5c5n,3c_like_proteinase,SARS-CoV,0,1.73
5c5o,"Full length 3C-like protease from SARS-CoV forming a dimer with a phenyl-beta-alanyl (S,R)-N-decalin type inhibitor in the active site. This X-ray crystal structure has data to a resolution of 1.5Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/5c5o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/5c5o,3c_like_proteinase,SARS-CoV,0,1.46
5n19,Full length 3C-like protease from SARS-CoV forming a monomer with an alpha-ketoamide in the active site. This X-ray crystal structure has data to a resolution of 1.62Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/5n19,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/5n19,3c_like_proteinase,SARS-CoV,0,1.26
5n5o,Full length 3C-like protease from SARS-CoV forming a monomer with an alpha-ketoamide in the active site. This X-ray crystal structure has data to a resolution of 2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/5n5o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/5n5o,3c_like_proteinase,SARS-CoV,0,1.5
5r7y,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, N-(2-phenylethyl)methanesulfonamide. This X-ray crystal structure has data to a resolution of 1.65Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r7y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r7y,3c_like_proteinase,SARS-CoV-2,0,1.42
5r7z,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, ~{N}-[2-(5-fluoranyl-1~{H}-indol-3-yl)ethyl]ethanamide. This X-ray crystal structure has data to a resolution of 1.59Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r7z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r7z,3c_like_proteinase,SARS-CoV-2,0,1.64
5r80,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, methyl 4-sulfamoylbenzoate. This X-ray crystal structure has data to a resolution of 1.93Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r80,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r80,3c_like_proteinase,SARS-CoV-2,0,1.65
5r81,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide. This X-ray crystal structure has data to a resolution of 1.95Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r81,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r81,3c_like_proteinase,SARS-CoV-2,0,1.75
5r82,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 6-(ethylamino)pyridine-3-carbonitrile. This X-ray crystal structure has data to a resolution of 1.31Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r82,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r82,3c_like_proteinase,SARS-CoV-2,0,1.43
5r83,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, N-phenyl-N'-pyridin-3-ylurea. This X-ray crystal structure has data to a resolution of 1.58Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r83,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r83,3c_like_proteinase,SARS-CoV-2,0,1.55
5r84,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide. This X-ray crystal structure has data to a resolution of 1.83Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r84,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r84,3c_like_proteinase,SARS-CoV-2,0,2.0
5r8t,Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is a ground state model used for screening against a number of fragment libraries. This X-ray crystal structure has data to a resolution of 1.27Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5r8t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5r8t,3c_like_proteinase,SARS-CoV-2,0,1.24
5re4,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, N-(4-methylpyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.88Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re4,3c_like_proteinase,SARS-CoV-2,0,1.83
5re5,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, N~1~-phenylpiperidine-1,4-dicarboxamide. This X-ray crystal structure has data to a resolution of 2.07Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re5,3c_like_proteinase,SARS-CoV-2,0,1.89
5re6,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 	N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide. This X-ray crystal structure has data to a resolution of 1.87Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re6,3c_like_proteinase,SARS-CoV-2,0,1.48
5re7,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, N-[(4-sulfamoylphenyl)methyl]acetamide. This X-ray crystal structure has data to a resolution of 1.79Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re7,3c_like_proteinase,SARS-CoV-2,0,1.59
5re8,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 1-(3-fluorophenyl)-N-[(furan-2-yl)methyl]methanamine. This X-ray crystal structure has data to a resolution of 1.81Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re8,3c_like_proteinase,SARS-CoV-2,0,1.62
5re9,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 2-(4-methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone. This X-ray crystal structure has data to a resolution of 1.72Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5re9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5re9,3c_like_proteinase,SARS-CoV-2,0,1.95
5rea,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, (azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone. This X-ray crystal structure has data to a resolution of 1.63Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rea,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rea,3c_like_proteinase,SARS-CoV-2,0,1.45
5reb,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 1-[(thiophen-3-yl)methyl]piperidin-4-ol. This X-ray crystal structure has data to a resolution of 1.68Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5reb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5reb,3c_like_proteinase,SARS-CoV-2,0,1.25
5rec,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol. This X-ray crystal structure has data to a resolution of 1.73Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rec,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rec,3c_like_proteinase,SARS-CoV-2,0,1.53
5red,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 4-[2-(phenylsulfanyl)ethyl]morpholine. This X-ray crystal structure has data to a resolution of 1.47Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5red,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5red,3c_like_proteinase,SARS-CoV-2,0,1.47
5ree,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, (2R,3R)-1-benzyl-2-methylpiperidin-3-ol. This X-ray crystal structure has data to a resolution of 1.77Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5ree,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5ree,3c_like_proteinase,SARS-CoV-2,0,1.52
5ref,Full length 3C-like protease from SARS-CoV with Z24758179 ligand bound. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.61Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5ref,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5ref,3c_like_proteinase,SARS-CoV-2,0,1.61
5reg,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide. This X-ray crystal structure has data to a resolution of 1.67Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5reg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5reg,3c_like_proteinase,SARS-CoV-2,0,1.76
5reh,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea. This X-ray crystal structure has data to a resolution of 1.80Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5reh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5reh,3c_like_proteinase,SARS-CoV-2,0,1.87
5rei,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 4-[(3-chlorophenyl)methyl]morpholine. This X-ray crystal structure has data to a resolution of 1.82Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rei,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rei,3c_like_proteinase,SARS-CoV-2,0,1.35
5rej,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(thiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.72Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rej,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rej,3c_like_proteinase,SARS-CoV-2,0,1.28
5rek,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(3-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.74Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rek,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rek,3c_like_proteinase,SARS-CoV-2,0,1.33
5rel,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(3-methylphenyl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.62Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rel,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rel,3c_like_proteinase,SARS-CoV-2,0,1.38
5rem,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1 1-(4-(2-nitrophenyl)piperazin-1-yl)ethan-1-one. This X-ray crystal structure has data to a resolution of 1.96Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rem,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rem,3c_like_proteinase,SARS-CoV-2,0,1.68
5ren,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[(3R)-3-(1,3-benzothiazol-2-yl)piperidin-1-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 2.15Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5ren,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5ren,3c_like_proteinase,SARS-CoV-2,0,1.68
5reo,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(2H-1,3-benzodioxol-5-yl)methyl]acetamide. This X-ray crystal structure has data to a resolution of 1.88Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5reo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5reo,3c_like_proteinase,SARS-CoV-2,0,1.52
5rep,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(2,6-difluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.81Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rep,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rep,3c_like_proteinase,SARS-CoV-2,0,1.51
5rer,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.88Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rer,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rer,3c_like_proteinase,SARS-CoV-2,0,1.56
5res,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.65Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5res,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5res,3c_like_proteinase,SARS-CoV-2,0,1.27
5ret,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(3-chlorophenyl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.68Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5ret,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5ret,3c_like_proteinase,SARS-CoV-2,0,1.64
5reu,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-[(4-acetylpiperazin-1-yl)sulfonyl]benzonitrile. This X-ray crystal structure has data to a resolution of 1.69Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5reu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5reu,3c_like_proteinase,SARS-CoV-2,0,1.34
5rev,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[3-(thiomorpholine-4-carbonyl)phenyl]acetamide. This X-ray crystal structure has data to a resolution of 1.60Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rev,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rev,3c_like_proteinase,SARS-CoV-2,0,1.32
5rew,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(1R)-1-(naphthalen-1-yl)ethyl]acetamide. This X-ray crystal structure has data to a resolution of 1.55Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rew,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rew,3c_like_proteinase,SARS-CoV-2,0,1.26
5rex,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(naphthalen-1-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 2.07Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rex,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rex,3c_like_proteinase,SARS-CoV-2,0,1.52
5rey,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(2-methylphenyl)methyl]-1,4-diazepan-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.96Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rey,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rey,3c_like_proteinase,SARS-CoV-2,0,1.54
5rez,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (1R,2S)-2-(thiophen-3-yl)cyclopentane-1-carboxamide. This X-ray crystal structure has data to a resolution of 1.79Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rez,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rez,3c_like_proteinase,SARS-CoV-2,0,1.68
5rf0,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, [1-(pyridin-2-yl)cyclopentyl]methanol. This X-ray crystal structure has data to a resolution of 1.65Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf0,3c_like_proteinase,SARS-CoV-2,0,1.31
5rf1,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 4-bromobenzene-1-sulfonamide. This X-ray crystal structure has data to a resolution of 1.73Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf1,3c_like_proteinase,SARS-CoV-2,0,1.47
5rf2,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-azanylpropylideneazanium. This X-ray crystal structure has data to a resolution of 1.53Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf2,3c_like_proteinase,SARS-CoV-2,0,1.15
5rf3,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, pyrimidin-5-amine. This X-ray crystal structure has data to a resolution of 1.50Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf3,3c_like_proteinase,SARS-CoV-2,0,1.22
5rf4,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, pyridin-2-ol. This X-ray crystal structure has data to a resolution of 1.61Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf4,3c_like_proteinase,SARS-CoV-2,0,1.27
5rf5,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1,1-bis(oxidanylidene)thietan-3-ol. This X-ray crystal structure has data to a resolution of 1.74Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf5,3c_like_proteinase,SARS-CoV-2,0,1.47
5rf6,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile. This X-ray crystal structure has data to a resolution of 1.45Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf6,3c_like_proteinase,SARS-CoV-2,0,1.34
5rf7,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one. This X-ray crystal structure has data to a resolution of 1.54Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf7,3c_like_proteinase,SARS-CoV-2,0,1.21
5rf8,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 4-amino-N-(pyridin-2-yl)benzenesulfonamide. This X-ray crystal structure has data to a resolution of 1.74Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf8,3c_like_proteinase,SARS-CoV-2,0,1.2
5rf9,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[(2~{S})-2-methylmorpholin-4-yl]-2-pyrazol-1-yl-ethanone. This X-ray crystal structure has data to a resolution of 1.43Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rf9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rf9,3c_like_proteinase,SARS-CoV-2,0,1.32
5rfa,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 	1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide. This X-ray crystal structure has data to a resolution of 1.48Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfa,3c_like_proteinase,SARS-CoV-2,0,1.2
5rfb,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 	N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine. This X-ray crystal structure has data to a resolution of 1.48Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfb,3c_like_proteinase,SARS-CoV-2,0,1.43
5rfc,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, mentmethyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate. This X-ray crystal structure has data to a resolution of 1.40Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfc,3c_like_proteinase,SARS-CoV-2,0,1.2
5rfd,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule fragment, 2-[(methylsulfonyl)methyl]-1H-benzimidazole. This X-ray crystal structure has data to a resolution of 1.41Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfd,3c_like_proteinase,SARS-CoV-2,0,1.24
5rfe,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide. This X-ray crystal structure has data to a resolution of 1.46Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfe,3c_like_proteinase,SARS-CoV-2,0,1.2
5rff,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(4-chlorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.78Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rff,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rff,3c_like_proteinase,SARS-CoV-2,0,1.42
5rfg,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(3S)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-phenylacetamide. This X-ray crystal structure has data to a resolution of 2.32Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfg,3c_like_proteinase,SARS-CoV-2,0,1.73
5rfh,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.58Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfh,3c_like_proteinase,SARS-CoV-2,0,1.42
5rfi,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(2,5-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.69Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfi,3c_like_proteinase,SARS-CoV-2,0,1.25
5rfj,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.80Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfj,3c_like_proteinase,SARS-CoV-2,0,1.61
5rfk,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(1-acetylpiperidin-4-yl)benzamide. This X-ray crystal structure has data to a resolution of 1.75Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfk,3c_like_proteinase,SARS-CoV-2,0,1.47
5rfl,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-acetyl-N-(2-hydroxyphenyl)piperidine-4-carboxamide. This X-ray crystal structure has data to a resolution of 1.64Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfl,3c_like_proteinase,SARS-CoV-2,0,1.27
5rfm,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-methylphenyl)acetamide. This X-ray crystal structure has data to a resolution of 2.06Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfm,3c_like_proteinase,SARS-CoV-2,0,1.77
5rfn,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(3R)-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-thiophen-3-yl]-N-(4-fluorophenyl)acetamide. This X-ray crystal structure has data to a resolution of 1.80Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfn,3c_like_proteinase,SARS-CoV-2,0,1.32
5rfo,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[4-(piperidine-1-carbonyl)piperidin-1-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.83Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfo,3c_like_proteinase,SARS-CoV-2,0,2.18
5rfp,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(1S)-1-(3-chlorophenyl)ethyl]acetamide. This X-ray crystal structure has data to a resolution of 2.03Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfp,3c_like_proteinase,SARS-CoV-2,0,1.89
5rfq,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide. This X-ray crystal structure has data to a resolution of 1.82Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfq,3c_like_proteinase,SARS-CoV-2,0,1.27
5rfr,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(5-bromothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.71Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfr,3c_like_proteinase,SARS-CoV-2,0,1.53
5rfs,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(thiophen-3-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.70Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfs,3c_like_proteinase,SARS-CoV-2,0,1.31
5rft,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[(4S)-4-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.58Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rft,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rft,3c_like_proteinase,SARS-CoV-2,0,1.41
5rfu,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(5-chlorothiophen-2-yl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.53Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfu,3c_like_proteinase,SARS-CoV-2,0,1.46
5rfv,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.48Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfv,3c_like_proteinase,SARS-CoV-2,0,1.2
5rfw,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.43Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfw,3c_like_proteinase,SARS-CoV-2,0,1.42
5rfx,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[4-(4-methoxyphenyl)piperazin-1-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.55Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfx,3c_like_proteinase,SARS-CoV-2,0,1.27
5rfy,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-acetyl-N-methyl-N-(propan-2-yl)piperidine-4-carboxamide. This X-ray crystal structure has data to a resolution of 1.9Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfy,3c_like_proteinase,SARS-CoV-2,0,1.61
5rfz,Full length 3C-like protease from SARS-CoV with PCM-0102274 ligand bound. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.68Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rfz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rfz,3c_like_proteinase,SARS-CoV-2,0,1.31
5rg0,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1,1'-(piperazine-1,4-diyl)di(ethan-1-one). This X-ray crystal structure has data to a resolution of 1.72Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rg0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rg0,3c_like_proteinase,SARS-CoV-2,0,1.69
5rg1,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide. This X-ray crystal structure has data to a resolution of 1.65Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rg1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rg1,3c_like_proteinase,SARS-CoV-2,0,1.52
5rg2,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N~2~-acetyl-N-prop-2-en-1-yl-D-allothreoninamide. This X-ray crystal structure has data to a resolution of 1.63Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rg2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rg2,3c_like_proteinase,SARS-CoV-2,0,1.56
5rg3,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N~2~-acetyl-N~1~-prop-2-en-1-yl-L-aspartamide. This X-ray crystal structure has data to a resolution of 1.58Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rg3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rg3,3c_like_proteinase,SARS-CoV-2,0,1.35
5rgg,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 4-methyl-N-phenylpiperazine-1-carboxamide. This X-ray crystal structure has data to a resolution of 2.26Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgg,3c_like_proteinase,SARS-CoV-2,0,1.68
5rgh,Full length 3C-like protease from SARS-CoV with a Fluorine based ligand in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgh,3c_like_proteinase,SARS-CoV-2,0,1.28
5rgi,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea. This X-ray crystal structure has data to a resolution of 1.57Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgi,3c_like_proteinase,SARS-CoV-2,0,1.38
5rgj,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane. This X-ray crystal structure has data to a resolution of 1.34Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgj,3c_like_proteinase,SARS-CoV-2,0,1.38
5rgk,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide. This X-ray crystal structure has data to a resolution of 1.43Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgk,3c_like_proteinase,SARS-CoV-2,0,1.19
5rgl,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[4-(4-methylbenzene-1-carbonyl)piperazin-1-yl]ethan-1-one. This X-ray crystal structure has data to a resolution of 1.76Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgl,3c_like_proteinase,SARS-CoV-2,0,1.23
5rgm,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N'-acetyl-4,5,6,7-tetrahydro-1-benzothiophene-2-carbohydrazide. This X-ray crystal structure has data to a resolution of 2.04Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgm,3c_like_proteinase,SARS-CoV-2,0,1.79
5rgn,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(4-methylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.86Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgn,3c_like_proteinase,SARS-CoV-2,0,1.49
5rgo,SARS-CoV-2 main protease fragment screen -- Crystal Structure of SARS-CoV-2 main protease in complex with PCM-0102248 (Mpro-x0736) (PanDDA analysis group deposition). Ligand is 1-[4-(furan-2-carbonyl)piperazin-1-yl]ethan-1-one.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgo,3c_like_proteinase,SARS-CoV-2,0,1.38
5rgp,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(2,4-dimethylphenyl)sulfonyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 2.07Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgp,3c_like_proteinase,SARS-CoV-2,0,1.44
5rgq,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-(4-fluoro-2-methylphenyl)methanesulfonamide. This X-ray crystal structure has data to a resolution of 2.15Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgq,3c_like_proteinase,SARS-CoV-2,0,1.46
5rgr,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine. This X-ray crystal structure has data to a resolution of 1.41Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgr,3c_like_proteinase,SARS-CoV-2,0,1.38
5rgs,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, [(2~{R})-4-(phenylmethyl)morpholin-2-yl]methanol. This X-ray crystal structure has data to a resolution of 1.72Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgs,3c_like_proteinase,SARS-CoV-2,0,1.24
5rgt,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)propanamide. This X-ray crystal structure has data to a resolution of 2.22Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgt,3c_like_proteinase,SARS-CoV-2,0,1.24
5rgu,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide. This X-ray crystal structure has data to a resolution of 2.11Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgu,3c_like_proteinase,SARS-CoV-2,0,1.37
5rgv,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(isoquinolin-4-yl)-N-phenylacetamide. This X-ray crystal structure has data to a resolution of 1.82Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgv,3c_like_proteinase,SARS-CoV-2,0,1.25
5rgw,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(5-cyanopyridin-3-yl)-N-(pyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.43Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgw,3c_like_proteinase,SARS-CoV-2,0,1.0
5rgx,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.69Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgx,3c_like_proteinase,SARS-CoV-2,0,1.06
5rgy,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(4-methoxypyridin-2-yl)-2-(naphthalen-2-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.98Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgy,3c_like_proteinase,SARS-CoV-2,0,1.73
5rgz,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(3-cyanophenyl)-N-(pyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.52Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rgz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rgz,3c_like_proteinase,SARS-CoV-2,0,1.27
5rh0,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(5-methylthiophen-2-yl)-N'-pyridin-3-ylurea. This X-ray crystal structure has data to a resolution of 1.92Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh0,3c_like_proteinase,SARS-CoV-2,0,1.5
5rh1,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(5-chlorothiophen-2-yl)-N-(pyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.96Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh1,3c_like_proteinase,SARS-CoV-2,0,1.42
5rh2,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide. This X-ray crystal structure has data to a resolution of 1.83Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh2,3c_like_proteinase,SARS-CoV-2,0,1.4
5rh3,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide. This X-ray crystal structure has data to a resolution of 1.69Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh3,3c_like_proteinase,SARS-CoV-2,0,1.29
5rh4,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (2R)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid. This X-ray crystal structure has data to a resolution of 1.34Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh4,3c_like_proteinase,SARS-CoV-2,0,1.2
5rh5,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(5-tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide. This X-ray crystal structure has data to a resolution of 1.72Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh5,3c_like_proteinase,SARS-CoV-2,0,1.05
5rh6,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]-N-[6-(propan-2-yl)pyridin-3-yl]propanamide. This X-ray crystal structure has data to a resolution of 1.60Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh6,3c_like_proteinase,SARS-CoV-2,0,1.08
5rh7,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-(5-tert-butyl-1H-pyrazol-3-yl)-N-[(1R)-2-[(2-ethyl-6-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide. This X-ray crystal structure has data to a resolution of 1.71Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh7,3c_like_proteinase,SARS-CoV-2,0,1.16
5rh8,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 2-(cyanomethoxy)-N-[(1,2-thiazol-4-yl)methyl]benzamide. This X-ray crystal structure has data to a resolution of 1.81Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh8,3c_like_proteinase,SARS-CoV-2,0,1.3
5rh9,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, N-{4-[(1S)-1-methoxyethyl]phenyl}-N-[(1R)-2-[(4-methoxy-2-methylphenyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide. This X-ray crystal structure has data to a resolution of 1.91Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rh9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rh9,3c_like_proteinase,SARS-CoV-2,0,1.55
5rha,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one. This X-ray crystal structure has data to a resolution of 1.51Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rha,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rha,3c_like_proteinase,SARS-CoV-2,0,1.15
5rhb,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (E)-1-(pyrimidin-2-yl)methanimine. This X-ray crystal structure has data to a resolution of 1.58Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rhb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rhb,3c_like_proteinase,SARS-CoV-2,0,1.08
5rhc,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, (E)-1-(1H-imidazol-2-yl)methanimine. This X-ray crystal structure has data to a resolution of 1.58Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rhc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rhc,3c_like_proteinase,SARS-CoV-2,0,1.05
5rhd,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-[4-(methylsulfonyl)phenyl]piperazine. This X-ray crystal structure has data to a resolution of 1.57Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rhd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rhd,3c_like_proteinase,SARS-CoV-2,0,1.15
5rhe,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-acetyl-N-(6-methoxypyridin-3-yl)piperidine-4-carboxamide. This X-ray crystal structure has data to a resolution of 1.56Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rhe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rhe,3c_like_proteinase,SARS-CoV-2,0,1.08
5rhf,"Full length 3C-like protease from SARS-CoV-2 forming a dimer. This protein is bound to a small molecule frag, 1-acetyl-N-methyl-N-phenylpiperidine-4-carboxamide. This X-ray crystal structure has data to a resolution of 1.76Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rhf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rhf,3c_like_proteinase,SARS-CoV-2,0,1.23
6lnq,The co-crystal structure of the SARS-CoV 3c like protease with aldehyde inhibitor M7.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6lnq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6lnq,3c_like_proteinase,SARS-CoV,0,2.52
6lny,Full length 3C-like protease from SARS-CoV with an aldehyde m15 ligand bound. This X-ray crystal structure was phased using PDB entry 1uj1 for molecular replacement & has data to a resolution of 2.25Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6lny,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6lny,3c_like_proteinase,SARS-CoV-2,0,1.27
6lo0,Full length 3C-like protease from SARS-CoV with an aldehyde m14 ligand bound. This X-ray crystal structure was phased using PDB entry 1uj1 for molecular replacement & has data to a resolution of 1.94Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6lo0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6lo0,3c_like_proteinase,SARS-CoV-2,0,1.13
6lu7,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor N3 in the active site. This X-ray crystal structure was phased using PDB entry 2hob for molecular replacement & has data to a resolution of 2.16Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6lu7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6lu7,3c_like_proteinase,SARS-CoV-2,0,1.43
6lze,"X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, in complex with an inhibitor 11a.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6lze,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6lze,3c_like_proteinase,SARS-CoV-2,0,1.19
6m03,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.99Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6m03,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6m03,3c_like_proteinase,SARS-CoV-2,1,1.4
6m0k,"Full length 3C-like protease from SARS-CoV with a Fluorine based ligand, 11b, in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.7Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6m0k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6m0k,3c_like_proteinase,SARS-CoV-2,0,1.21
6m2n,Full length 3C-like protease from SARS-CoV with a novel inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 2.2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6m2n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6m2n,3c_like_proteinase,SARS-CoV-2,0,1.76
6m2q,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6m2q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6m2q,3c_like_proteinase,SARS-CoV-2,0,0.85
6w63,"Full length 3C-like protease from SARS-CoV with a non-covalent inhibitor, X77 in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 2.1Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6w63,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6w63,3c_like_proteinase,SARS-CoV-2,0,1.79
6w79,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to potent broad-spectrum non-covalent inhibitor X77. The resolution is 1.46 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6w79,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6w79,3c_like_proteinase,SARS-CoV-2,0,1.06
6wnp,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor Boceprevir in the active site. This X-ray crystal structure was phased using PDB entry 6w63 for molecular replacement & has data to a resolution of 1.45Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wnp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wnp,3c_like_proteinase,SARS-CoV-2,0,1.12
6wqf,"Room temperature structure of the SARS-CoV-2 3cl main protease active site cavity, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wqf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wqf,3c_like_proteinase,SARS-CoV-2,0,1.06
6wtj,"X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, in complex with Feline coronavirus drug (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wtj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wtj,3c_like_proteinase,SARS-CoV-2,0,1.77
6wtk,Full length 3C-like protease from SARS-CoV with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 6y7m for molecular replacement & has data to a resolution of 2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wtk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wtk,3c_like_proteinase,SARS-CoV-2,0,1.74
6wtm,X-ray diffraction data. Structure of the main-protease of SARS-CoV-2.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wtm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wtm,3c_like_proteinase,SARS-CoV-2,0,1.23
6wtt,"Crystals structure of the SARS-CoV-2 main protease with inhibitor GC-376, forming a homodimer. Further ligands are magnesium ions, chloride ions, glycerol, di(hydroxyethyl)ether and N~2~-[(benzyloxy)carbonyl]-N-[(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-(trimethyl-lambda~4~-sulfanyl)propan-2-yl]-L-leucinamide.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6wtt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6wtt,3c_like_proteinase,SARS-CoV-2,0,2.09
6xa4,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor UAW241 in the active site. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.65Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xa4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xa4,3c_like_proteinase,SARS-CoV-2,0,1.18
6xb0,Full length 3C-like protease from SARS-CoV. This data was collected at room temperature and has an oxidised Cysteine 145. This X-ray crystal structure was phased using PDB entry 6wqf for molecular replacement & has data to a resolution of 1.8Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xb0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xb0,3c_like_proteinase,SARS-CoV-2,0,1.19
6xb1,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 6wqf for molecular replacement & has data to a resolution of 1.8Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xb1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xb1,3c_like_proteinase,SARS-CoV-2,0,1.55
6xb2,Full length 3C-like protease from SARS-CoV. This data was collected at room temperature. This X-ray crystal structure was phased using PDB entry 6wqf for molecular replacement & has data to a resolution of 2.1Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xb2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xb2,3c_like_proteinase,SARS-CoV-2,0,1.84
6xbg,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor UAW246 in the active site. This X-ray crystal structure was phased using PDB entry 7brr for molecular replacement & has data to a resolution of 1.45Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xbg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xbg,3c_like_proteinase,SARS-CoV-2,0,1.4
6xbh,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor UAW247 in the active site. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.6Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xbh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xbh,3c_like_proteinase,SARS-CoV-2,0,1.2
6xbi,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor UAW248 in the active site. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xbi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xbi,3c_like_proteinase,SARS-CoV-2,0,1.52
6xch,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor Leupeptin in the active site. This X-ray crystal structure was phased using PDB entry 6wqf for molecular replacement & has data to a resolution of 2.2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xch,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xch,3c_like_proteinase,SARS-CoV-2,0,1.53
6xfn,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor UAW243 in the active site. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xfn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xfn,3c_like_proteinase,SARS-CoV-2,0,3.83
6xg2,Full length 3C-like protease from SARS-CoV. This structure has an oxidised Cysteine 145. This X-ray crystal structure was phased using PDB entry 5r8t for molecular replacement & has data to a resolution of 1.28Ã….,X-RAY DIFFRACTION,../pdb\3c_like_proteinase\SARS-CoV-2\6xg2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\3c_like_proteinase\SARS-CoV-2\6xg2,..,pdb\3c_like_proteinase\SARS-CoV-2,0,1.53
6xhm,"Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) with keton-based N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide. The resolution is 1.41 Å",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xhm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xhm,3c_like_proteinase,SARS-CoV-2,0,0.94
6xhu,Full length 3C-like protease from SARS-CoV. This data was collected at room temperature. This X-ray crystal structure was phased using PDB entry 6wqf for molecular replacement & has data to a resolution of 1.8Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xhu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xhu,3c_like_proteinase,SARS-CoV-2,0,3.5
6xkf,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts. Cys145 is oxidised (Sulfenic acid cysteine)",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xkf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xkf,3c_like_proteinase,SARS-CoV-2,0,1.18
6xkh,"X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, with oxidised C145 (sulfinic acid cysteine).",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xkh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xkh,3c_like_proteinase,SARS-CoV-2,0,1.22
6xmk,Full length 3C-like protease from Sars-Cov-2 with a 1.70A resolution and in complex with inhibitor 7j. It was done via x-ray diffraction to check inhibition potency. [QYS] (https://www.rcsb.org/ligand/QYS) is bound to the cleavage site.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xmk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xmk,3c_like_proteinase,SARS-CoV-2,0,0.96
6xoa,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts,. Cys145 is mutated to Ser1450",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xoa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xoa,3c_like_proteinase,SARS-CoV-2,0,1.66
6xqs,Room-temperature X-ray Crystal structure of SARS-CoV-2 main protease in complex with Telaprevir. Cyclic homo-2-mer with one unique protein chain.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xqs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xqs,3c_like_proteinase,SARS-CoV-2,0,1.34
6xqt,This X-ray crystal structure shows the SARS-CoV-2 main protease in complex with Narlaprevir. The malleability of the SARS-CoV-2 3CL M pro active-site cavity facilitates the binding of clinical antivirals.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xqt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xqt,3c_like_proteinase,SARS-CoV-2,0,1.75
6xqu,"Room-temperature X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, in complex with Boceprevir.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xqu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xqu,3c_like_proteinase,SARS-CoV-2,0,1.48
6xr3,"1.45 Å X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts in complex with GRL-024-20",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6xr3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6xr3,3c_like_proteinase,SARS-CoV-2,0,1.08
6y2e,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 2bx4 for molecular replacement & has data to a resolution of 1.75Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6y2e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6y2e,3c_like_proteinase,SARS-CoV-2,0,1.45
6y2f,"Crystal structure of the SARS-CoV-2 main protease in complex with ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate (alpha-ketoamide 13b) and the ligand dimethyl sulfoxide, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6y2f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6y2f,3c_like_proteinase,SARS-CoV-2,0,1.82
6y2g,"Crystal structure of the SARS-CoV-2 main protease in complex with ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate (alpha-ketoamide 13b), forming a homodimer with glycine as a second ligand.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6y2g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6y2g,3c_like_proteinase,SARS-CoV-2,0,2.04
6y7m,Full length 3C-like protease from SARS-CoV with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 2bx4 for molecular replacement & has data to a resolution of 1.9Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6y7m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6y7m,3c_like_proteinase,SARS-CoV,0,
6y84,"X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, with unliganded active site.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6y84,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6y84,3c_like_proteinase,SARS-CoV-2,0,1.14
6yb7,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.25Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6yb7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6yb7,3c_like_proteinase,SARS-CoV-2,0,1.15
6ynq,Full length 3C-like protease from SARS-CoV with a 2-Methyl-1-tetralone ligand bound. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.8Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6ynq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6ynq,3c_like_proteinase,SARS-CoV-2,0,1.94
6yt8,Full length 3C-like protease from SARS-CoV with a 2-Methyl-1-tetralone ligand bound. This X-ray crystal structure was phased using PDB entry 6yb7 for molecular replacement & has data to a resolution of 1.8Ã….,X-RAY DIFFRACTION,../pdb\3c_like_proteinase\SARS-CoV-2\6yt8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\3c_like_proteinase\SARS-CoV-2\6yt8,..,pdb\3c_like_proteinase\SARS-CoV-2,0,1.58
6yvf,"The structure of the SARS-CoV-2 main protease bound to AZD6482 with a resolution of 1.6 脜, forming a dimer. As ligands it has chloride ions, a calcium ion, dimethyl sulfoxide, di(hydroxyethyl)ether and 2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxidanylidene-pyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6yvf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6yvf,3c_like_proteinase,SARS-CoV-2,0,1.41
6yz6,X-ray diffraction data. Structure of the hemiacetal complex between the main-protease of SARS-CoV-2 and Leupeptin.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6yz6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6yz6,3c_like_proteinase,SARS-CoV-2,0,
6z2e,Full length 3C-like protease from SARS-CoV with a peptide like activity-based probe in the active site. This X-ray crystal structure was phased using PDB entry 6y2e for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6z2e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6z2e,3c_like_proteinase,SARS-CoV-2,0,
6zrt,"Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) in complex with inhibitor Telaprevir. Docking studies, enzyme inhibition and co-crystal structure analyses showed that telaprevir does not inhibit.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6zrt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6zrt,3c_like_proteinase,SARS-CoV-2,0,1.64
6zru,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with repurposed anti-HCV drug, Boceprevir. This is protease inhibitor which binds covalently to Serine.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/6zru,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/6zru,3c_like_proteinase,SARS-CoV-2,0,1.37
7aku,"Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to Calpeptin. It binds covalently via its aldehyde group to Cys145, forming a thiohemiacetal. This peptidomimetic inhibitor occupies substrate pockets S1 to S3. ",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aku,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aku,3c_like_proteinase,SARS-CoV-2,0,2.39
7bqy,Full length 3C-like protease from SARS-CoV with a peptide like enzyme inhibitor in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.7Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bqy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bqy,3c_like_proteinase,SARS-CoV-2,0,1.17
7bro,Full length 3C-like protease from SARS-CoV. This X-ray crystal structure was phased using PDB entry 3f9f for molecular replacement & has data to a resolution of 2Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bro,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bro,3c_like_proteinase,SARS-CoV-2,0,1.5
7brp,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor Boceprevir in the active site. This X-ray crystal structure was phased using PDB entry 3f9f for molecular replacement & has data to a resolution of 1.8Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7brp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7brp,3c_like_proteinase,SARS-CoV-2,0,1.28
7brr,Full length 3C-like protease from SARS-CoV with the peptide like enzyme inhibitor Boceprevir in the active site. This X-ray crystal structure was phased using PDB entry 3f9f for molecular replacement & has data to a resolution of 1.8Ã….,X-RAY DIFFRACTION,../pdb\3c_like_proteinase\SARS-CoV-2\7brr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\3c_like_proteinase\SARS-CoV-2\7brr,..,pdb\3c_like_proteinase\SARS-CoV-2,0,1.24
7buy,Full length 3C-like protease from SARS-CoV with an antineoplastic drug carmofur in the active site. This X-ray crystal structure was phased using PDB entry 6lu7 for molecular replacement & has data to a resolution of 1.6Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7buy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7buy,3c_like_proteinase,SARS-CoV-2,0,1.54
7c2q,"Crystal structure of the SARS-CoV-2 main protease in the apo-state, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c2q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c2q,3c_like_proteinase,SARS-CoV-2,0,1.24
7c2y,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in the apo state.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c2y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c2y,3c_like_proteinase,SARS-CoV-2,0,1.12
7c6s,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with repurposed anti-HCV drug, Boceprevir. This is protease inhibitor which binds covalently to Serine.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c6s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c6s,3c_like_proteinase,SARS-CoV-2,0,1.19
7c6u,"Crystal structure of the SARS-CoV-2 main protease in complex with GC376, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c6u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c6u,3c_like_proteinase,SARS-CoV-2,0,1.4
7c7p,"X-ray diffraction data. Structure of the main-protease of SARS-CoV-2, in complex with Telaprevir.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c7p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c7p,3c_like_proteinase,SARS-CoV-2,0,1.89
7c8b,Crystal structure of the SARS-CoV-2 main protease in complex with Z-VAD(OMe)-FMK. It has a chloride ion as ligand and one modified residue.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c8b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c8b,3c_like_proteinase,SARS-CoV-2,0,1.66
7c8r,"Complex Structure of SARS-CoV-2 3CL Protease with TG-0203770. Cyclic homo-2-mer with one unique protein chain. Ligand is ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c8r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c8r,3c_like_proteinase,SARS-CoV-2,0,2.21
7c8t,Full length 3C-like protease from SARS-CoV with the inhibitor TG-0205221 in the active site. This X-ray crystal structure was phased using PDB entry 2zu4 for molecular replacement & has data to a resolution of 2.05Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c8t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c8t,3c_like_proteinase,SARS-CoV-2,0,2.22
7c8u,"Crystal structure of COVID-19 main protease in complex with GC376. Cyclic homo-2-mer with one unique protein chain. Ligand is (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7c8u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7c8u,3c_like_proteinase,SARS-CoV-2,0,5.57
7cbt,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) in complex with protease inhibitor GC376.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cbt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cbt,3c_like_proteinase,SARS-CoV-2,0,2.21
7com,"Crystal structure of the SARS-CoV-2 main protease in complex with boceprevir (space group P212121), forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7com,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7com,3c_like_proteinase,SARS-CoV-2,0,1.44
7cwb,"Ambient-Temperature Serial Femtosecond X-ray crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts. Shows altered conformation of active site",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cwb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cwb,3c_like_proteinase,SARS-CoV-2,0,1.5
7cwc,Ambient-Temperature Serial Femtosecond X-ray diffraction data. Structure of the main-protease of SARS-CoV-2.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cwc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cwc,3c_like_proteinase,SARS-CoV-2,0,1.83
7cx9,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with INZ-1",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cx9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cx9,3c_like_proteinase,SARS-CoV-2,0,1.71
7d1m,"Crystal structure of SARS-CoV-2 main protease complexed with GC376. Cyclic homo-2-mer. Ligand is (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid, a nucleotide analogue that inhibits viral RNA dependent RNA polymerase (RdRp), results in sterilizing additive effect.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7d1m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7d1m,3c_like_proteinase,SARS-CoV-2,0,1.43
7d1o,"Crystal structure of the SARS-CoV-2 main protease in complex with narlaprevir, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7d1o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7d1o,3c_like_proteinase,SARS-CoV-2,0,1.38
7d3i,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with MI-23. MI-23 is a bicycloproline-containing Mpro inhibitor. Measurement was part of a drug screen of potential inhibitors which are derived from either Boceprevir or Telaprevir.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7d3i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7d3i,3c_like_proteinase,SARS-CoV-2,0,1.02
7jkv,Full length 3C-like protease from Sars-Cov-2 with a 1.25A resolution and in complex with inhibitor FRL-2420. It was done via x-ray diffraction and [V7G] (https://www.rcsb.org/ligand/V7G) is bound.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jkv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jkv,3c_like_proteinase,SARS-CoV-2,0,1.44
7jox,Full length 3C-like protease from SARS-CoV with the inhibitor TG-0205221 in the active site. This X-ray crystal structure was phased using PDB entry 2zu4 for molecular replacement & has data to a resolution of 2.05Ã….,X-RAY DIFFRACTION,../pdb\3c_like_proteinase\SARS-CoV-2\7jox,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\3c_like_proteinase\SARS-CoV-2\7jox,..,pdb\3c_like_proteinase\SARS-CoV-2,0,1.93
7joy,Crystal structure of SARS CoV2 3C-like protease C145A mutant in complex with its C-terminal autoprocessing sequence. Product bound state at 2.0 Å resolution. Mutation of the catalytic cysteine to alanine (C145A) abolishes activity.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7joy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7joy,3c_like_proteinase,SARS-CoV-2,0,1.74
7jp1,"Crystal structure of 3C-like protease from SARS CoV2 (Homodimer), wild-type substrate free.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jp1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jp1,3c_like_proteinase,SARS-CoV-2,0,1.37
7jr3,Crystal structure of the SARS-CoV-2 main protease crystallized under reducing conditions. It forms a homodimer and has a resolution of 1.55 脜.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jr3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jr3,3c_like_proteinase,SARS-CoV-2,0,1.38
7jr4,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) with alternative conformation of the active site promoted by methylene-bridged cysteine and lysine residues. The resolution is 1.55 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jr4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jr4,3c_like_proteinase,SARS-CoV-2,0,1.16
7ju7,"The crystal structure of the SARS-CoV-2 main protease in complex with masitinib, forming a homodimer. Further ligands are dimethyl sulfoxide and glycerol. The structure has a resolution of 1.60 脜.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ju7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ju7,3c_like_proteinase,SARS-CoV-2,0,1.08
7jun,"Joint neutron/X-ray structure of SARS-CoV-2 3CL Mpro at room temperature. Cyclic homo-2-mer with one unique protein chain.Room-temperature neutron structure of 3CL Mpro, which allowed direct determination of hydrogen atom positions and, hence, protonation states in the protease..",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jun,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jun,3c_like_proteinase,SARS-CoV-2,0,2.99
7jvz,"Room temperature structure of the SARS-CoV-2 main protease, forming a homodimer.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jvz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jvz,3c_like_proteinase,SARS-CoV-2,0,3.05
7jyc,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) in complex with covalent inhibitor narlaprevir. Narlaprevir is an hepatitis C serine protease inhibitor.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jyc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jyc,3c_like_proteinase,SARS-CoV-2,0,1.38
7k3t,Crystal Structure of SARS-CoV-2 Main Protease (3CLpro/Mpro) in the Apo Form at 1.2 A Resolution,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k3t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k3t,3c_like_proteinase,SARS-CoV-2,0,1.19
7k40,The crystal structure of SARS-CoV-2 main protease (3CLpro/Mpro) in complex with covalent inhibitor boceprevir at 1.35 脜 resolution with dimethyl sulfide as ligand.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k40,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k40,3c_like_proteinase,SARS-CoV-2,0,1.42
7k6d,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) ‒ Co-Crystal Structure with Telaprevir. Determined from Crystals Grown with 40 nL Acoustically Ejected Mpro Droplets. The resolution is 1.48 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k6d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k6d,3c_like_proteinase,SARS-CoV-2,0,1.07
7k6e,SARS-CoV-2 Main Protease Co-Crystal Structure with Telaprevir Determined from Crystals Grown with 40 nL Acoustically Ejected Mpro Droplets at 1.63 A Resolution (Direct Vitrification).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k6e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k6e,3c_like_proteinase,SARS-CoV-2,0,1.06
7kfi,SARS-CoV-2 Main protease immature form - apo structure. Cyclic homo-2-mer with one unique protein chain. Resolution of 1.6 A.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kfi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kfi,3c_like_proteinase,SARS-CoV-2,0,1.31
7kfj,Full length 3C-like protease from SARS-CoV with the inhibitor TG-0205221 in the active site. This X-ray crystal structure was phased using PDB entry 2zu4 for molecular replacement & has data to a resolution of 2.05Ã….,X-RAY DIFFRACTION,../pdb\3c_like_proteinase\SARS-CoV-2\7kfj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\3c_like_proteinase\SARS-CoV-2\7kfj,..,pdb\3c_like_proteinase\SARS-CoV-2,0,1.64
7khp,Crystal structure of Acyl-enzyme intermediate structure of SARS-CoV-2 3C-like protease in complex with its native C-terminal autocleavage sequence.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7khp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7khp,3c_like_proteinase,SARS-CoV-2,0,1.94
7koa,Structure of SARS-CoV-2 Nsp10/16 Methyltransferase. The structure consists two Nsp chains dimerized. The Nsp16 chain is in complex with [Cap-0/GTA] (https://www.rcsb.org/ligand/GTA) and [SAM] (https://www.rcsb.org/ligand/SAM). It was determined with pink-beam serial crystallography.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7koa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7koa,methyltransferase-nsp10,SARS-CoV-2,0,1.65
7kph,"1.45 Å X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in mature form.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kph,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kph,3c_like_proteinase,SARS-CoV-2,0,1.23
2h85,"Full length SARS-CoV Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains one Nsp15 monomers which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This X-ray crystal structure has data to a resolution of 2.60Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV/2h85,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV/2h85,endornase,SARS-CoV,0,2.02
2ozk,"A truncated SARS-CoV Nsp15 (endoribonuclease) from residue 28-355 featuring a truncated N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains four Nsp15 monomers and is unable to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This X-ray crystal structure has data to a resolution of 2.90Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV/2ozk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV/2ozk,endornase,SARS-CoV,1,3.2
2rhb,"Full length SARS-CoV Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains six Nsp15 monomers forming the full biological assembly (a hexamer consisting of a dimer of trimers). This protein has a H234A mutation. This X-ray crystal structure has data to a resolution of 2.80Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV/2rhb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV/2rhb,endornase,SARS-CoV,0,2.56
6vww,"Full length SARS-CoV-2 Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to two magnesium ions not related to the active site. This X-ray crystal structure has data to a resolution of 2.20Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6vww,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6vww,endornase,SARS-CoV-2,1,1.09
6w01,"Full length SARS-CoV-2 Nsp15 (endoribonuclease)featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to a citrate molecule. This X-ray crystal structure has data to a resolution of 1.90Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6w01,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6w01,endornase,SARS-CoV-2,1,0.99
6wlc,"Full length SARS-CoV-2 Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to uridine-5'-monophosphate. This X-ray crystal structure has data to a resolution of 1.82Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6wlc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6wlc,endornase,SARS-CoV-2,0,1.21
6wxc,"Full length SARS-CoV-2 Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to a potentially repurposed drug, Tipiracil (5-Chloro-6-(1-(2-iminopyrolidinyl) methyl) uracil). This X-ray crystal structure has data to a resolution of 1.85Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6wxc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6wxc,endornase,SARS-CoV-2,0,1.4
6x1b,"Full length SARS-CoV-2 Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to product nucleotide GpU. This X-ray crystal structure has data to a resolution of 1.97Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6x1b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6x1b,endornase,SARS-CoV-2,0,1.18
6x4i,"Full length SARS-CoV-2 Nsp15 (endoribonuclease) featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to 3'-uridinemonophosphate. This X-ray crystal structure has data to a resolution of 1.85Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6x4i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6x4i,endornase,SARS-CoV-2,0,0.97
6xdh,"Full length SARS-CoV-2 Nsp15 (endoribonuclease)featuring an N-terminal oligomerisation domain, the middle domain, and the catalytic NendoU domain at the C-terminal. The model contains two Nsp15 monomers, one from each of the two trimers, which can be used to produce the full biological assembly (a hexamer consisting of a dimer of trimers) though generation of symmetry mates. This protein is bound to a citric acid. This X-ray crystal structure has data to a resolution of 2.35Å.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/6xdh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/6xdh,endornase,SARS-CoV-2,0,0.94
7k1l,"The crystal structure of the nsp15 endoribonuclease in complex with uridine-2',3'-vanadate. Further ligands are sulfate ion, acetate ion and 1,2-ethanediol.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7k1l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7k1l,endornase,SARS-CoV-2,0,1.19
7k1o,"The nsp15 endoribonuclease crystal structure in complex with uridine-3',5'-diphosphate. A further ligand is 1,2-ethanediol.",X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7k1o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7k1o,endornase,SARS-CoV-2,0,1.18
7k9p,The nsp15 endoribonuclease room temperature structure solved using SFX. As ligand it has citric acid.,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7k9p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7k9p,endornase,SARS-CoV-2,0,1.34
5c8s,Exonuclease (NSP14) in complex with NSP10 from SARS-CoV. This X-ray crystal structure has data to a resolution of 3.326Å resolution. This model has a SAH and GpppA present as functional ligands. Exonuclease has two domains responsible for guanine-N7-methyltransferase & 3'-5' exoribonuclease activity with a flexible linker between. NSP10 acts as an activator protein for NSP14.,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV/5c8s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV/5c8s,exonuclease-nsp10,SARS-CoV,0,3.4
5c8t,Exonuclease (NSP14) in complex with NSP10 from SARS-CoV. This X-ray crystal structure was phased using single-wavelength anomalous dispersion to 3.2Å resolution. This model has a SAM present as a functional ligand. Exonuclease has two domains responsible for guanine-N7-methyltransferase & 3'-5' exoribonuclease activity with a flexible linker between. NSP10 acts as an activator protein for NSP14.,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV/5c8t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV/5c8t,exonuclease-nsp10,SARS-CoV,1,3.11
5c8u,Exonuclease (NSP14) in complex with NSP10 from SARS-CoV. This X-ray crystal structure was phased was phased using molecular replacement & has data to a resolution of 3.401Å resolution. Exonuclease has two domains responsible for guanine-N7-methyltransferase & 3'-5' exoribonuclease activity with a flexible linker between. NSP10 acts as an activator protein for NSP14.,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV/5c8u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV/5c8u,exonuclease-nsp10,SARS-CoV,0,3.41
5nfy,Exonuclease (NSP14) in complex with NSP10 from SARS-CoV. This X-ray crystal structure was phased using multi-wavelength anomalous dispersion to 3.38Å resolution. Exonuclease has two domains responsible for guanine-N7-methyltransferase & 3'-5' exoribonuclease activity with a flexible linker between. NSP10 acts as an activator protein for NSP14.,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV/5nfy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV/5nfy,exonuclease-nsp10,SARS-CoV,1,2.38
6jyt,Full length structure of Helicase (NSP13) from SARS-CoV. This X-ray crystal structure was phased using single-wavelength anomalous dispersion to 2.8Å resolution. Helicase is a 5 domain protein responsible for the unwinding & separation of double stranded RNA & DNA with a 5'-3' polarity with an N-terminal zinc binding domain.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV/6jyt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV/6jyt,helicase,SARS-CoV,1,2.69
5rl6,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z198195770. Its ligands are zinc ions, phosphate ions and N-[3-(carbamoylamino)phenyl]acetamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rl6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rl6,helicase,SARS-CoV-2,0,1.94
5rl7,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VVD](https://www.rcsb.org/ligand/VVD).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rl7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rl7,helicase,SARS-CoV-2,0,2.17
5rl8,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VVG](https://www.rcsb.org/ligand/VVG).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rl8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rl8,helicase,SARS-CoV-2,0,2.28
5rl9,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1703168683. Its ligands are zinc ions, phosphate ions and 1-(3-fluoro-4-methylphenyl)methanesulfonamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rl9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rl9,helicase,SARS-CoV-2,0,1.76
5rlb,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z216450634. Its ligands are zinc ions, phosphate ions and N-cycloheptyl-N-methylmethanesulfonamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlb,helicase,SARS-CoV-2,0,2.23
5rlc,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlc,helicase,SARS-CoV-2,0,2.02
5rld,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z19735981. Its ligands are zinc ions, phosphate ions and 2-phenoxy-1-(pyrrolidin-1-yl)ethan-1-one.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rld,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rld,helicase,SARS-CoV-2,0,2.16
5rle,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1429867185. Its ligands are zinc ions, phosphate ions and 4-methoxy-1H-indole.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rle,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rle,helicase,SARS-CoV-2,0,2.27
5rlf,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z235341991. Its ligands are zinc ions, phosphate ions and N-(2-methoxy-5-methylphenyl)glycinamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlf,helicase,SARS-CoV-2,0,2.08
5rlg,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VW1](https://www.rcsb.org/ligand/VW1).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlg,helicase,SARS-CoV-2,0,2.17
5rlh,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z2856434778. Its ligands are zinc ions, phosphate ions and 2-(trifluoromethoxy)benzoic acid.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlh,helicase,SARS-CoV-2,0,2.26
5rli,Crystal Structure of SARS-CoV-2 helicase in complex with Z45617795 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is N-(2-phenylethyl)methanesulfonamide.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rli,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rli,helicase,SARS-CoV-2,0,2.3
5rlj,Crystal Structure of PHIP in complex with NCL-00024662 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is (4-bromo-2-methoxyphenyl)methanol.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlj,helicase,SARS-CoV-2,0,1.79
5rlk,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1509882419. Its ligands are zinc iions, phosphate ions and 1-(propan-2-yl)-1H-imidazole-4-sulfonamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlk,helicase,SARS-CoV-2,0,1.95
5rll,Crystal Structure of SARS-CoV-2 helicase in complex with Z425387594 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is 1-(2-ethoxyphenyl)piperazine.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rll,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rll,helicase,SARS-CoV-2,0,2.24
5rlm,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlm,helicase,SARS-CoV-2,0,1.88
5rln,Crystal Structure of SARS-CoV-2 helicase in complex with Z364328788 (PanDDA analysis group deposition). Ligand is 3-(acetylamino)-4-fluorobenzoic acid.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rln,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rln,helicase,SARS-CoV-2,0,2.05
5rlo,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1454310449. Its ligands are zinc ions, phosphate ions and N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlo,helicase,SARS-CoV-2,0,2.16
5rlp,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlp,helicase,SARS-CoV-2,0,2.22
5rlq,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [UVA](https://www.rcsb.org/ligand/UVA).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlq,helicase,SARS-CoV-2,0,2.06
5rlr,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z822382694. Its ligands are zinc ions, phosphate ions and (1R)-2-(methylsulfonyl)-1-phenylethan-1-ol.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlr,helicase,SARS-CoV-2,0,2.32
5rls,Crystal Structure of SARS-CoV-2 helicase in complex with Z59181945 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is N-hydroxyquinoline-2-carboxamide.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rls,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rls,helicase,SARS-CoV-2,0,2.29
5rlt,Crystal Structure of SARS-CoV-2 helicase in complex with Z53116498 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is 3-(2-methyl-1H-benzimidazol-1-yl)propanamide.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlt,helicase,SARS-CoV-2,0,2.15
5rlu,Crystal Structure of SARS-CoV-2 helicase in complex with Z744754722 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is 2-(thiophen-2-yl)-1H-imidazole.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlu,helicase,SARS-CoV-2,0,2.37
5rlv,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z2467208649. Its ligands are zinc ions, phosphate ions and N-(propan-2-yl)-1H-benzimidazol-2-amine.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlv,helicase,SARS-CoV-2,0,2.27
5rlw,"Crystal structure of the SARS-CoV-2 helicase in complex with Z45705015. Its ligands are zinc ions, phosphate ions and ~{N}-[2-(4-fluorophenyl)ethyl]methanesulfonamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlw,helicase,SARS-CoV-2,0,2.01
5rly,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z2027049478. Its ligands are zinc ions, phosphate ions and 5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rly,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rly,helicase,SARS-CoV-2,0,2.25
5rlz,Crystal Structure of SARS-CoV-2 helicase in complex with Z2293643386 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is (3R)-1-acetyl-3-hydroxypiperidine-3-carboxylic acid.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rlz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rlz,helicase,SARS-CoV-2,0,2.15
5rm0,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1492796719. Its ligands are zinc ions, phosphate ions and ~{N}-[(3~{R})-1,2,3,4-tetrahydroquinolin-3-yl]ethanamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm0,helicase,SARS-CoV-2,0,2.0
5rm1,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm1,helicase,SARS-CoV-2,0,1.78
5rm2,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1741964527. Its ligands are zinc ions, phosphate ions and 1-(diphenylmethyl)azetidin-3-ol.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm2,helicase,SARS-CoV-2,0,2.0
5rm3,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1745658474. Its ligands are zinc ions, phosphate ions and 2-(trifluoromethyl)pyrimidine-5-carboxamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm3,helicase,SARS-CoV-2,0,2.39
5rm4,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm4,helicase,SARS-CoV-2,0,2.45
5rm5,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z373768900. Its ligands are zinc ions, phosphate ions and N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm5,helicase,SARS-CoV-2,0,2.12
5rm6,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z396380540. Its ligands are zinc ions, phosphate ions and ~{N}-(cyclobutylmethyl)-1,5-dimethyl-pyrazole-4-carboxamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm6,helicase,SARS-CoV-2,0,2.08
5rm7,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z69118333. Its ligands are zinc ions, phosphate ions and ~{N}-(4-hydroxyphenyl)-3-phenyl-propanamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm7,helicase,SARS-CoV-2,0,2.05
5rm8,Crystal Structure of SARS-CoV-2 helicase in complex with Z1614545742 (PanDDA analysis group deposition) with a resolution of 2.14 A. Asymmetric monomer with one unique protein chain.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm8,helicase,SARS-CoV-2,0,2.06
5rm9,Crystal Structure of the SARS-CoV-2 helicase in complex with Z2856434942. Its ligands are zinc ions. phosphate ions and ~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rm9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rm9,helicase,SARS-CoV-2,0,2.08
5rma,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rma,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rma,helicase,SARS-CoV-2,0,1.95
5rmb,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z2856434920. Its ligands are zinc ions, phosphate ions and ethyl (1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)acetate.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmb,helicase,SARS-CoV-2,0,2.14
5rmc,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z24758179. Its ligands are zinc ions, phosphate ions and methyl 3-(methylsulfonylamino)benzoate.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmc,helicase,SARS-CoV-2,0,2.19
5rmd,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z57614330. Its ligands are zinc ionszinc ions, phosphate ions and N-ethyl-4-[(methylsulfonyl)amino]benzamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmd,helicase,SARS-CoV-2,0,1.93
5rme,Crystal Structure of SARS-CoV-2 helicase in complex with Z26333434 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is 4-(benzimidazol-1-ylmethyl)benzenecarbonitrile.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rme,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rme,helicase,SARS-CoV-2,0,2.48
5rmf,"Crystal Structure of SARS-CoV-2 helicase in complex with Z54226006 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is (2,6-difluorophenyl)(pyrrolidin-1-yl)methanone.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmf,helicase,SARS-CoV-2,0,2.19
5rmg,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmg,helicase,SARS-CoV-2,0,2.16
5rmh,Crystal Structure of SARS-CoV-2 helicase in complex with Z1101755952 (PanDDA analysis group deposition) with a resolution of 2.02 A. Asymmetric monomer with one unique protein chain.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmh,helicase,SARS-CoV-2,0,2.07
5rmi,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z53860899. Its ligands are zinc ions, phosphate ions and ~{N}-(1,3-benzodioxol-5-ylmethyl)ethanesulfonamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmi,helicase,SARS-CoV-2,0,2.02
5rmj,Crystal Structure of SARS-CoV-2 helicase in complex with Z68299550 (PanDDA analysis group deposition). Asymmetric monomer with one unique protein chain. Ligand is 3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide.,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmj,helicase,SARS-CoV-2,0,2.36
5rmk,"Crystal Structure of the SARS-CoV-2 helicase in complex with Z1273312153. Its ligands are zinc ions, phosphate ions and N-methyl-1H-indole-7-carboxamide.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmk,helicase,SARS-CoV-2,0,2.07
5rml,Part of PanDDA analysis group deposition. SARS-Cov-2 helicase NSP13 screened against the DSL Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [ZN](https://www.rcsb.org/ligand/ZN).,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rml,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rml,helicase,SARS-CoV-2,0,2.51
5rmm,"Crystal Structure of the SARS-CoV-2 helicase in complex with POB0066. Its ligands are zinc ions, phosphate ions and (3S,4S)-1-acetyl-4-phenylpyrrolidine-3-carboxylic acid.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rmm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rmm,helicase,SARS-CoV-2,0,2.13
6zsl,"Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution. SARS-CoV-2 helicase NSP13, asymmetric monomer.",X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/6zsl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/6zsl,helicase,SARS-CoV-2,0,1.69
1o86,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1o86,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1o86,..,pdb\human_interaction_partners\ACE2,0,0.0
1o8a,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1o8a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1o8a,..,pdb\human_interaction_partners\ACE2,0,0.0
1r42,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1r42,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1r42,..,pdb\human_interaction_partners\ACE2,1,3.05
1r4l,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1r4l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1r4l,..,pdb\human_interaction_partners\ACE2,0,3.97
1uze,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1uze,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1uze,..,pdb\human_interaction_partners\ACE2,0,3.97
1uzf,"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex (RTC) reveals an intermediate state in cap structure synthesis. Cryo-EM structure of an extended RTC assembled by nsp7-nsp8 2 -nsp12-nsp13 2 -RNA and a single RNA-binding protein, nsp9. Nsp9 binds tightly to nsp12 (RdRp) NiRAN, allowing nsp9 N terminus inserting into the catalytic center of nsp12 NiRAN, which then inhibits activity.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\1uzf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\1uzf,..,pdb\human_interaction_partners\ACE2,0,3.97
2ajf,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2ajf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2ajf,surface_glycoprotein,SARS-CoV,0,3.08
2c6f,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2c6f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2c6f,..,pdb\human_interaction_partners\ACE2,0,3.32
2c6n,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2c6n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2c6n,..,pdb\human_interaction_partners\ACE2,0,3.67
2iul,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2iul,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2iul,..,pdb\human_interaction_partners\ACE2,0,1.54
2iux,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2iux,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2iux,..,pdb\human_interaction_partners\ACE2,0,2.55
2oc2,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2oc2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2oc2,..,pdb\human_interaction_partners\ACE2,0,1.94
2xy9,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2xy9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2xy9,..,pdb\human_interaction_partners\ACE2,0,1.45
2xyd,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2xyd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2xyd,..,pdb\human_interaction_partners\ACE2,0,1.39
2ydm,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\2ydm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\2ydm,..,pdb\human_interaction_partners\ACE2,0,1.7
3bkk,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\3bkk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\3bkk,..,pdb\human_interaction_partners\ACE2,0,2.06
3bkl,"The non-polymer only dimer is a 4 chain structure. It shows the spike receptor-binding domain S complexed with its receptor ACE2. S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The two proteins clarify the importance of residue changes that facilitate cross-species infection and human-to-human transmission.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\3bkl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\3bkl,..,pdb\human_interaction_partners\ACE2,0,2.01
3d0g,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS-CoV human strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3d0g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3d0g,surface_glycoprotein,SARS-CoV,0,2.88
3d0h,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS-CoV civet strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3d0h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3d0h,surface_glycoprotein,SARS-CoV,0,3.2
3d0i,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS-CoV civet strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3d0i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3d0i,surface_glycoprotein,SARS-CoV,0,3.1
3kbh,"The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS-CoV civet strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets."" ",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\3kbh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\3kbh,..,pdb\human_interaction_partners\ACE2,0,3.39
3l3n,"The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS-CoV civet strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets."" ",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\3l3n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\3l3n,..,pdb\human_interaction_partners\ACE2,0,2.04
3nxq,"The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only tetramer is a 4 chain crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS-CoV civet strain complexed with human-civet chimeric receptor ACE2. It is a basis for understanding the species barriers between humans and civets."" ",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\3nxq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\3nxq,..,pdb\human_interaction_partners\ACE2,0,1.45
3sci,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human strain complexed with human receptor ACE2.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3sci,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3sci,surface_glycoprotein,SARS-CoV,0,3.17
3scj,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3scj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3scj,surface_glycoprotein,SARS-CoV,0,3.24
3sck,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3sck,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3sck,surface_glycoprotein,SARS-CoV,0,3.49
3scl,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3scl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3scl,surface_glycoprotein,SARS-CoV,0,3.16
4aph,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4aph,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4aph,..,pdb\human_interaction_partners\ACE2,0,1.55
4apj,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4apj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4apj,..,pdb\human_interaction_partners\ACE2,0,1.23
4bxk,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4bxk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4bxk,..,pdb\human_interaction_partners\ACE2,0,1.24
4bzr,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4bzr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4bzr,..,pdb\human_interaction_partners\ACE2,0,1.11
4bzs,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4bzs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4bzs,..,pdb\human_interaction_partners\ACE2,0,1.28
4c2n,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4c2n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4c2n,..,pdb\human_interaction_partners\ACE2,0,1.17
4c2o,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4c2o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4c2o,..,pdb\human_interaction_partners\ACE2,0,1.08
4c2p,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4c2p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4c2p,..,pdb\human_interaction_partners\ACE2,0,1.13
4c2q,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4c2q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4c2q,..,pdb\human_interaction_partners\ACE2,0,1.22
4c2r,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4c2r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4c2r,..,pdb\human_interaction_partners\ACE2,0,1.1
4ca5,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4ca5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4ca5,..,pdb\human_interaction_partners\ACE2,0,1.16
4ca6,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4ca6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4ca6,..,pdb\human_interaction_partners\ACE2,0,1.4
4ufa,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4ufa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4ufa,..,pdb\human_interaction_partners\ACE2,0,1.18
4ufb,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\4ufb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\4ufb,..,pdb\human_interaction_partners\ACE2,0,1.05
5am8,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\5am8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\5am8,..,pdb\human_interaction_partners\ACE2,0,1.02
5am9,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\5am9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\5am9,..,pdb\human_interaction_partners\ACE2,0,0.96
5ama,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\5ama,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\5ama,..,pdb\human_interaction_partners\ACE2,0,0.86
5amb,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\5amb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\5amb,..,pdb\human_interaction_partners\ACE2,0,1.07
5amc,The spike receptor-binding domain S attaches the virus to ACE2. The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\5amc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\5amc,..,pdb\human_interaction_partners\ACE2,0,0.9
6en5,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6en5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6en5,..,pdb\human_interaction_partners\ACE2,0,0.88
6en6,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6en6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6en6,..,pdb\human_interaction_partners\ACE2,0,1.02
6f9r,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6f9r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6f9r,..,pdb\human_interaction_partners\ACE2,0,1.09
6f9t,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6f9t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6f9t,..,pdb\human_interaction_partners\ACE2,0,1.08
6f9u,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6f9u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6f9u,..,pdb\human_interaction_partners\ACE2,0,0.84
6f9v,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6f9v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6f9v,..,pdb\human_interaction_partners\ACE2,0,1.21
6h5w,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6h5w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6h5w,..,pdb\human_interaction_partners\ACE2,0,0.98
6h5x,"SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles. This study reveal that stabilized spikes resist conformational changes induced by receptor.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6h5x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6h5x,..,pdb\human_interaction_partners\ACE2,0,1.07
6lzg,"Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2. This structure highlights the key interaction between the spike and ACE2, later confirmed by EM structures.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6lzg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6lzg,surface_glycoprotein,SARS-CoV-2,0,1.38
6m0j,"Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2. This structure highlights the key interaction between the spike and ACE2, later confirmed by EM structures.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6m0j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6m0j,surface_glycoprotein,SARS-CoV-2,1,1.62
6qs1,Receptor binding domain in complex with full lenght ACE2 and amino acid transporter B0AT1. Study highlight the entry mechanism of SARS-CoV-2 in cells.,X-RAY DIFFRACTION,../pdb\human_interaction_partners\ACE2\6qs1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\ACE2\6qs1,..,pdb\human_interaction_partners\ACE2,0,1.43
6vw1,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6vw1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6vw1,surface_glycoprotein,SARS-CoV-2,1,2.07
1cjl,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\1cjl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\1cjl,..,pdb\human_interaction_partners\Cathepsin_L,0,1.81
1cs8,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\1cs8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\1cs8,..,pdb\human_interaction_partners\Cathepsin_L,0,1.44
1icf,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\1icf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\1icf,..,pdb\human_interaction_partners\Cathepsin_L,0,1.44
1mhw,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\1mhw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\1mhw,..,pdb\human_interaction_partners\Cathepsin_L,0,1.88
2nqd,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2nqd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2nqd,..,pdb\human_interaction_partners\Cathepsin_L,0,1.76
2vhs,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2vhs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2vhs,..,pdb\human_interaction_partners\Cathepsin_L,0,1.06
2xu1,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2xu1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2xu1,..,pdb\human_interaction_partners\Cathepsin_L,0,1.56
2xu3,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2xu3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2xu3,..,pdb\human_interaction_partners\Cathepsin_L,0,1.39
2xu4,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2xu4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2xu4,..,pdb\human_interaction_partners\Cathepsin_L,0,1.34
2xu5,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2xu5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2xu5,..,pdb\human_interaction_partners\Cathepsin_L,0,1.33
2yj2,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2yj2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2yj2,..,pdb\human_interaction_partners\Cathepsin_L,0,1.13
2yj8,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2yj8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2yj8,..,pdb\human_interaction_partners\Cathepsin_L,0,1.29
2yj9,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2yj9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2yj9,..,pdb\human_interaction_partners\Cathepsin_L,0,1.0
2yjb,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2yjb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2yjb,..,pdb\human_interaction_partners\Cathepsin_L,0,1.16
2yjc,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\2yjc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\2yjc,..,pdb\human_interaction_partners\Cathepsin_L,0,1.26
3bc3,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3bc3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3bc3,..,pdb\human_interaction_partners\Cathepsin_L,0,2.18
3h89,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3h89,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3h89,..,pdb\human_interaction_partners\Cathepsin_L,0,2.51
3h8b,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3h8b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3h8b,..,pdb\human_interaction_partners\Cathepsin_L,0,2.23
3h8c,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3h8c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3h8c,..,pdb\human_interaction_partners\Cathepsin_L,0,2.67
3hha,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3hha,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3hha,..,pdb\human_interaction_partners\Cathepsin_L,0,1.36
3hwn,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3hwn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3hwn,..,pdb\human_interaction_partners\Cathepsin_L,0,2.51
3iv2,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3iv2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3iv2,..,pdb\human_interaction_partners\Cathepsin_L,0,2.7
3k24,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3k24,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3k24,..,pdb\human_interaction_partners\Cathepsin_L,0,2.78
3kse,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3kse,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3kse,..,pdb\human_interaction_partners\Cathepsin_L,0,2.08
3of8,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3of8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3of8,..,pdb\human_interaction_partners\Cathepsin_L,0,2.44
3of9,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\3of9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\3of9,..,pdb\human_interaction_partners\Cathepsin_L,0,2.17
4axl,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\4axl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\4axl,..,pdb\human_interaction_partners\Cathepsin_L,0,1.5
4axm,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\4axm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\4axm,..,pdb\human_interaction_partners\Cathepsin_L,0,2.59
5f02,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\5f02,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\5f02,..,pdb\human_interaction_partners\Cathepsin_L,0,0.9
5i4h,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\5i4h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\5i4h,..,pdb\human_interaction_partners\Cathepsin_L,0,1.37
5mae,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\5mae,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\5mae,..,pdb\human_interaction_partners\Cathepsin_L,0,1.35
5maj,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\5maj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\5maj,..,pdb\human_interaction_partners\Cathepsin_L,0,1.69
5mqy,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\5mqy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\5mqy,..,pdb\human_interaction_partners\Cathepsin_L,0,1.52
6ezp,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\6ezp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\6ezp,..,pdb\human_interaction_partners\Cathepsin_L,0,0.97
6ezx,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\6ezx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\6ezx,..,pdb\human_interaction_partners\Cathepsin_L,0,2.34
6f06,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\6f06,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\6f06,..,pdb\human_interaction_partners\Cathepsin_L,0,2.27
6jd0,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\6jd0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\6jd0,..,pdb\human_interaction_partners\Cathepsin_L,0,2.03
6jd8,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Cathepsin_L\6jd8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Cathepsin_L\6jd8,..,pdb\human_interaction_partners\Cathepsin_L,0,2.55
5ek0,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\TCP2\5ek0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\5ek0,..,pdb\human_interaction_partners\TCP2,0,2.59
6n4i,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\TCP2\6n4i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\TCP2\6n4i,..,pdb\human_interaction_partners\TCP2,0,2.37
1xak,"SARS-CoV ORF7a accessory protein, a unique type I transmembrane protein of unknown function. Has a short cytoplasmic tail and a transmembrane domain. Consists of one chain (chain A), that forms a compact seven-stranded beta sandwich.",X-RAY DIFFRACTION,pdb/hypothetical_protein_sars7a/SARS-CoV/1xak,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/hypothetical_protein_sars7a/SARS-CoV/1xak,hypothetical_protein_sars7a,SARS-CoV,1,2.37
7k3n,"This X-Ray structure shows the SARS-CoV-2 leader protein (Nsp1) at a resolution of 1.65 Å but with several unmodelled regions. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",X-RAY DIFFRACTION,pdb/leader_protein/SARS-CoV-2/7k3n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7k3n,leader_protein,SARS-CoV-2,0,1.55
7k7p,"This X-Ray structure shows the full length SARS-CoV-2 leader protein (Nsp1) at a resolution of 1.77 Å. The protein inserts its C-terminal domain into the mRNA channel of the ribosome, where it interferes with mRNA binding and inhibits cellular (not viral) translation. Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection.",X-RAY DIFFRACTION,pdb/leader_protein/SARS-CoV-2/7k7p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7k7p,leader_protein,SARS-CoV-2,0,1.89
2xyq,"nsp16-nsp10 SARS coronavirus complex with S-ADENOSYL-L-HOMOCYSTEINE. Nsp-16 is a S-adenosylmethionine-dependent (nucleoside-2'-O)-methyltransferase only active in the presence of its activating partner nsp10. Structure consists of two chains, nsp10 is bound to nsp16 through a ∼930 Å² surface area in nsp10. Key residues involved in nsp10/nsp16 association, and in RNA binding or catalysis.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV/2xyq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV/2xyq,methyltransferase-nsp10,SARS-CoV,0,1.52
2xyr,nsp16-nsp10 SARS coronavirus complex with Sinefungin. Nsp-16 is a S-adenosylmethionine-dependent (nucleoside-2'-O)-methyltransferase only active in the presence of its activating partner nsp10.Sinefungin influences the RNA-binding capacity of the complex.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV/2xyr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV/2xyr,methyltransferase-nsp10,SARS-CoV,0,1.74
2xyv,"nsp16-nsp10 SARS coronavirus complex S-ADENOSYL-L-HOMOCYSTEINE. Nsp-16 is a S-adenosylmethionine-dependent (nucleoside-2'-O)-methyltransferase only active in the presence of its activating partner nsp10. Structure consists of two chains, nsp10 is bound to nsp16 through a ∼930 Å² surface area in nsp10. Key residues involved in nsp10/nsp16 association, and in RNA binding or catalysis.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV/2xyv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV/2xyv,methyltransferase-nsp10,SARS-CoV,0,1.35
3r24,"nsp16-nsp10 SARS coronavirus complex or SARS-CoV 2'-O-MTase bound with methyl donor SAM. The structure the interaction interface shows that nsp10 may stabilize the SAM-binding pocket and extend the RNA-binding groove of nsp16, which suggests that the nsp16/nsp10 interface may represent a beter drug target than the viral MTase active site fordeveloping highly specific anti-coronavirus drugs.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV/3r24,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV/3r24,methyltransferase-nsp10,SARS-CoV,1,2.63
6w4h,"NSP16 - NSP10 Complex from SARS-CoV-2. Methyltransferase that mediates mRNA cap methylation of viral mRNAs, which is essential to evade immune system. Forms complex and only functions with nsp-10.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6w4h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6w4h,methyltransferase-nsp10,SARS-CoV-2,0,1.19
6w61,"Methyltransferase-stimulatory factor complex of NSP16 and NSP10 from SARS CoV-2. 2'-O-methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA cap to the structure of viral mRNAs, which is essential to evade immune system.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6w61,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6w61,methyltransferase-nsp10,SARS-CoV-2,0,1.5
6w75,"NSP10 - NSP16 Complex from SARS-CoV-2. Methyltransferase that mediates mRNA cap of viral mRNAs. Therefore plays an essential role inviral mRNAs cap methylation, which is essential to evade immune system.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6w75,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6w75,methyltransferase-nsp10,SARS-CoV-2,0,1.29
6wjt,Nsp16-Nsp10 Heterodimer from SARS-CoV-2 in Complex with S-Adenosyl-L-Homocysteine. Methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA cap methylation of viral mRNAs. The Methyltransfearse is dependent on S-Adenosyl-l-homocysteine which could be a possible drug target to inhibit the complex.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wjt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wjt,methyltransferase-nsp10,SARS-CoV-2,0,1.34
6wkq,"NSP16-NSP10 Heterodimer from SARS-CoV-2 in Complex with Sinefungin. Chain A and C show nsp-16, the methyltransferase that interacts with nsp-10 (chain B,D) to mediate mRNA cap methylation. Sinefungin is known to inhibit DNA-methyltransferases which could be used to inactivate complex and immune system invasion of virus.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wkq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wkq,methyltransferase-nsp10,SARS-CoV-2,0,1.12
6wks,"SARS-CoV-2 nsp16-nsp10 ternary complex. Methyltransferase that mediates mRNA cap methylation of viral mRNAs, which is essential to evade immune system. Nsp-10 binding to nsp-16 is cruitial for full catalytic function, but excact role of nsp-10 is yet to be determined.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wks,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wks,methyltransferase-nsp10,SARS-CoV-2,0,
6wq3,"Nsp16-Nsp10 Heterodimer from SARS-CoV-2 in Complex with 7-methyl-GpppA and S-adenosyl-L-homocysteine. Methyltransferase nsp-16 interacts with nsp10 and mediates mRNA cap methylation of viral mRNAs. 7-methyl-GpppA shows specific binding options with the complex, and could inhibit its S-Adenosyl-l-homocysteine-depentend function or assembly.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wq3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wq3,methyltransferase-nsp10,SARS-CoV-2,0,1.0
6wrz,"Nsp16-Nsp10 Heterodimer from SARS-CoV-2 with 7-methyl-GpppA and S-adenosyl-L-homocysteine in the Active Site and Sulfates in the mRNA Binding Groove. Methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA cap methylation of viral mRNAs. 7-methyl-GpppA shows specific binding options with the complex, and could inhibit its S-Adenosyl-l-homocysteine-depentend function or assembly. Sulfates in the binding-groovee could prevent correct RNA binding, hence inhibit catalytic action.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wrz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wrz,methyltransferase-nsp10,SARS-CoV-2,0,1.08
6wvn,"Nsp16-Nsp10 from SARS-CoV-2 in Complex with 7-methyl-GpppA and S-Adenosylmethionine. Methyltransferase nsp-16 interacts with nsp-10 tomediate mRNAcap of viral mRNAs. Both 7-methyl-GpppA and S-Adenosylmethionine show specific binding options with the complex, and could inhibit its function or assembly.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6wvn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6wvn,methyltransferase-nsp10,SARS-CoV-2,0,1.08
6xkm,Room Temperature Structure of SARS-CoV-2 NSP10/NSP16 Methyltransferase in a Complex with SAM Determined by Fixed-Target Serial Crystallography. S-ADENOSYLMETHIONINE plays a cruital role in the function and assembly of the complex and may be an interesing target for inhibition of the Methyltransferase.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/6xkm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/6xkm,methyltransferase-nsp10,SARS-CoV-2,0,1.26
6yz1,SARS-CoV-2 nsp10-nsp16 methyltransferase complex with Sinefungin. Methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA cap methylation of viral mRNAs. Sinefungin is known to inhibit DNA-methyltransferases which could be used to inactivate complex and immune system invasion of virus.,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/6yz1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/6yz1,nsp10,SARS-CoV-2,0,7.03
7bq7,"2019-nCoV nsp16-nsp10 complex.Methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA methylation of viral mRNAs, which is essential to evade immune system. S-ADENOSYLMETHIONINEincluded in structural complex, influence on nsp10-nsp16 interaction is yet to be determined.",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7bq7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7bq7,nsp10,SARS-CoV-2,0,2.01
7c2i,"Crystal structure of nsp16-nsp10 heterodimer from SARS-CoV-2 in complex with SAM (with additional SAM during crystallization). Replicase polyprotein 1ab, consisting of two chains.  S-ADENOSYLMETHIONINE as an important cofactor for the full function of the protein complex.",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7c2i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7c2i,nsp10,SARS-CoV-2,0,1.12
7c2j,nsp16-nsp10 heterodimer from SARS-CoV-2 in complex with SAM (without additional SAM during crystallization). Methyltransferase nsp-16 interacts with nsp-10 to mediate mRNA cap methylation of viral mRNAs. S-Adenosylmethionin could influence the assembly and function of the methyltransfrase-complex.,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7c2j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7c2j,nsp10,SARS-CoV-2,0,1.48
7jhe,"Room Temperature Structure of SARS-CoV-2 Nsp10/Nsp16 Methyltransferase in a Complex with 2'-O-methylated m7GpppA Cap-1 and SAH Determined by Fixed-Target Serial Crystallography with a resolution of 2.25 A. 2'-O-methyltransferase (chain A) in complex with non-structural protein 10 (chain B) with the Ligands 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-(2'-O-METHYL)-ADENOSINE, 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE and S-ADENOSYL-L-HOMOCYSTEINE.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7jhe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7jhe,methyltransferase-nsp10,SARS-CoV-2,0,1.35
7jib,"Room Temperature Crystal Structure of Nsp10/Nsp16 from SARS-CoV-2 with Substrates and Products of 2""-O-methylation of the Cap-1 with a resolution of 2.65 A. Consist of 2 unique protein chains.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7jib,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7jib,methyltransferase-nsp10,SARS-CoV-2,0,1.13
7jpe,Room Temperature Structure of SARS-CoV-2 Nsp10/Nsp16 Methyltransferase in a Complex with m7GpppA Cap-0 and SAM Determined by Fixed-Target Serial Crystallography. Resolution of 2.18 A. 2'-O-methyltransferase (chain A) in complex with non-structural protein 10 (chain B).,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7jpe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7jpe,methyltransferase-nsp10,SARS-CoV-2,0,1.09
7jyy,Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA)pUpUpApApA (Cap-0) and S-Adenosylmethionine (SAM) with a resolution of 2.05 A. Asymmetric complex with Hetero 2-mer-A1B1 stoecheometry.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7jyy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7jyy,methyltransferase-nsp10,SARS-CoV-2,0,1.32
7jz0,Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1) and S-Adenosyl-L-homocysteine (SAH) with a resolution of 2.15 A. Consists of two unique protein chains and one unique nucleic acid chain.,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7jz0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7jz0,methyltransferase-nsp10,SARS-CoV-2,0,1.29
2fyg,"NSP10 from Sars coronavirus. Single domain protein consisting of a pair of antiparallel N-terminal helices stacked against an irregular beta-sheet,a coil-rich C terminus, and two Zn fingers. Nsp10 represents a novel fold and is the first structural representative of this family of Zn finger proteins found so far exclusively in coronaviruses. Exact role within the replicase complex is still not clear.",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV/2fyg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV/2fyg,nsp10,SARS-CoV,0,1.82
2g9t,"NSP10 from Sars coronavirus. The nsp10 structure has a novel fold, and 12 identical subunits assemble to form a unique spherical dodecameric architecture. Two zinc fingers have been identified from the nsp10 monomer structure. The zinc finger sequence motifs are conserved among all three coronavirus antigenic groups, implicating an essential function for nsp10 in all coronaviruses.",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV/2g9t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV/2g9t,nsp10,SARS-CoV,0,2.45
2ga6,"NSP10 from Sars coronavirus without zinc ionas additive. The nsp10 structure has a novel fold, and12 identical subunits assemble to form a unique spherical dodecameric architecture. Two zinc fingers havebeen identified from the nsp10 monomer structure. Thezinc finger sequence motifs are conserved among all three coronavirus antigenic groups, implicating an essential function for nsp10 in all coronaviruses.Zinc-concentration could influence binding capabilities of nsp10",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV/2ga6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV/2ga6,nsp10,SARS-CoV,0,2.94
6zct,Nonstructural protein 10 (nsp10) from SARSCoV-2. NSP-10 forms a dodecamer and interacts with nsp14 and nsp16; these interactions enhance nsp14 and nsp16 enzymatic activities. The hydrophobic domains(HD) could mediate the membrane association of the replication complex and thereby alter the architecture of the host cell membrane.,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/6zct,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/6zct,nsp10,SARS-CoV-2,0,2.83
6zpe,"The non-structural protein nsp10 of SARS-CoV-2, where it acts as allosteric activator for nsp14 and nsp16. Its ligands are chlorideions,  zinc ions and glycerol. It has a resolution of 1.58 脜.",X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/6zpe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/6zpe,nsp10,SARS-CoV-2,0,1.37
2acf,"The crystal structure of the conserved Mac1 domain of nsp3 from SARS-CoV has been solved by single-wavelength anomalous dispersion to 1.4 A resolution. The structure of this Mac1 domain. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/2acf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2acf,nsp3,SARS-CoV,0,1.23
2fav,"The crystal structure of the SARS-CoV Mac1 domain was determined at 1.8-Angstroms resolution in complex with ADP-ribose. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/2fav,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2fav,nsp3,SARS-CoV,0,1.42
2fe8,"In this entry, the 1.85-A crystal structure of the catalytic core of the PLpro domain is shown. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/2fe8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2fe8,nsp3,SARS-CoV,0,1.7
2w2g,"The crystal structures of fragment 389-652 (Mac2) of Nsp3, which comprises 264 of the 338 residues of the domain. This domains function is connected to RNA binding, preferentially binds oligo G.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/2w2g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2w2g,nsp3,SARS-CoV,0,2.11
2wct,"The crystal structures of fragment 389-652 (Mac2) of Nsp3, which comprises 264 of the 338 residues of the domain. This domains function is connected to RNA binding, preferentially binds oligo G.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/2wct,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/2wct,nsp3,SARS-CoV,0,2.29
3e9s,No article published to this date. Structure of PL2pro.Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/3e9s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/3e9s,nsp3,SARS-CoV,0,2.24
3mj5,"Crystal structure of nsp3 Plpro with the potential inhibitor N-(1,3-benzodioxol-5-ylmethyl)-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide as a ligand. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/3mj5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/3mj5,nsp3,SARS-CoV,0,2.8
4m0w,The crystal structure of SARS-CoV PLpro C112S mutant in complex with ubiquitin  reported at 1.4 Å resolution. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/4m0w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/4m0w,nsp3,SARS-CoV,0,1.23
4mm3,The X-ray crystal structure of PLpro in complex with ubiquitin-aldehyde reported at 2.75 Å resolution. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/4mm3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/4mm3,nsp3,SARS-CoV,0,2.29
4ovz,The X-ray crystal structure of PLpro in complex with N-[(4-fluorophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide reported at 2.50 Å resolution. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/4ovz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/4ovz,nsp3,SARS-CoV,0,2.73
4ow0,The X-ray crystal structure of PLpro in complex with N-[(3-fluorophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide reported at  2.10 Å resolution. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/4ow0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/4ow0,nsp3,SARS-CoV,0,2.24
5e6j,The X-ray crystal structure Structure of SARS PLpro bound to a Lys48-linked di-ubiquitin activity based probe.Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/5e6j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/5e6j,nsp3,SARS-CoV,0,1.39
5tl6,The X-ray crystal structure of SARS-CoV Plpro in complex with the C-terminal domain of human ISG15.Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/5tl6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/5tl6,nsp3,SARS-CoV,0,1.56
5tl7,The X-ray crystal structure of SARS-CoV Plpro in complex with the C-terminal domain of mouse ISG15.Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/5tl7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/5tl7,nsp3,SARS-CoV,0,1.85
5y3e,The X-ray Crystal structure of SARS Plpro in complex with glycerol reported at 1.65 Å. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/5y3e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/5y3e,nsp3,SARS-CoV,0,1.25
5y3q,The X-ray Crystal structure of SARS Plpro in complex with beta-mercaptoethanol reported at 1.65 Å. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/5y3q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/5y3q,nsp3,SARS-CoV,0,1.46
6vxs,"2 Å Crystal Structure of Mac1 domain of NSP3 from SARS CoV-2. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6vxs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6vxs,nsp3,SARS-CoV-2,1,1.13
6w02,"1,5 Å Crystal Structure of Mac1 domain of NSP3 from SARS CoV-2 in the complex with ADP ribose. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6w02,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6w02,nsp3,SARS-CoV-2,0,1.07
6w6y,"1,5 Å Crystal Structure of Mac1 domain of NSP3 from SARS CoV-2 in complex with AMP. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6w6y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6w6y,nsp3,SARS-CoV-2,0,0.83
6w9c,2.7 Å crystal structure of papain-like protease of SARS CoV-2. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6w9c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6w9c,nsp3,SARS-CoV-2,1,2.7
6wcf,1.065 Å Crystal Structure of ADP ribose phosphatase of NSP3 from SARS-CoV-2 in complex with MES (2-(N-MORPHOLINO)-ETHANESULFONIC ACID) ,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wcf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wcf,nsp3,SARS-CoV-2,0,1.2
6wen,"The x-ray Crystal Structure of Mac1 of NSP3 from SARS-CoV-2 in the apo form. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wen,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wen,nsp3,SARS-CoV-2,0,0.63
6wey,"0.95 Å resolution structure of the SARS-CoV-2 NSP3 Mac1 domain. This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wey,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wey,nsp3,SARS-CoV-2,0,0.93
6woj,"2.20 Å. resolution X-ray diffraction Structure of the SARS-CoV-2 Mac1 (NSP3) in complex with ADP-ribose.  This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6woj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6woj,nsp3,SARS-CoV-2,0,1.46
6wrh,"1.6 Å resolution crystal structure of Pl2pro domain of SARS CoV-2 , C111S is mutated. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wrh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wrh,nsp3,SARS-CoV-2,0,1.04
6wuu,Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR250. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wuu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wuu,nsp3,SARS-CoV-2,0,1.54
6wx4,Crystal structure of the SARS CoV-2 Papain-like protease in complex with peptide inhibitor VIR251. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wx4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wx4,nsp3,SARS-CoV-2,0,1.19
6wzu,1.79 Å resolution  crystal structure of PL2pro domain of SARS CoV-2 with P3221 space group. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6wzu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6wzu,nsp3,SARS-CoV-2,0,1.28
6xa9,"The crystal structure of the PLpro domain in complex with ISG15 C-terminal domain propargylamide. Structure reported as Hetero 2-mer. ISG15 is one of the targets of PLpro, the structure shows the interaction between PLpro and ISG15",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6xa9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6xa9,nsp3,SARS-CoV-2,0,1.29
6xaa,"The crystal structure of the PLpro domain in complex with ubiquitin propargylamide. Structure reported as Hetero 2-mer.Ubq is one of the targets of PLpro, the structure shows the interaction between PLpro and Ubq",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6xaa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6xaa,nsp3,SARS-CoV-2,0,1.43
6xg3,The crystal structure of the PLpro domain. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.C111S mutant measured at room temperature.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6xg3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6xg3,nsp3,SARS-CoV-2,0,2.18
6yva,"The crystal structure of PLpro-C111S in complex with mISG15. Pl2pro is responsible for the cleaving of nsp1 to nsp4 of the polyprotein and also has a role in reducing the human immune response.Structure reported as Hetero 2-mer. ISG15 is one of the targets of PLpro, the structure shows the interaction between PLpro and ISG15",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6yva,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6yva,nsp3,SARS-CoV-2,0,1.59
6ywk,"The crystal structure of SARS-CoV-2 NSP3 Mac1 in complex with a potential inhibitor HEPES (4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID).This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6ywk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6ywk,nsp3,SARS-CoV-2,0,1.1
6ywl,"The crystal structure of SARS-CoV-2 nsp3 Mac1 domain in complex with ADP-ribose.This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6ywl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6ywl,nsp3,SARS-CoV-2,0,1.1
6ywm,"The crystal structure of SARS-CoV-2 (Covid-19) NSP3 Mac1 domain in complex with MES (2-(N-MORPHOLINO)-ETHANESULFONIC ACID). This domain has a function as an ADP ribose 1""-phosphatase.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6ywm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6ywm,nsp3,SARS-CoV-2,0,1.25
7c33,X-ray diffraction data. Structure of macro domain of nsp3 of SARS CoV-2 in complex with ADP-ribose.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7c33,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7c33,nsp3,SARS-CoV-2,0,1.48
7cjd,"X-ray diffraction data. Structure of the SARS-CoV-2 papain-like protease domain of nsp3, C112S mutant.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7cjd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7cjd,nsp3,SARS-CoV-2,0,2.32
7cjm,X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 in complex with GRL0617.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7cjm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7cjm,nsp3,SARS-CoV-2,0,1.74
7cmd,"X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 , C112S mutant, in complex with GRL0617.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7cmd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7cmd,nsp3,SARS-CoV-2,0,2.06
7cz4,X-ray diffraction data. Structure of macro domain of nsp3 of SARS CoV-2 in complex with ADP-ribose.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7cz4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7cz4,nsp3,SARS-CoV-2,0,1.48
7d47,"X-ray diffraction data. Structure of the SARS-CoV-2 papain-like protease domain of nsp3, C112S mutant.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7d47,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7d47,nsp3,SARS-CoV-2,0,1.84
7d6h,"X-ray diffraction data. Structure of the SARS-CoV-2 papain-like protease domain of nsp3, C112S mutant.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7d6h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7d6h,nsp3,SARS-CoV-2,0,0.85
7d7t,"X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 , C112S mutant, bound to compound S43.",X-RAY DIFFRACTION,../pdb\nsp3\SARS-CoV-2\7d7t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\nsp3\SARS-CoV-2\7d7t,..,pdb\nsp3\SARS-CoV-2,0,1.84
7jir,"X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 , C111S mutant, in complex with PLP_Snyder457.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jir,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jir,nsp3,SARS-CoV-2,0,1.39
7jit,"X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 , C111S mutant, in complex with PLP_Snyder495",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jit,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jit,nsp3,SARS-CoV-2,0,1.28
7jiv,"X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2, C111S mutant, in complex with PLP_Snyder530.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jiv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jiv,nsp3,SARS-CoV-2,0,1.72
7jiw,X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 in complex with PLP_Snyder530.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jiw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jiw,nsp3,SARS-CoV-2,0,1.57
7jme,X-ray diffraction data. Structure of macro domain of nsp3 of SARS CoV-2 in complex with cyclic AMP.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jme,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jme,nsp3,SARS-CoV-2,0,0.75
7jn2,X-ray diffraction data. Structure of Papain-Like Protease domain of nsp3 of SARS CoV-2 in complex with PLP_Snyder441.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jn2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jn2,nsp3,SARS-CoV-2,0,1.5
7jrn,X-ray diffraction data. Structure of the wild type SARS-CoV-2 papain-like protease (PLPro) with inhibitor GRL0617.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7jrn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7jrn,nsp3,SARS-CoV-2,0,1.5
7kag,X-ray diffraction data. Structure of ubiquitin-like-domain of nsp3 of SARS CoV-2.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kag,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kag,nsp3,SARS-CoV-2,0,1.82
7kg3,X-ray diffraction data. Structure of macro domain of nsp3 of SARS CoV-2.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kg3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kg3,nsp3,SARS-CoV-2,0,1.1
7koj,"The crystal structure of the nsp3 papain-like protease (PLpro) with a C111S mutant in complex with PLP_Snyder494. The ligands are 2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]-5-{[(prop-2-en-1-yl)carbamoyl]amino}benzamide, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, and ions of zinc, acetate, chloride and an unknown atom or ion.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7koj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7koj,nsp3,SARS-CoV-2,0,1.91
7kok,"The crystal structure of the nsp3 papain-like protease. The structure is in complex with PLP_Snyder496 and has a C111S mutant. Its ligands are 5-[(E)-(hydroxyimino)methyl]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID. Further zinc, acetate and chloride ions as well as an unknown atom or ion.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kok,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kok,nsp3,SARS-CoV-2,0,1.68
7kol,"The X-ray crystal structure of the nsp3 papain-like protease (PLpro) in complex with PLP_Snyder496. The ligands of this structure are 5-[(E)-(hydroxyimino)methyl]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, and four zinc and chloride ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kol,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kol,nsp3,SARS-CoV-2,0,1.83
2ahm,Full length NSP7 in complex with full length NSP8 from SARS-CoV. This X-ray crystal structure was phased using multi-wavelength anomalous dispersion to 2.4Å resolution. Four heterodimers seen with either a kinked or elongated conformation of NSP8. The NSP12-NSP7-NSP8 complex replicates viral RNA.,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV/2ahm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV/2ahm,nsp7-nsp8,SARS-CoV,0,2.74
5f22,C-terminal domain of NSP8 in complex with NSP7 from SARS-CoV. This X-ray crystal structure was phased using molecular replacement & has data to a resolution of 2.15Å. The NSP12-NSP7-NSP8 complex replicates viral RNA.,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV/5f22,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV/5f22,nsp7-nsp8,SARS-CoV,0,2.31
6m5i,"This crystal structure shows the nsp7-nsp8c complex of SARS-CoV-2. It is an asymmetric  heterodimer of two entities, each consisting of one chain. The structure covers the globular domain of nsp8 (nsp8c, residues 82-196) and the nsp7 completely (residues 1-81). The complex is a multimeric RNA polymerase capable of de novo initiation and primer extension. The long helix motif of nsp 8 is thereby involved in nucleic acid binding.",X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6m5i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6m5i,nsp7-nsp8,SARS-CoV-2,0,2.32
6wiq,C-terminal domain of NSP8 in complex with NSP7 from SARS-CoV2. This X-ray crystal structure was phased using PDB entry 5f22 for molecular replacement & has data to a resolution of 2.85Å. The NSP12-NSP7-NSP8 complex replicates viral RNA.,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6wiq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6wiq,nsp7-nsp8,SARS-CoV-2,0,1.24
6wqd,C-terminal domain of NSP8 in complex with NSP7 from SARS-CoV2. This X-ray crystal structure was phased using PDB entry 6wiq for molecular replacement & has data to a resolution of 1.95Å. The NSP12-NSP7-NSP8 complex replicates viral RNA.,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6wqd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6wqd,nsp7-nsp8,SARS-CoV-2,0,1.19
6wtc,C-terminal domain of NSP8 in complex with NSP7 from SARS-CoV2. This X-ray crystal structure was phased using PDB entry 6wiq for molecular replacement & has data to a resolution of 1.85Å. The NSP12-NSP7-NSP8 complex replicates viral RNA.,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6wtc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6wtc,nsp7-nsp8,SARS-CoV-2,0,1.13
6xip,"This crystal structure shows the SARS-CoV-2 complex of nsp 7 and the C-terminal domain of nsp8. It is an asymmetric  heterotetramer of two entities, each consisting of two chains. The structure has a high resolution of 1.5 Å and features three ligand interactions with 1,2-Ethanediol. The complex is a multimeric RNA polymerase capable of de novo initiation and primer extension.",X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6xip,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6xip,nsp7-nsp8,SARS-CoV-2,0,3.1
6yhu,"This crystal structure shows the nsp7-nsp8 complex of SARS-CoV-2. It is an asymmetric  heterodimer of two entities, each consisting of two chains. The complex is a multimeric RNA polymerase capable of de novo initiation and primer extension. The selection criteria for this structure was the fact that it has no restraint violations (clashscore=0).",X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/6yhu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/6yhu,nsp7-nsp8,SARS-CoV-2,0,0.57
7jlt,Crystal Structure of SARS-CoV-2 nsp7-nsp8 complex. Nsp7 and nsp8 work as co-factors for nsp12 to form the minimal core polymerase complex for the RNA synthesis of the virus.,X-RAY DIFFRACTION,pdb/nsp8/SARS-CoV-2/7jlt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp8/SARS-CoV-2/7jlt,nsp8,SARS-CoV-2,0,12.49
1qz8,This X-ray crystal structure of SARS-CoV RNA-replicase (NSP9) was phased using single-wavelength anomalous dispersion at 2.7Å resolution. This protein has a unique fold forming a dimer through a GXXXG motif which is biologically important & seen in solution.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV/1qz8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV/1qz8,nsp9,SARS-CoV,0,2.91
1uw7,This X-ray crystal structure of SARS-CoV RNA-replicase (NSP9) was phased using multi-wavelength anomalous dispersion to 2.8Å resolution. This protein has a unique fold forming a dimer through a GXXXG motif which is biologically important & seen in solution.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV/1uw7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV/1uw7,nsp9,SARS-CoV,0,3.86
3ee7,This X-ray crystal structure of SARS-CoV RNA-replicase (NSP9) was phased using PDB entry 1qz8 for molecular replacement & has data to a resolution of 2.6Å. This structure has a mutation of G104E that interferes with the dimerisation of the protein necessary for protein function.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV/3ee7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV/3ee7,nsp9,SARS-CoV,0,2.31
6w4b,This X-ray crystal structure of SARS-CoV2 RNA-replicase (NSP9) was phased using PDB entry 1uw7 for molecular replacement & has data to a resolution of 2.95Å. This protein has a unique fold forming a dimer through a GXXXG motif which is biologically important & seen in solution.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/6w4b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/6w4b,nsp9,SARS-CoV-2,1,2.36
6w9q,This X-ray crystal structure of SARS-CoV2 RNA-replicase (NSP9) was phased using PDB entry 1qz8 for molecular replacement & has data to a resolution of 2.05Å. N-terminus has an extra 7 residues that forms beta strand hydrogen fold with the normal N-terminus of NSP9. Structure published alongside PDB entry 6wxd.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/6w9q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/6w9q,nsp9,SARS-CoV-2,0,2.05
6wc1,Crystal structure of peptide-bound SARS-CoV-2 Nsp9 RNA-replicase. Studying putative peptide-binding site at the dimer interface of the SARS-CoV-2 Nsp9 RNA-replicase.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/6wc1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/6wc1,nsp9,SARS-CoV-2,0,2.17
6wxd,This X-ray crystal structure of SARS-CoV2 RNA-replicase (NSP9) was phased using PDB entry 1qz8 for molecular replacement & has data to a resolution of 2.0Å. This protein has a unique fold forming a dimer through a GXXXG motif which is biologically important & seen in solution. Structure published alongside PDB entry 6w9q.,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/6wxd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/6wxd,nsp9,SARS-CoV-2,0,2.05
2cjr,This Crystal structure shows the oligomerization domain located in the C-terminus of SARS-CoV nucleocapsid protein (N). The structure is an oligomer of 8 identical monomers that form four tetramers. Interactions within this structure stabilize the oligomerization. Crystal packaging of the octamer forms the helical structure of the nucleocapsid. The structure also has RNA binding activity.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV/2cjr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/2cjr,nucleocapsid_protein,SARS-CoV,0,3.77
2gib,This Crystal structure shows the dimerization domain located in the C-terminus of SARS-CoV nucleocapsid protein (N). The structure is a dimer of two identical monomers and exhibits  interactions with the ligand SO4. Strong interactions between both subunits suggest that the dimeric form is a functional unit.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV/2gib,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/2gib,nucleocapsid_protein,SARS-CoV,0,1.61
2ofz,"This Crystal structure shows the N-terminal RNA binding domain of SARS-CoV nucleocapsid protein (N). The structure is a monomer in a monoclinic crystal form at a resolution of 1.17 Å and exhibits interactions with the ligand 1,2-Ethandiol. The N-terminal domain provides structural features for RNA binding.",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV/2ofz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/2ofz,nucleocapsid_protein,SARS-CoV,0,1.63
2og3,This Crystal structure shows the N-terminal RNA binding domain of SARS-CoV nucleocapsid protein (N). The structure is a monomer  in a cubic crystal form at a resolution of 1.85 Å. The N-terminal domain provides structural features for RNA binding.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV/2og3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV/2og3,nucleocapsid_protein,SARS-CoV,0,2.29
6m3m,"This Crystal structure shows the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein (N). It consists of four identical monomers. The structure displays a great overall similarity to other nucleocapsid protein N-terminal domains, but exhibits a unique potential RNA binding pocket alongside the  β -sheet core.",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6m3m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6m3m,nucleocapsid_protein,SARS-CoV-2,1,1.79
6vyo,"This Crystal structure shows the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein (N). The structure consists of four identical monomers and exhibits interactions with the ligands Cl-, Zn2+, Glycerol, and 2-(N-Morpholino)-Ethanesulfonic Acid. The N-terminal domain provides structural features for RNA binding.",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6vyo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6vyo,nucleocapsid_protein,SARS-CoV-2,1,1.08
6wji,This Crystal structure shows the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein (N). The structure consists of six identical monomers forming three homodimers and exhibits interactions with the ligand Cl-. The C-terminus provides structural features for oligomerization.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6wji,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6wji,nucleocapsid_protein,SARS-CoV-2,0,1.34
6wkp,This Crystal structure shows the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein (N) in a monoclinic crystal form. The structure consists of four identical monomers and exhibits interactions with the ligands Zn2+ and 2-(N-Morpholino)-Ethanesulfonic Acid. The N-terminal domain provides structural features for RNA binding.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6wkp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6wkp,nucleocapsid_protein,SARS-CoV-2,0,1.41
6wzo,"This Crystal structure shows the C-terminal N2b/dimerization domain of SARS-CoV-2 nucleocapsid protein (N) in a triclinic (P1) crystal form. In solution, this structure was found to build a homodimer, but it is also proposed to be involved in tetramer formation. The structure is a tetramer of two homodimers at a resolution of 1.4 Å",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6wzo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6wzo,nucleocapsid_protein,SARS-CoV-2,0,0.91
6wzq,"This Crystal structure shows the C-terminal N2b/dimerization domain of SARS-CoV-2 nucleocapsid protein (N) in a monoclinic (P1211) crystal form. In solution, this structure was found to build a homodimer, but it is also proposed to be involved in tetramer formation. The structure is a tetramer of two homodimers at a resolution of 1.45 Å and exhibits interactions with the ligand SO4.",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6wzq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6wzq,nucleocapsid_protein,SARS-CoV-2,0,1.07
6yun,This crystal structure shows the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein (N) in a orthorhombic (P212121) crystal form. The structure is a homodimer at a resolution of 1.45 Å and provides structural features for oligomerization.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6yun,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6yun,nucleocapsid_protein,SARS-CoV-2,0,1.15
6zco,This crystal structure shows the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein (N) in an orthorhombic crystal form. The structure is a monomer with a high resolution of 1.36 Å and provides structural features for oligomerization. ,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/6zco,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/6zco,nucleocapsid_protein,SARS-CoV-2,0,1.04
7c22,This crystal structure shows the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein (N) in a triclinic (P1) crystal form. The structure is a tetramer of two identical homodimers and exhibits interaction with the ligands Di-(hydroxyethyl)-ether and acetate ion.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7c22,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7c22,nucleocapsid_protein,SARS-CoV-2,0,1.57
7cdz,N-terminal RNA-binding domain of SARS-CoV-2 nucleocapsid protein. Solved via x-ray diffraction.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7cdz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7cdz,nucleocapsid_protein,SARS-CoV-2,0,1.42
7ce0,C-terminal dimerisation domain of SARS-CoV-2 nucleocapsid protein in dimerized form. It was made via x-ray diffraction and the resolution is 1.50A. The group published this structure together with an N-terminal domain structure to discuss possible ways how the ribonucleoprotein-complex could form.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7ce0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7ce0,nucleocapsid_protein,SARS-CoV-2,0,1.31
7jtl,Structure of the SARS-CoV-2 ORF8 accessory protein.,X-RAY DIFFRACTION,pdb/orf8/SARS-CoV-2/7jtl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf8/SARS-CoV-2/7jtl,orf8,SARS-CoV-2,0,1.47
7jx6,Structure of the SARS-CoV-2 ORF8 encoded accessory protein. It has a sodium ion as ligand and a resolution of 1.61 脜.,X-RAY DIFFRACTION,pdb/orf8/SARS-CoV-2/7jx6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf8/SARS-CoV-2/7jx6,orf8,SARS-CoV-2,0,1.59
6z4u,This crystal structure shows the Orf9b/Protein 9b of SARS-CoV-2. The gene encoding this protein is included within the N gene. The structure is a homodimer of two chains and features a ligand interaction with Polyethylene Glycole. It is suggested to play a role in host-virus interaction by binding non-covalently to intracellular bilayers.,X-RAY DIFFRACTION,pdb/orf9b/SARS-CoV-2/6z4u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf9b/SARS-CoV-2/6z4u,orf9b,SARS-CoV-2,0,1.98
1xjr,,X-RAY DIFFRACTION,pdb/rna/SARS-CoV/1xjr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV/1xjr,rna,SARS-CoV,0,1.86
1wnc,"The Fusion Core spike glycoprotein contains of two heptad repeat domains (HR1, HR2). The structure is a six-helix bundle (homo trimer). The three parallel HR1 form a central coiled coil. The three HR2 are packed against the surface. The fusion-active conformation is used for viral entry.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1wnc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1wnc,surface_glycoprotein,SARS-CoV,0,4.45
1wyy,The spike glycoprotein is a membrane protein with two heptad repeat domains (HR1&HR2). Here. HR1 and HR2 adapt an antiparallel post-fusion hairpin conformation. The HR1 helices form a long coiled coil (120 Å). Conserved ASP and GLU residues of HR1 force HR2 to adopt an extended conformation at either end of a short HR2 alpha-helix.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1wyy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1wyy,surface_glycoprotein,SARS-CoV,0,1.9
1zv7,The homo tetramer composition is a 2 chain structure. It is one of the four alpha-helical domains derived from the heptad-repeat (HR) regions of the S2 fusion subunit. They suggest a possible mechanism to promote membrane fusion.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1zv7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1zv7,surface_glycoprotein,SARS-CoV,0,1.28
1zv8,The non-polymer only hexamer composition is a 12 chain structure. It is one of the four alpha-helical domains derived from the heptad-repeat (HR) regions of the S2 fusion subunit. They suggest a possible mechanism to promote membrane fusion.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1zv8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1zv8,surface_glycoprotein,SARS-CoV,0,2.37
1zva,The homo dimer is a 1 chain structure. It is one of the four alpha-helical domains derived from the heptad-repeat (HR) regions of the S2 fusion subunit. They suggest a possible mechanism to promote membrane fusion.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1zva,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1zva,surface_glycoprotein,SARS-CoV,0,1.21
1zvb,The homo trimer is a 3 chain. It is one of the four alpha-helical domains derived from the heptad-repeat (HR) regions of the S2 fusion subunit. They suggest a possible mechanism to promote membrane fusion.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/1zvb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/1zvb,surface_glycoprotein,SARS-CoV,0,1.51
2beq,The spike glycoprotein S2 is a membrane protein with two heptad repeat domains (HR1&HR2). Non-polymer only dodecamer is a 6 chain structure. Structure of a Proteolytically Resistant Core from HR1 and HR2. The structure can open the path to the design of small-molecule inhibitors and candidate vaccine antigens.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2beq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2beq,surface_glycoprotein,SARS-CoV,0,1.72
2bez,"The spike glycoprotein S2 is a membrane protein with two heptad repeat domains (HR1&HR2). Non-polymer only hexamer is a 2 chain structure of an HR1-HR2 S core fragment, containing a shorter HR1 peptide and a C-terminally longer HR2 peptide that extends up to the transmembrane region.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2bez,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2bez,surface_glycoprotein,SARS-CoV,0,1.93
2dd8,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The Non-polymer only trimer is a 3 chain crystal structure of RBD complexed with neutralizing antibody. The structure indicates that other conformational changes or coreceptors than ACE2 may involve.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2dd8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2dd8,surface_glycoprotein,SARS-CoV,0,2.66
2ghv,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The homo dimer is a 2 chain crystal structure of spike protein receptor binding domain. The dimer could play a role in virus stability and infectivity.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2ghv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2ghv,surface_glycoprotein,SARS-CoV,0,2.12
2ghw,"The spike glycoprotein is a membrane protein with two heptad repeat domains (HR1&HR2). The non-polymer only dimer is a 4 chain crystal structure of spike protein receptor binding domain in complex with a neutralizing antibody, 80r. The dimer could play a role in virus stability and infectivity.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/2ghw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/2ghw,surface_glycoprotein,SARS-CoV,0,2.27
3bgf,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). Non-polymer only trimer is a 6 chain X-ray crystal structure of the spike RBD in complex with F26g19 Fab. The complex is the first example of the structural characterization of an antibody elicited by an immune response.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/3bgf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/3bgf,surface_glycoprotein,SARS-CoV,0,2.55
5x4s,"The spike receptor-binding domain S attaches the virus to ACE2, mediated by a receptor-binding domain (RBD). The monomeric is a 1 chain structure of the N-terminal domain (ntd) spike protein in its pre-fusion conformation. It shows, that HR1 region and the central helix are potential targets for eliciting broadly neutralizing antibodies.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/5x4s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5x4s,surface_glycoprotein,SARS-CoV,0,2.3
5zvm,The spike glycoprotein is a membrane protein with two heptad repeat domains (HR1&HR2). The non-polymer only hexamer is a 6 chain crystal structure of the human coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1. It has both short alpha-HCoV and long beta-HCoV HR1s and is a region as a pan-CoV target site.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/5zvm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/5zvm,surface_glycoprotein,SARS-CoV,0,1.63
6waq,Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/6waq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/6waq,surface_glycoprotein,SARS-CoV,0,1.7
6lvn,Structure of the 2019-nCoV HR2 Domain,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6lvn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6lvn,surface_glycoprotein,SARS-CoV-2,1,1.16
6lxt,Structure of post fusion core of 2019-nCoV S2 subunit. We can observe here the fusion helix bundle.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6lxt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6lxt,surface_glycoprotein,SARS-CoV-2,1,2.11
6m1v,Crystal structure of post fusion core of 2019-nCoV S2 subunit. Homo trimer with 1 chain. The S2 subunit is important to mediate virus fusion. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6m1v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6m1v,surface_glycoprotein,SARS-CoV-2,0,0.87
6w41,Crystal structure of SARS-CoV-2 receptor binding domain in complex with the antibody CR3022 which binds to an epitope that is conserved between SARS CoV-2 and SARS-CoV. Non-Polymer only trimer with 3 chains. The antibody binds more to SARS-CoV because of a glycan that is not present in SARS-CoV-2. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6w41,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6w41,surface_glycoprotein,SARS-CoV-2,1,1.46
6xc2,"Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing antibody CC12.1. Non polymer only trimer, spike with two chains and antibody with a heavy and a light chain with two chains each. Immunoglobulin G heavy-chain is the most frequently used IGHV gene for targeting RBDs of the spike protein CC12.1 is a neutralizing antibody for this gene.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xc2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xc2,surface_glycoprotein,SARS-CoV-2,0,1.87
6xc3,"Crystal structure of SARS-CoV-2 RBD in complex with the antibodies CC12.1 and CR3022. Non polymer only pentamer, spike protein with one chain antibodies with a heavy and light chain with one chain each. Immunoglobulin G heavy-chain is the most frequently used IGHV gene for targeting RBDs of the spike protein CC12.1 is a neutralizing antibody for this gene.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xc3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xc3,surface_glycoprotein,SARS-CoV-2,0,1.44
6xc4,"Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing antibody CC12.3. Non polymer only trimer, spike with two chains and antibody with a heavy and a light chain with two chains each. Immunoglobulin G heavy-chain is the most frequently used IGHV gene for targeting RBDs of the spike protein CC12.3 is a neutralizing antibody for this gene.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xc4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xc4,surface_glycoprotein,SARS-CoV-2,0,1.41
6xc7,"Crystal structure of SARS-CoV-2 receptor binding domain in complex with the antibodies CC12.3 and CR3022. Non-polymer only pentamer with 5 chains. CC12.3 bound to the ACE2 binding site on SARS-CoV-2 receptor binding domain. Other relevant structures are 6xc3, 6xc2 and 6xc4 which show the complex with CC12.1 and CR3022, CC12.1 without CR3022 and CC12.3 without 3022. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xc7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xc7,surface_glycoprotein,SARS-CoV-2,0,1.65
6xe1,X-ray crystal structure of the SARS-CoV-2 S1 spike protein receptor binding domain in complex with the antibody CV30 Fab (heavy and kappa chain). Non-polymer only trimer with 3 chains. CV30 and ACE2 are competing for binding to the receptor binding domain. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xe1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xe1,surface_glycoprotein,SARS-CoV-2,0,3.32
6xkp,"Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing antibody CV07-270. Non polymer only trimer, spike with two chains, antibody with a heavy and a light chain with two chains each. Antibody have a weak neutralizing effect competition of the antibody with ACE2 binding is very weak. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xkp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xkp,surface_glycoprotein,SARS-CoV-2,0,1.62
6xkq,"Crystal structure of SARS-CoV-2 receptor binding domain in complex with the neutralizing antibody CV07-250. Non polymer only trimer, spike with one chain. Antibody with one heavy and one light chain. CV07-250 reduces ACE2 binding to the RBD to 58.3%. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6xkq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6xkq,surface_glycoprotein,SARS-CoV-2,0,1.46
6yla,Crystallographic structure of the SARS-CoV-2 RBD in complex with the antibody CR3022 Fab ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6yla,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6yla,surface_glycoprotein,SARS-CoV-2,0,1.7
6ym0,Second crystal form of the Crystallographic structure of the SARS-CoV-2 RBD in complex with the antibody CR3022 Fab,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6ym0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6ym0,surface_glycoprotein,SARS-CoV-2,0,3.18
6yz5,"Crystal structure of the SARS-CoV-2 spike RBD in complex with the nanobody H11-D4. Non polymer only dimer, spike protein with one chain and nanobody with one chain. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6yz5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6yz5,surface_glycoprotein,SARS-CoV-2,0,1.13
6yz7,"X-ray diffraction of a ternary complex with SARS-CoV-2 receptor binding domain, the H11-D4 nanobody and the antibody CR2022. Non-polymer only tetramer with 8 chains. Another relevant structure is 6z2m which is the same complex in a 90-degree deviation and with a different resolution, the original resolution was 3.3Å the new one is 2.71Å. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6yz7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6yz7,surface_glycoprotein,SARS-CoV-2,0,
6z2m,"X-RAY diffraction of a ternary complex with SARS-CoV-2 RBD the nanobody H11-D4 and the antibody CR3022. Non polymer only tetramer, spike with two chains, nanobody with two chains and antibody with a heavy and a light chain with two chains each. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6z2m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6z2m,surface_glycoprotein,SARS-CoV-2,0,1.82
6zbp,"Crystal Structure of SARS-CoV-2 RBD in complex with the nanobody H11-H4. Non polymer only dimer, spike with an EEE chain and Nanobody with an FFF chain. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6zbp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zbp,surface_glycoprotein,SARS-CoV-2,0,
6zcz,"Crystal structure of SARS-CoV-2 spike glycoprotein receptor binding domain in ternary complex with the antibody EY6A Fab (one heavy, one light chain) and a nanobody. Non-Polymer only tetramer with 4 chains. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6zcz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zcz,surface_glycoprotein,SARS-CoV-2,0,4.8
6zer,"Crystal structure of SARS-CoV-2 spike glycoprotein RBD in complex with the antibody ey6a Fab. The antibody ey6a neutralises SARS-CoV-2 and cross-reacts with SARS-CoV-1. It binds tightly to the receptor binding domain of the viral Spike glycoprotein. Non-polymer only trimer with 9 chains. One other relevant structure is 6zdh. It is also an antibody ey6a in a complex with a SARS-CoV-2 Spike glycoprotein, but the antibody does not bind on the RBD. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6zer,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zer,surface_glycoprotein,SARS-CoV-2,0,8.21
6zh9,"X-RAY diffraction of a Ternary complex between the antibody CR3022 the Nanobody H11-H4 and the SARS-CoV-2 RBD. Non polymer only tetramer, spike with one Chain and nanobody with one chain, antibody with one heavy and one light chain. The structure shows that the nanobody and antibody recognize different epitopes",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6zh9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zh9,surface_glycoprotein,SARS-CoV-2,0,
7bwj,Crystal structure of SARS-CoV-2 receptor binding domain in complex with the antibody P2B-2F6 Fab (light and heavy chain). Non-polymer only trimer with 3 chains. The antibody uses mainly the heavy chain to bind with the RBD. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bwj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bwj,surface_glycoprotein,SARS-CoV-2,0,2.15
7bz5,The spike receptor-binding domain (RBD) attaches the virus to ACE2. The hetero trimer is a 3 chain structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody. It provides a structural basis for rational vaccine design.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bz5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bz5,surface_glycoprotein,SARS-CoV-2,0,1.25
7c01,"The spike receptor-binding domain (RBD) attaches the virus to ACE2. The hetero trimer is a 6 chain structure, a molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7c01,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c01,surface_glycoprotein,SARS-CoV-2,0,1.73
7c8v,"Crystal structure of SARS-CoV-2 spike glycoprotein receptor binding domain in complex with a synthetic nanobody SR4. Non-polymer only dimer with 2 chains. SR4 binds to the receptor binding domain which resembles a short backrest high chair, on its seat and backrest but does not change its conformation. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7c8v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c8v,surface_glycoprotein,SARS-CoV-2,0,3.4
7c8w,X-ray diffraction of the SARS-CoV-2 spike glycoprotein receptor binding domain in complex with the synthetic antibody MR17. Non-polymer only dimer with 2 chains. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7c8w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c8w,surface_glycoprotein,SARS-CoV-2,0,7.87
7can,X-ray diffraction structure of SARS-CoV-2 S receptor binding domain in complex with the synthetic antibody MR17-K99Y. Non-polymer only dimer with 2 chains. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7can,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7can,surface_glycoprotein,SARS-CoV-2,0,6.74
7cdi,This X-ray structure shows the SARS-CoV-2 spike RBD bound to antibody P2C-1F11.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cdi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cdi,surface_glycoprotein,SARS-CoV-2,0,2.32
7cdj,"Crystal structure of SARS-CoV-2 spike protein RBD bound to antibody P2C-1A3. Hetero trimer, spike with one chain and antibody with one heavy and one light chain.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cdj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cdj,surface_glycoprotein,SARS-CoV-2,0,2.9
7ch4,"Crystal structure of SARS-CoV-2 Spike RBD in complex with the antibody BD-604. Non polymer only pentamer, spike with three chains, antibody with a light and a heavy chain. BD-604 binds to the RBD a related structure is 7chf which shows the antibody with another antibody (BD-368-2). ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ch4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ch4,surface_glycoprotein,SARS-CoV-2,0,1.81
7ch5,"Crystal structure of the SARS-CoV-2 Spike RBD in complex with the neutralizing antibody BD-629 fab. Non polymer only trimer, spike with one chain. Antibody with one heavy and one light chain. Pairing the antibodies BD-368-2 with BD-629 can efficiently neutralize several naturally occurring S mutants. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ch5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ch5,surface_glycoprotein,SARS-CoV-2,0,1.65
7chb,"Crystal structure of SARS-CoV-2 RBD in complex with the antibody BD-236. Non polymer only trimer, spike with one chain, antibody with one heavy and one light chain. Antibody binds to the RBD, one related structure 7che, it shows the antibody together with the anitbody BD-368-2. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7chb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chb,surface_glycoprotein,SARS-CoV-2,0,1.78
7chc,"Crystal structure of SARS-CoV-2 RBD in complex with the antibodies BD-629 and BD-368-2. Non polymer only pentamer, Spike protein with one chain, both antibodies have a heavy and a light chain with one chain each. BD-368-2 fully blocks ACE2 recognition both antibodies bind to the RBD. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7chc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chc,surface_glycoprotein,SARS-CoV-2,0,1.78
7che,"Crystal structure of SARS-CoV-2 RBD in complex with the antibodies BD-236 and BD-368-2. Non polymer only pentamer, Spike protein with one chain, both antibodies have a heavy and a light chain with one chain each. BD-368-2 fully blocks ACE2 recognition both antibodies bind to the RBD. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7che,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7che,surface_glycoprotein,SARS-CoV-2,0,2.57
7chf,"Crystal structure of SARS-CoV-2 RBD in complex with the antibodies BD-604 and BD-368-2. Non polymer only pentamer, Spike protein with one chain, both antibodies have a heavy and a light chain with one chain each. BD-368-2 fully blocks ACE2 recognition both antibodies bind to the RBD. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7chf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chf,surface_glycoprotein,SARS-CoV-2,0,2.3
7cjf,"Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody fab. Non polymer only trimer, antibody with one heavy and one light chain. Spike protein with one chain.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cjf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cjf,surface_glycoprotein,SARS-CoV-2,0,1.4
7jmo,"Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing antibody COVA2-04. Non polymer only trimer, spike protein with one chain and antibody with a heavy and a light chain with one chain each. COVA2-04 is a IGHV3-53 antibody but with a longer CDR H3 than usual antibodies. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7jmo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jmo,surface_glycoprotein,SARS-CoV-2,0,1.31
7jmp,"Crystal structure of SARS-CoV-2 receptor binding domain in complex with the neutralizing antibody COVA2-39. Non polymer only trimer, antibody with one heavy and one light chain. Spike protein with one chain. The COVA2-39 antibody interacts with the RBD and engage the ACE2-binding ridge. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7jmp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jmp,surface_glycoprotein,SARS-CoV-2,0,1.28
7jmw,"Crystal structure of SARS-CoV-2 spike protein RBD in complex with the cross-neutralizing antibody COVA 1-16. Non polymer only trimer, spike with one chain and antibody with one heavy and one light chain. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7jmw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jmw,surface_glycoprotein,SARS-CoV-2,0,1.71
7jx3,"Crystal structure of SARS-CoV-2 RBD in complex with the antibodies S304, S309 and S2H14. Non polymer only heptamer spike protein with one chain, each antibody has one heavy and one light chain. S304 recognizes a cryptic epitope the residues of this epitopes are shown in this structure. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7jx3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jx3,surface_glycoprotein,SARS-CoV-2,0,1.21
7k8m,"X-RAY diffraction of SARS-CoV-2 RBD in complex with the human neutralizing antibody Fab fragment C102. Non polymer only trimer, spike with one chain antibody with one heavy and one light chain. Binding with a C102 like interaction requires a short CDRH3, C102 overlap with the ACE2 binding site. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7k8m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k8m,surface_glycoprotein,SARS-CoV-2,0,2.03
7k9z,"Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing antibodie fab fragments 298 and 52. Non polymer only pentamer, spike with one chain, Antibodies with one heavy and one light chain each. The antibody 298 binds almost exclusively to the ACE2 receptor binding motif of the RBD. ",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7k9z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7k9z,surface_glycoprotein,SARS-CoV-2,0,2.08
6w2a,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6w2a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6w2a,3c_like_proteinase,SARS-CoV,0,1.12
6xhl,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6xhl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6xhl,3c_like_proteinase,SARS-CoV,0,1.36
6xhn,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6xhn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6xhn,3c_like_proteinase,SARS-CoV,0,1.4
6xho,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/6xho,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/6xho,3c_like_proteinase,SARS-CoV,0,1.37
5rl0,Part of PanDDA analysis group deposition SARS-CoV-2 main protease deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VEG](https://www.rcsb.org/ligand/VEG).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl0,3c_like_proteinase,SARS-CoV-2,0,1.18
5rl1,Part of PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VEJ](https://www.rcsb.org/ligand/VEJ).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl1,3c_like_proteinase,SARS-CoV-2,0,1.46
5rl2,Part of PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [VEM](https://www.rcsb.org/ligand/VEM).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl2,3c_like_proteinase,SARS-CoV-2,0,1.37
5rl3,Part of PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [DMS](https://www.rcsb.org/ligand/DMS).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl3,3c_like_proteinase,SARS-CoV-2,0,1.04
5rl4,Part of PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [DMS](https://www.rcsb.org/ligand/DMS).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl4,3c_like_proteinase,SARS-CoV-2,0,1.32
5rl5,Part of PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors. SARS-CoV-2 main protease from Coronaviridae sp. screened against computationally designed covalent inhibitors by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [DMS](https://www.rcsb.org/ligand/DMS).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/5rl5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/5rl5,3c_like_proteinase,SARS-CoV-2,0,0.92
7a1u,Full length 3C-like protease from Sars-Cov-2 with 1.68A resolution and in complex with Fusidic Acid.. It was solved with X-ray diffraction and [FUA] (https://www.rcsb.org/ligand/FUA) and [DMS] (https://www.rcsb.org/ligand/DMS) are bound. It was done in scope of a larger drug-binding screen.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7a1u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7a1u,3c_like_proteinase,SARS-CoV-2,0,1.14
7abu,The crystal structure of the main protease bound to RS102895. Further ligands are dimethyl sulfoxide and imidazole. The data has a resolution of 1.60 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7abu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7abu,3c_like_proteinase,SARS-CoV-2,0,1.05
7adw,"The crystal structure of the main protease bound to 2,4'-dimethylpropiophenone. Further ligands are dimethyl sulfoxide, imidazole and chloride ions. The data has a resolution of 1.63 Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7adw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7adw,3c_like_proteinase,SARS-CoV-2,0,1.21
7af0,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with Ipidacrine. Ipidacrine is a reversible acetylcholinesterase inhibitor. Measurement was part of a drug screen to find a suitable inhibitor candidate in already approved drugs.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7af0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7af0,3c_like_proteinase,SARS-CoV-2,0,1.03
7aga,Full length 3C-like protease from Sars-Cov-2 with 1.68A resolution. It was solved with X-ray diffraction and [LZE] (https://www.rcsb.org/ligand/LZE) and [DMS] (https://www.rcsb.org/ligand/DMS) are bound. It was done in scope of a larger drug-binding screen.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aga,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aga,3c_like_proteinase,SARS-CoV-2,0,1.23
7aha,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, bound to Maleate. Measurement was part of a drug screen to find a suitable inhibitor candidate in already approved drugs.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aha,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aha,3c_like_proteinase,SARS-CoV-2,0,0.97
7ak4,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to Tretazicar. It binds non-covalently to the active site. The resolution is 1.63 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ak4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ak4,3c_like_proteinase,SARS-CoV-2,0,8.74
7alh,The crystal structure of the main protease (3CLpro/Mpro) in spacegroup C2. The data has a resolution of 1.65 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7alh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7alh,3c_like_proteinase,SARS-CoV-2,0,0.85
7ali,Full length 3C-like protease from Sars-CoV-2 with 1.65A resolution. The spacegroup is P2(1).,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ali,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ali,3c_like_proteinase,SARS-CoV-2,0,1.03
7amj,"Crystal structure of 3C-like protease from SARS-CoV-2 (Homodimer) bound to PD 168568 to study allosteric drug-binding. PD-168568 employs the hydrophobic pocket (Ile213, Leu253, Gln256, Val297 and Cys300) within the C-terminal dimerization domain by inserting an aromatic moiety. The resolution is 1.59 Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7amj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7amj,3c_like_proteinase,SARS-CoV-2,0,1.05
7ans,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to Adrafinil. Its two phenyl rings are inserted into pockets S1’ and S2 via Van der Waals interactions.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ans,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ans,3c_like_proteinase,SARS-CoV-2,0,1.13
7aol,"Structure of SARS-CoV-2 Main Protease bound to Climbazole. Climbazole binds as observed only by van der Waals interactions in a shallow surface pocket, wedged between two crystallographic symmetry-related molecules. One monomer contributes with residues Phe103, Val104, Arg105 and Glu178 to this binding site, while the other monomer contributes Asn228, Asn231, Leu232, Met235 and Pro241.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aol,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aol,3c_like_proteinase,SARS-CoV-2,0,1.4
7ap6,"Structure of SARS-CoV-2 Main Protease bound to MUT056399. MUT056399 binds without a covalent bond to active-site Cys145 and reduced viral replication. Its diphenyl ether core blocks access to the catalytic site consisting of Cys145 and His41. The terminal carboxamide group occupies pocket S1 and forms hydrogen bonds to the side chain of His163 and the backbone of Phe140. The other part of the molecule reaches deep into pocket S2, which is enlarged by a 210 shift of the side chain of Met49 out of the substrate binding pocket",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ap6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ap6,3c_like_proteinase,SARS-CoV-2,0,1.23
7aph,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aph,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aph,3c_like_proteinase,SARS-CoV-2,0,7.96
7aqe,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aqe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aqe,3c_like_proteinase,SARS-CoV-2,0,1.3
7aqi,Structure of SARS-CoV-2 Main Protease bound to Ifenprodil. Mpro which cleaves the SC2 polyprotein pp1ab at eleven distinct sites has its core cleavage motif at LeuGln↓(Ser/Ala/Gly)(1). Mpro allosteric site (dimerization domain) is in direct vicinity of the S1 pocket of the adjacent monomer within the native dimer and shows potential for antiviral inhibition when bound to ifenprodil.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aqi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aqi,3c_like_proteinase,SARS-CoV-2,0,1.75
7aqj,"Structure of SARS-CoV-2 Main Protease bound to Triglycidyl isocyanurate adopts a covalent and non-covalent binding mode to the Mpro active site. In both modes, the compound’s central ring sits on top of the catalytic dyad (His41, Cys145) and its three epoxypropyl substituents reach into subsites S1’, S1 and S2. The non-covalent binding mode is stabilized by hydrogen bonds to the main chain of Gly143 and Gly166, and to the side chain of His163. In the covalently 190 bound form, one oxirane ring is opened by nucleophilic attack of Cys145 forming a thioether",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aqj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aqj,3c_like_proteinase,SARS-CoV-2,0,1.3
7ar5,"1.45 Å X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in an unbound state. Measured with small beta angle",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ar5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ar5,3c_like_proteinase,SARS-CoV-2,0,1.37
7ar6,Full length 3C-like protease from SARS-CoV-2. It has a large beta angle and the spacegroup is C2. This structure was resolved using x-ray crystallography to identify possible binding compounds in approved drugs or drugs in clinical trial. Resolution is 1.40A.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ar6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ar6,3c_like_proteinase,SARS-CoV-2,0,1.19
7arf,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7arf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7arf,3c_like_proteinase,SARS-CoV-2,0,1.28
7avd,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to SEN1269 ligand. SEN1269 (Amyloid-β aggregation inhibitor) binds to the active site of one protomer in the native dimer. This causes a break in the crystallographic symmetry. The central pyrazine ring forms a hydrogen bond to Gln189.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7avd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7avd,3c_like_proteinase,SARS-CoV-2,0,1.38
7awr,"1.34 Å X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts. Protein is in complex with allosteric binding drug Tegafur. Measurement was part of a massive drug screen find a candidate drug to repurpose as inhibitor for main protease. ",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7awr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7awr,3c_like_proteinase,SARS-CoV-2,0,1.27
7aws,The crystal structure of the main protease bound to TH-302. Further ligands are dimethyl sulfoxide and chloride ions. The data has a resolution of 1.81 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aws,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aws,3c_like_proteinase,SARS-CoV-2,0,1.08
7awu,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, bound to LSN2463359. LSN2463359 is selective positive allosteric modulator of the mGlu5 receptor. Measurement was part of a drug screen to find a suitable inhibitor candidate in already approved drugs.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7awu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7awu,3c_like_proteinase,SARS-CoV-2,0,1.24
7aww,Structure of 3C-like protease from SARS-CoV-2 (Homodimer) bound to Clonidine to study allosteric drug-binding. The resolution is 1.65 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aww,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aww,3c_like_proteinase,SARS-CoV-2,0,1.37
7ax6,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to Glutathione isopropyl ester. This compound binds covalently to Cys156.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ax6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ax6,3c_like_proteinase,SARS-CoV-2,0,1.64
7axm,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) bound to Pelitinib. Its halogenated benzene ring binds to the hydrophobic groove. The central 3-cyanoquinoline moiety interacts with the end of the C-terminal helix (Ser301). The ethyl ether substituent pushes against Tyr118 and Asn142 (from loop 141-144 of the S1 pocket) of the opposing protomer within the native dimer.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7axm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7axm,3c_like_proteinase,SARS-CoV-2,0,1.27
7axo,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, bound to AR-42. AR-42 is a Histone deacetylase inhibitor. Measurement was part of a drug screen to find a suitable inhibitor candidate in already approved drugs.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7axo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7axo,3c_like_proteinase,SARS-CoV-2,0,0.91
7ay7,"The crystal structure of the main protease bound to isofloxythepin. The ligands are 9-fluoranyl-3-propan-2-yl-5,6-dihydrobenzo[b][1]benzothiepine, di(hydroxyethyl)ether, dimethyl sulfoxide and imidazole. The data has a resolution of 1.55 Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ay7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ay7,3c_like_proteinase,SARS-CoV-2,0,1.31
7b3e,"Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) covalently bound to myricetin, a hexahydroxyflavone.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7b3e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7b3e,3c_like_proteinase,SARS-CoV-2,0,1.23
7b83,Full length 3C-like protease from Sars-Cov-2 with 1.80A resolution. It was solved with X-ray diffraction and [PK8] (https://www.rcsb.org/ligand/PK8) and [DMS] (https://www.rcsb.org/ligand/DMS) are bound. It was done in scope of a larger drug-binding screen.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7b83,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7b83,3c_like_proteinase,SARS-CoV-2,0,1.34
7bb2,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bb2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bb2,3c_like_proteinase,SARS-CoV-2,0,1.04
7be7,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7be7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7be7,3c_like_proteinase,SARS-CoV-2,0,1.11
7bfb,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bfb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bfb,3c_like_proteinase,SARS-CoV-2,0,1.27
7bgp,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bgp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bgp,3c_like_proteinase,SARS-CoV-2,0,1.29
7jpy,Crystal structure of 3C-like protease from SARS-CoV-2 (Homodimer) in its apo-form. Structure was refined to a 1.6 Å resolution.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jpy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jpy,3c_like_proteinase,SARS-CoV-2,0,1.52
7jpz,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with MPI1. Part of a drug screen which investigates β‐(S‐2‐oxopyrrolidin‐3‐yl)‐alaninal derivates which reversibly bind Cys145",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jpz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jpz,3c_like_proteinase,SARS-CoV-2,0,1.59
7jq0,"Structure of Main Protease (Mpro) bound at its cysteine C145 active site to MPI3, an inhibitor which contains β-(S-2-oxopyrrolidin-3-yl)-alaninal (Opal). MPI3 is bound to the P1, P2 and P4 cavities of C145 active site via a reversible covalent bond and leaves the P3 binding pocket empty. This binding investigates the inhibition of proteolytic processing of Nsps in SC2",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq0,3c_like_proteinase,SARS-CoV-2,0,1.47
7jq1,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with MPI4. Part of a drug screen which investigates β‐(S‐2‐oxopyrrolidin‐3‐yl)‐alaninal derivates which reversibly bind Cys145",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq1,3c_like_proteinase,SARS-CoV-2,0,1.68
7jq2,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with MPI5. Part of a drug screen which investigates β‐(S‐2‐oxopyrrolidin‐3‐yl)‐alaninal derivates which reversibly bind Cys145",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq2,3c_like_proteinase,SARS-CoV-2,0,1.43
7jq3,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with MPI6. Part of a drug screen which investigates β‐(S‐2‐oxopyrrolidin‐3‐yl)‐alaninal derivates which reversibly bind Cys145",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq3,3c_like_proteinase,SARS-CoV-2,0,1.84
7jq4,"Crystal structure of 3C-like protease from SARS-CoV-2 (Homodimer) in complex with Opal‐based inhibitor MP17. The enzyme shows changes (M49, N142, and the P168‐containing loop) to accommodate inhibitors and a covalent interaction. The resolution is 1.65 Å.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq4,3c_like_proteinase,SARS-CoV-2,0,1.76
7jq5,"Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI8 to study inhibition of Mpro. MPI8 completely prevented cytopathogenic effect of SC2 in Vero E6 cells however, it had a much higher potency in A549/ACE2 cells which possess different host protease proteomes. As a result, is likely MPI8 inhibit some host proteases that serve critical functions in the SC2 entry into and replication in host cells and therefore exert different SC2 inhibition.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jq5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jq5,3c_like_proteinase,SARS-CoV-2,0,1.83
7jst,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jst,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jst,3c_like_proteinase,SARS-CoV-2,0,1.16
7jsu,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jsu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jsu,3c_like_proteinase,SARS-CoV-2,0,1.37
7jt0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jt0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jt0,3c_like_proteinase,SARS-CoV-2,0,0.97
7jt7,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jt7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jt7,3c_like_proteinase,SARS-CoV-2,0,1.46
7jw8,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jw8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jw8,3c_like_proteinase,SARS-CoV-2,0,1.36
7k0f,Full length 3C-like protease from Sars-Cov-2 in complex with a deuterated GC376 alpha-ketoamide analog. The resolution is 1.65A and it was solved with X-ray diffraction. [VR4](https://www.rcsb.org/ligand/VR4) is bound ,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k0f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k0f,3c_like_proteinase,SARS-CoV-2,0,1.25
7kvg,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with N and C terminal residues of nsp4. Cys145 is mutated to Ser145",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kvg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kvg,3c_like_proteinase,SARS-CoV-2,0,2.32
7kvl,X-ray diffraction crystal structure of SARS-CoV-2 main protease immature form. Main protease is responsible for cutting the polyprotein into functional parts.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kvl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kvl,3c_like_proteinase,SARS-CoV-2,0,1.55
7kvr,This X-ray crystal structure shows the SARS-CoV-2 main protease in its immature form.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kvr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kvr,3c_like_proteinase,SARS-CoV-2,0,1.69
7kx5,Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with noncovalent inhibitor Jun8-76-3A.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kx5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kx5,3c_like_proteinase,SARS-CoV-2,0,1.95
7kyu,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) with the formation of Cys145-1H-indole-5-carboxylate. The resolution is 1.48 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7kyu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7kyu,3c_like_proteinase,SARS-CoV-2,0,0.93
7l0d,"Full length 3C-like protease from Sars-Cov-2 in complex with con-covalent inhibitor ML188. It was solved with x-ray diffraction to determine the the potency of ML188""s attachment to the protein. [0EN] (https://www.rcsb.org/ligand/0EN) is bound.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l0d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l0d,3c_like_proteinase,SARS-CoV-2,0,1.64
7l10,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l10,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l10,3c_like_proteinase,SARS-CoV-2,0,1.56
7l11,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l11,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l11,3c_like_proteinase,SARS-CoV-2,0,1.26
7l12,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l12,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l12,3c_like_proteinase,SARS-CoV-2,0,1.32
7l13,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l13,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l13,3c_like_proteinase,SARS-CoV-2,0,2.09
7l14,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l14,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l14,3c_like_proteinase,SARS-CoV-2,0,1.03
7l5d,This X-ray crystal structure shows the SARS-CoV-2 main protease in complex with demethylated analog of masitinib.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l5d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l5d,3c_like_proteinase,SARS-CoV-2,0,1.35
7lb7,"Joint X-ray/neutron structure of SARS-CoV-2 main protease (Homodimer) in complex with Telaprevir. Three active-site histidine residues (His41, His163 and His164) adapt to ligand binding, altering their protonation states to bind telaprevir.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lb7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lb7,3c_like_proteinase,SARS-CoV-2,0,4.81
7lbn,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) with Calpain I Inhibitor.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lbn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lbn,3c_like_proteinase,SARS-CoV-2,0,0.84
7ldx,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in immature form",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ldx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ldx,3c_like_proteinase,SARS-CoV-2,0,1.79
7lfe,SARS-CoV-2 Main protease immature form - F2X Entry Library E03 fragment.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lfe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lfe,3c_like_proteinase,SARS-CoV-2,0,1.81
7lfp,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer). Immature form - F2X Entry Library G05 fragment.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lfp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lfp,3c_like_proteinase,SARS-CoV-2,0,1.86
7lkr,"X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with inhibitor 2a. Part of a drug screen together with 7lkt.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkr,3c_like_proteinase,SARS-CoV-2,0,0.94
7lks,"Full length 3C-like protease from Sars-CoV-2 in complex with inhibitor 2f. The resolution is 1.70A and it was solved with X-ray diffraction. [Y7G](https://www.rcsb.org/ligand/Y7G), [Y4P] (https://www.rcsb.org/ligand/Y4P) and [PG4] (https://www.rcsb.org/ligand/PG4) are bound ",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lks,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lks,3c_like_proteinase,SARS-CoV-2,0,0.97
7lkt,"1.5 Å X-ray diffraction crystal structure of SARS-CoV-2 main protease, which is responsible for cutting the polyprotein into functional parts, in complex with inhibitor 2k. Part of a drug screen together with 7lkr.",X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkt,3c_like_proteinase,SARS-CoV-2,0,1.09
7lku,1.65 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 3b (deuterated analog of inhibitor 2a),X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lku,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lku,3c_like_proteinase,SARS-CoV-2,0,1.0
7lkv,Full length 3C-like protease from Sars-Cov-2 with a 1.55A resolution and in complex with inhibitor 3c. It was done via x-ray diffraction and [Y64] (https://www.rcsb.org/ligand/QYS) and [Y4J] (https://www.rcsb.org/ligand/Y4J) are bound.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkv,3c_like_proteinase,SARS-CoV-2,0,0.87
7lkw,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) in complex with inhibitor 3d (deuterated analog of inhibitor 3c). The resolution is 1.65 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkw,3c_like_proteinase,SARS-CoV-2,0,1.02
7lkx,Crystal structure of 3C-like protease from SARS CoV2 (Homodimer) in complex with inhibitor 3e. The resolution is 1.6 Å.,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkx,3c_like_proteinase,SARS-CoV-2,0,1.02
7ltj,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ltj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ltj,3c_like_proteinase,SARS-CoV-2,0,1.53
7lyh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lyh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lyh,3c_like_proteinase,SARS-CoV-2,0,1.41
7lyi,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lyi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lyi,3c_like_proteinase,SARS-CoV-2,0,1.32
7nbr,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nbr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nbr,3c_like_proteinase,SARS-CoV-2,0,
7nbs,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nbs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nbs,3c_like_proteinase,SARS-CoV-2,0,
7nby,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nby,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nby,3c_like_proteinase,SARS-CoV-2,0,0.83
7nev,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nev,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nev,3c_like_proteinase,SARS-CoV-2,0,0.98
5s6x,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s6x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s6x,endornase,SARS-CoV-2,0,1.25
5s6y,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s6y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s6y,endornase,SARS-CoV-2,0,1.49
5s6z,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s6z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s6z,endornase,SARS-CoV-2,0,1.18
5s70,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s70,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s70,endornase,SARS-CoV-2,0,1.26
5s71,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s71,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s71,endornase,SARS-CoV-2,0,1.21
5s72,Part of PanDDA analysis group deposition. XDomainX of XOrganismX None screened against the XXX Fragment Library by X-ray Crystallography at the XChem facility of Diamond Light Source beamline I04-1. The potential binding ligand(s): [CIT](https://www.rcsb.org/ligand/CIT).,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5s72,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5s72,endornase,SARS-CoV-2,0,2.16
7keg,The crystal structure of the nsp15 NendoU. As ligands it has phosphate ions.,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7keg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7keg,endornase,SARS-CoV-2,0,1.86
7keh,The crystal structure of the nsp15 NendoU. As ligands it has sulfate ions.,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7keh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7keh,endornase,SARS-CoV-2,0,1.84
7kf4,The nsp15 NendoU crystal structure. As a ligand it has citric acid.,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7kf4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7kf4,endornase,SARS-CoV-2,0,1.67
5rob,,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/5rob,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/5rob,helicase,SARS-CoV-2,0,1.86
7nio,,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/7nio,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/7nio,helicase,SARS-CoV-2,0,2.23
7lfz,"Chimeric receptor-binding domain where the binding site contains a loop and core domain from SARS and RBD SARS-CoV2, complexed with its receptor human ACE2.",X-RAY DIFFRACTION,../pdb\human_interaction_partners\Beta-2 microglobulin\7lfz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb\human_interaction_partners\Beta-2 microglobulin\7lfz,..,pdb\human_interaction_partners\Beta-2 microglobulin,0,2.07
7lg0,"Human leukocyte antigen HLA-B*0702 in complex with SARS-CoV-2 epitope SPRWYFYYL. HLA-B*0702 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 is bound between the 2 alpha-helices. The structure was solved via X-ray diffraction to dertermine possible immune response to the peptide.""   ",X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7lg0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7lg0,nucleocapsid_protein,SARS-CoV-2,0,1.79
7lg2,Crystal structure of human leukocyte antigen A*0201 (HLA-A*02) in complex with SARS-CoV2 epitope ALWEIQQVV. HLA-A corresponds to MHC I complex and is central to the cellular immune response.,X-RAY DIFFRACTION,pdb/orf8/SARS-CoV-2/7lg2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf8/SARS-CoV-2/7lg2,orf8,SARS-CoV-2,0,1.76
7lg3,Crystal structure of human leukocyte antigen A*0201 (HLA-A*02) in complex with SARS-CoV2 epitope KLWAQCVQL. HLA-A corresponds to MHC I complex and is central to the cellular immune response.,X-RAY DIFFRACTION,pdb/nsp7/SARS-CoV-2/7lg3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7/SARS-CoV-2/7lg3,nsp7,SARS-CoV-2,0,1.61
7l6r,"Crystal structure of SARS-CoV-2 NSP 10/16 in complex with methyltransferase and RNA 5' > 3'. Hetero trimer, NSP10 with one chain and methyltransferase and RNA with one chain each.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7l6r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7l6r,methyltransferase-nsp10,SARS-CoV-2,0,1.12
7l6t,"Crystal structure of SARS-CoV-2 NSP 10/16 in complex with Methyltransferase and RNA 5' > 3'. Hetero trimer, NSP 10/16, Methyltransferase and RNA with one chain each.",X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7l6t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7l6t,methyltransferase-nsp10,SARS-CoV-2,0,1.14
6yxj,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/6yxj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/6yxj,nsp3,SARS-CoV,0,2.31
5rs7,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W4Y](https://www.rcsb.org/ligand/W4Y).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rs7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rs7,nsp3,SARS-CoV-2,0,1.38
5rs8,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [H35](https://www.rcsb.org/ligand/H35).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rs8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rs8,nsp3,SARS-CoV-2,0,1.17
5rs9,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W4V](https://www.rcsb.org/ligand/W4V).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rs9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rs9,nsp3,SARS-CoV-2,0,1.1
5rsb,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W4S](https://www.rcsb.org/ligand/W4S).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsb,nsp3,SARS-CoV-2,0,1.05
5rsc,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5S](https://www.rcsb.org/ligand/W5S).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsc,nsp3,SARS-CoV-2,0,1.19
5rsd,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [1LQ](https://www.rcsb.org/ligand/1LQ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsd,nsp3,SARS-CoV-2,0,1.08
5rse,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5P](https://www.rcsb.org/ligand/W5P).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rse,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rse,nsp3,SARS-CoV-2,0,1.19
5rsf,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5M](https://www.rcsb.org/ligand/W5M).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsf,nsp3,SARS-CoV-2,0,1.0
5rsg,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5J](https://www.rcsb.org/ligand/W5J).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsg,nsp3,SARS-CoV-2,0,1.42
5rsh,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5G](https://www.rcsb.org/ligand/W5G).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsh,nsp3,SARS-CoV-2,0,1.03
5rsi,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5D](https://www.rcsb.org/ligand/W5D).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsi,nsp3,SARS-CoV-2,0,1.63
5rsj,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W5A](https://www.rcsb.org/ligand/W5A).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsj,nsp3,SARS-CoV-2,0,1.0
5rsk,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W57](https://www.rcsb.org/ligand/W57).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsk,nsp3,SARS-CoV-2,0,1.03
5rsl,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W51](https://www.rcsb.org/ligand/W51).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsl,nsp3,SARS-CoV-2,0,1.21
5rsm,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4SO](https://www.rcsb.org/ligand/4SO).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsm,nsp3,SARS-CoV-2,0,0.98
5rsn,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [51X](https://www.rcsb.org/ligand/51X).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsn,nsp3,SARS-CoV-2,0,0.88
5rso,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [TYZ](https://www.rcsb.org/ligand/TYZ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rso,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rso,nsp3,SARS-CoV-2,0,1.01
5rsp,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [LSA](https://www.rcsb.org/ligand/LSA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsp,nsp3,SARS-CoV-2,0,0.9
5rsq,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [MOK](https://www.rcsb.org/ligand/MOK).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsq,nsp3,SARS-CoV-2,0,0.99
5rsr,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [XIY](https://www.rcsb.org/ligand/XIY).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsr,nsp3,SARS-CoV-2,0,0.92
5rss,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [NC3](https://www.rcsb.org/ligand/NC3).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rss,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rss,nsp3,SARS-CoV-2,0,1.15
5rst,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [5HN](https://www.rcsb.org/ligand/5HN).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rst,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rst,nsp3,SARS-CoV-2,0,1.06
5rsu,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [OHB](https://www.rcsb.org/ligand/OHB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsu,nsp3,SARS-CoV-2,0,1.06
5rsv,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4MB](https://www.rcsb.org/ligand/4MB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsv,nsp3,SARS-CoV-2,0,1.1
5rsw,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [6FZ](https://www.rcsb.org/ligand/6FZ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsw,nsp3,SARS-CoV-2,0,0.96
5rsx,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [YTX](https://www.rcsb.org/ligand/YTX).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsx,nsp3,SARS-CoV-2,0,0.81
5rsy,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3R6](https://www.rcsb.org/ligand/3R6).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsy,nsp3,SARS-CoV-2,0,1.1
5rsz,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [ZZA](https://www.rcsb.org/ligand/ZZA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rsz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rsz,nsp3,SARS-CoV-2,0,0.92
5rt0,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4BL](https://www.rcsb.org/ligand/4BL).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt0,nsp3,SARS-CoV-2,0,0.99
5rt1,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3A9](https://www.rcsb.org/ligand/3A9).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt1,nsp3,SARS-CoV-2,0,1.03
5rt2,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [5OF](https://www.rcsb.org/ligand/5OF).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt2,nsp3,SARS-CoV-2,0,1.03
5rt3,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [2FX](https://www.rcsb.org/ligand/2FX).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt3,nsp3,SARS-CoV-2,0,1.2
5rt4,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4BX](https://www.rcsb.org/ligand/4BX).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt4,nsp3,SARS-CoV-2,0,0.96
5rt5,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [07L](https://www.rcsb.org/ligand/07L).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt5,nsp3,SARS-CoV-2,0,1.08
5rt6,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [05R](https://www.rcsb.org/ligand/05R).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt6,nsp3,SARS-CoV-2,0,1.1
5rt7,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [GVH](https://www.rcsb.org/ligand/GVH).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt7,nsp3,SARS-CoV-2,0,0.93
5rt8,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [HLR](https://www.rcsb.org/ligand/HLR).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt8,nsp3,SARS-CoV-2,0,0.9
5rt9,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [54G](https://www.rcsb.org/ligand/54G).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rt9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rt9,nsp3,SARS-CoV-2,0,0.98
5rta,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [Q6T](https://www.rcsb.org/ligand/Q6T).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rta,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rta,nsp3,SARS-CoV-2,0,1.04
5rtb,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3XH](https://www.rcsb.org/ligand/3XH).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtb,nsp3,SARS-CoV-2,0,0.93
5rtc,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [EVE](https://www.rcsb.org/ligand/EVE).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtc,nsp3,SARS-CoV-2,0,1.12
5rtd,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [MHW](https://www.rcsb.org/ligand/MHW).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtd,nsp3,SARS-CoV-2,0,1.0
5rte,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4FL](https://www.rcsb.org/ligand/4FL).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rte,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rte,nsp3,SARS-CoV-2,0,1.12
5rtf,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [ISN](https://www.rcsb.org/ligand/ISN).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtf,nsp3,SARS-CoV-2,0,1.1
5rtg,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3HP](https://www.rcsb.org/ligand/3HP).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtg,nsp3,SARS-CoV-2,0,0.86
5rth,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3BZ](https://www.rcsb.org/ligand/3BZ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rth,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rth,nsp3,SARS-CoV-2,0,0.99
5rti,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [6U6](https://www.rcsb.org/ligand/6U6).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rti,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rti,nsp3,SARS-CoV-2,0,1.15
5rtj,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [PHB](https://www.rcsb.org/ligand/PHB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtj,nsp3,SARS-CoV-2,0,1.04
5rtk,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [BZX](https://www.rcsb.org/ligand/BZX).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtk,nsp3,SARS-CoV-2,0,0.98
5rtl,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4J8](https://www.rcsb.org/ligand/4J8).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtl,nsp3,SARS-CoV-2,0,1.12
5rtm,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [PZA](https://www.rcsb.org/ligand/PZA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtm,nsp3,SARS-CoV-2,0,1.03
5rtn,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [AQO](https://www.rcsb.org/ligand/AQO).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtn,nsp3,SARS-CoV-2,0,1.08
5rto,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4PN](https://www.rcsb.org/ligand/4PN).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rto,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rto,nsp3,SARS-CoV-2,0,0.98
5rtp,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [AOT](https://www.rcsb.org/ligand/AOT).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtp,nsp3,SARS-CoV-2,0,1.01
5rtq,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4JO](https://www.rcsb.org/ligand/4JO).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtq,nsp3,SARS-CoV-2,0,0.95
5rtr,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [SHA](https://www.rcsb.org/ligand/SHA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtr,nsp3,SARS-CoV-2,0,1.06
5rts,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [0LO](https://www.rcsb.org/ligand/0LO).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rts,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rts,nsp3,SARS-CoV-2,0,0.99
5rtt,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [NMI](https://www.rcsb.org/ligand/NMI).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtt,nsp3,SARS-CoV-2,0,1.08
5rtu,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [1FF](https://www.rcsb.org/ligand/1FF).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtu,nsp3,SARS-CoV-2,0,0.98
5rtv,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [PF0](https://www.rcsb.org/ligand/PF0).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtv,nsp3,SARS-CoV-2,0,1.19
5rtw,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [OHP](https://www.rcsb.org/ligand/OHP).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtw,nsp3,SARS-CoV-2,0,0.85
5rtx,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [6OT](https://www.rcsb.org/ligand/6OT).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtx,nsp3,SARS-CoV-2,0,1.0
5rty,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [HBD](https://www.rcsb.org/ligand/HBD).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rty,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rty,nsp3,SARS-CoV-2,0,0.99
5rtz,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [FHB](https://www.rcsb.org/ligand/FHB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rtz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rtz,nsp3,SARS-CoV-2,0,0.96
5ru0,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [2CL](https://www.rcsb.org/ligand/2CL).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru0,nsp3,SARS-CoV-2,0,1.12
5ru1,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [DFA](https://www.rcsb.org/ligand/DFA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru1,nsp3,SARS-CoV-2,0,1.14
5ru2,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [06Y](https://www.rcsb.org/ligand/06Y).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru2,nsp3,SARS-CoV-2,0,1.1
5ru3,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [8H8](https://www.rcsb.org/ligand/8H8).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru3,nsp3,SARS-CoV-2,0,0.99
5ru4,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [6V9](https://www.rcsb.org/ligand/6V9).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru4,nsp3,SARS-CoV-2,0,1.16
5ru5,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [BXW](https://www.rcsb.org/ligand/BXW).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru5,nsp3,SARS-CoV-2,0,1.06
5ru6,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [2UP](https://www.rcsb.org/ligand/2UP).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru6,nsp3,SARS-CoV-2,0,1.17
5ru7,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [PYD](https://www.rcsb.org/ligand/PYD).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru7,nsp3,SARS-CoV-2,0,1.08
5ru8,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [1SQ](https://www.rcsb.org/ligand/1SQ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru8,nsp3,SARS-CoV-2,0,0.93
5ru9,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4SV](https://www.rcsb.org/ligand/4SV).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ru9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ru9,nsp3,SARS-CoV-2,0,1.12
5rua,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [3EU](https://www.rcsb.org/ligand/3EU).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rua,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rua,nsp3,SARS-CoV-2,0,1.12
5ruc,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [NCA](https://www.rcsb.org/ligand/NCA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruc,nsp3,SARS-CoV-2,0,0.93
5rud,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [2D0](https://www.rcsb.org/ligand/2D0).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rud,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rud,nsp3,SARS-CoV-2,0,1.03
5rue,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [BHA](https://www.rcsb.org/ligand/BHA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rue,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rue,nsp3,SARS-CoV-2,0,0.99
5ruf,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [54T](https://www.rcsb.org/ligand/54T).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruf,nsp3,SARS-CoV-2,0,1.05
5rug,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [NOA](https://www.rcsb.org/ligand/NOA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rug,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rug,nsp3,SARS-CoV-2,0,0.86
5ruh,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [KNL](https://www.rcsb.org/ligand/KNL).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruh,nsp3,SARS-CoV-2,0,1.23
5rui,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4YS](https://www.rcsb.org/ligand/4YS).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rui,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rui,nsp3,SARS-CoV-2,0,0.9
5ruj,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [2SX](https://www.rcsb.org/ligand/2SX).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruj,nsp3,SARS-CoV-2,0,0.98
5ruk,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [NVU](https://www.rcsb.org/ligand/NVU).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruk,nsp3,SARS-CoV-2,0,0.86
5rul,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [5ZE](https://www.rcsb.org/ligand/5ZE).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rul,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rul,nsp3,SARS-CoV-2,0,1.08
5rum,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [52F](https://www.rcsb.org/ligand/52F).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rum,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rum,nsp3,SARS-CoV-2,0,1.15
5run,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [EXB](https://www.rcsb.org/ligand/EXB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5run,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5run,nsp3,SARS-CoV-2,0,0.93
5ruo,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6A](https://www.rcsb.org/ligand/W6A).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruo,nsp3,SARS-CoV-2,0,1.05
5rup,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [04R](https://www.rcsb.org/ligand/04R).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rup,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rup,nsp3,SARS-CoV-2,0,1.18
5ruq,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6D](https://www.rcsb.org/ligand/W6D).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruq,nsp3,SARS-CoV-2,0,1.01
5rur,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [FBB](https://www.rcsb.org/ligand/FBB).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rur,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rur,nsp3,SARS-CoV-2,0,1.05
5rus,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [HSM](https://www.rcsb.org/ligand/HSM).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rus,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rus,nsp3,SARS-CoV-2,0,0.96
5rut,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [APG](https://www.rcsb.org/ligand/APG).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rut,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rut,nsp3,SARS-CoV-2,0,0.93
5ruu,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6G](https://www.rcsb.org/ligand/W6G).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruu,nsp3,SARS-CoV-2,0,1.27
5ruv,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6J](https://www.rcsb.org/ligand/W6J).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruv,nsp3,SARS-CoV-2,0,1.06
5ruw,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6M](https://www.rcsb.org/ligand/W6M).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruw,nsp3,SARS-CoV-2,0,1.1
5rux,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6P](https://www.rcsb.org/ligand/W6P).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rux,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rux,nsp3,SARS-CoV-2,0,0.9
5ruy,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [XAN](https://www.rcsb.org/ligand/XAN).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruy,nsp3,SARS-CoV-2,0,1.14
5ruz,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6S](https://www.rcsb.org/ligand/W6S).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5ruz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5ruz,nsp3,SARS-CoV-2,0,0.95
5rv0,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W6V](https://www.rcsb.org/ligand/W6V).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv0,nsp3,SARS-CoV-2,0,1.06
5rv1,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [TFA](https://www.rcsb.org/ligand/TFA).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv1,nsp3,SARS-CoV-2,0,0.96
5rv2,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W7S](https://www.rcsb.org/ligand/W7S).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv2,nsp3,SARS-CoV-2,0,1.01
5rv3,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [MYI](https://www.rcsb.org/ligand/MYI).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv3,nsp3,SARS-CoV-2,0,1.05
5rv4,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [4FS](https://www.rcsb.org/ligand/4FS).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv4,nsp3,SARS-CoV-2,0,0.88
5rv5,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [JG8](https://www.rcsb.org/ligand/JG8).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv5,nsp3,SARS-CoV-2,0,1.3
5rv6,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [0HN](https://www.rcsb.org/ligand/0HN).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv6,nsp3,SARS-CoV-2,0,1.14
5rv7,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [JNZ](https://www.rcsb.org/ligand/JNZ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv7,nsp3,SARS-CoV-2,0,1.06
5rv8,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [8EJ](https://www.rcsb.org/ligand/8EJ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv8,nsp3,SARS-CoV-2,0,0.96
5rv9,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [EKZ](https://www.rcsb.org/ligand/EKZ).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rv9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rv9,nsp3,SARS-CoV-2,0,1.19
5rva,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [HQD](https://www.rcsb.org/ligand/HQD).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rva,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rva,nsp3,SARS-CoV-2,0,0.96
5rvb,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [7PD](https://www.rcsb.org/ligand/7PD).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvb,nsp3,SARS-CoV-2,0,1.08
5rvc,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W7V](https://www.rcsb.org/ligand/W7V).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvc,nsp3,SARS-CoV-2,0,1.01
5rvd,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W7Y](https://www.rcsb.org/ligand/W7Y).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvd,nsp3,SARS-CoV-2,0,1.69
5rve,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W8A](https://www.rcsb.org/ligand/W8A).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rve,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rve,nsp3,SARS-CoV-2,0,0.99
5rvf,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W8D](https://www.rcsb.org/ligand/W8D).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvf,nsp3,SARS-CoV-2,0,1.0
5rvg,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [W8J](https://www.rcsb.org/ligand/W8J).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvg,nsp3,SARS-CoV-2,0,1.06
5rvh,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [Q3C](https://www.rcsb.org/ligand/Q3C).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvh,nsp3,SARS-CoV-2,0,1.07
5rvi,"Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1, SSRL 12-1 and 12-2 and NSLS-II 17-ID-2. The potential binding ligand(s): [CLW](https://www.rcsb.org/ligand/CLW).",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvi,nsp3,SARS-CoV-2,0,1.14
5rvj,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [4JQ](https://www.rcsb.org/ligand/4JQ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvj,nsp3,SARS-CoV-2,0,1.05
5rvk,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [2AK](https://www.rcsb.org/ligand/2AK).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvk,nsp3,SARS-CoV-2,0,1.27
5rvl,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [BVF](https://www.rcsb.org/ligand/BVF).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvl,nsp3,SARS-CoV-2,0,1.24
5rvm,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [HBD](https://www.rcsb.org/ligand/HBD).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvm,nsp3,SARS-CoV-2,0,1.18
5rvn,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [ANN](https://www.rcsb.org/ligand/ANN).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvn,nsp3,SARS-CoV-2,0,1.44
5rvo,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [AQO](https://www.rcsb.org/ligand/AQO).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvo,nsp3,SARS-CoV-2,0,1.16
5rvp,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [1SQ](https://www.rcsb.org/ligand/1SQ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvp,nsp3,SARS-CoV-2,0,1.6
5rvq,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [4BY](https://www.rcsb.org/ligand/4BY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvq,nsp3,SARS-CoV-2,0,1.47
5rvr,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [LZ1](https://www.rcsb.org/ligand/LZ1).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvr,nsp3,SARS-CoV-2,0,1.47
5rvs,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [0LO](https://www.rcsb.org/ligand/0LO).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvs,nsp3,SARS-CoV-2,0,1.44
5rvt,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [4BL](https://www.rcsb.org/ligand/4BL).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvt,nsp3,SARS-CoV-2,0,0.95
5rvu,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [6P3](https://www.rcsb.org/ligand/6P3).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvu,nsp3,SARS-CoV-2,0,1.28
5rvv,Part of PanDDA analysis group deposition of SARS-CoV-2 NSP3 macrodomain fragment screen. SARS-CoV-2 NSP3 macrodomain from SARS-CoV-2 screened against the Enamine Essential fragment library (Enamine) and the UCSF_91 fragment library (UCSF) by X-ray Crystallography at UCSF using ALS 8.3.1 and SSRL 12-2. The potential binding ligand(s): [WB1](https://www.rcsb.org/ligand/WB1).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5rvv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5rvv,nsp3,SARS-CoV-2,0,1.52
5s18,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WOY](https://www.rcsb.org/ligand/WOY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s18,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s18,nsp3,SARS-CoV-2,0,1.17
5s1a,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WPS](https://www.rcsb.org/ligand/WPS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1a,nsp3,SARS-CoV-2,0,1.24
5s1c,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WPV](https://www.rcsb.org/ligand/WPV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1c,nsp3,SARS-CoV-2,0,0.91
5s1e,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WPY](https://www.rcsb.org/ligand/WPY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1e,nsp3,SARS-CoV-2,0,1.04
5s1g,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQ1](https://www.rcsb.org/ligand/WQ1).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1g,nsp3,SARS-CoV-2,0,0.84
5s1i,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQ4](https://www.rcsb.org/ligand/WQ4).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1i,nsp3,SARS-CoV-2,0,1.11
5s1k,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQ7](https://www.rcsb.org/ligand/WQ7).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1k,nsp3,SARS-CoV-2,0,1.16
5s1m,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [DE5](https://www.rcsb.org/ligand/DE5).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1m,nsp3,SARS-CoV-2,0,0.86
5s1o,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQA](https://www.rcsb.org/ligand/WQA).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1o,nsp3,SARS-CoV-2,0,1.03
5s1q,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQG](https://www.rcsb.org/ligand/WQG).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1q,nsp3,SARS-CoV-2,0,1.18
5s1s,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQJ](https://www.rcsb.org/ligand/WQJ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1s,nsp3,SARS-CoV-2,0,1.0
5s1u,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQM](https://www.rcsb.org/ligand/WQM).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1u,nsp3,SARS-CoV-2,0,1.19
5s1w,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQV](https://www.rcsb.org/ligand/WQV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1w,nsp3,SARS-CoV-2,0,0.91
5s1y,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WQY](https://www.rcsb.org/ligand/WQY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s1y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s1y,nsp3,SARS-CoV-2,0,1.16
5s20,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WRD](https://www.rcsb.org/ligand/WRD).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s20,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s20,nsp3,SARS-CoV-2,0,1.06
5s22,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WRJ](https://www.rcsb.org/ligand/WRJ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s22,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s22,nsp3,SARS-CoV-2,0,1.07
5s24,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WRM](https://www.rcsb.org/ligand/WRM).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s24,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s24,nsp3,SARS-CoV-2,0,1.07
5s26,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [L46](https://www.rcsb.org/ligand/L46).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s26,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s26,nsp3,SARS-CoV-2,0,0.99
5s27,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WSM](https://www.rcsb.org/ligand/WSM).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s27,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s27,nsp3,SARS-CoV-2,0,0.95
5s28,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WRV](https://www.rcsb.org/ligand/WRV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s28,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s28,nsp3,SARS-CoV-2,0,1.11
5s29,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WRY](https://www.rcsb.org/ligand/WRY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s29,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s29,nsp3,SARS-CoV-2,0,1.1
5s2a,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WS4](https://www.rcsb.org/ligand/WS4).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2a,nsp3,SARS-CoV-2,0,1.19
5s2b,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WSG](https://www.rcsb.org/ligand/WSG).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2b,nsp3,SARS-CoV-2,0,1.12
5s2c,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [WSJ](https://www.rcsb.org/ligand/WSJ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2c,nsp3,SARS-CoV-2,0,1.03
5s2d,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [U0P](https://www.rcsb.org/ligand/U0P).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2d,nsp3,SARS-CoV-2,0,0.83
5s2e,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VZM](https://www.rcsb.org/ligand/VZM).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2e,nsp3,SARS-CoV-2,0,0.95
5s2f,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [K0G](https://www.rcsb.org/ligand/K0G).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2f,nsp3,SARS-CoV-2,0,0.86
5s2g,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [JHJ](https://www.rcsb.org/ligand/JHJ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2g,nsp3,SARS-CoV-2,0,0.93
5s2h,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VWV](https://www.rcsb.org/ligand/VWV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2h,nsp3,SARS-CoV-2,0,0.94
5s2i,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [LUY](https://www.rcsb.org/ligand/LUY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2i,nsp3,SARS-CoV-2,0,0.98
5s2j,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [JGG](https://www.rcsb.org/ligand/JGG).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2j,nsp3,SARS-CoV-2,0,0.79
5s2k,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VZP](https://www.rcsb.org/ligand/VZP).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2k,nsp3,SARS-CoV-2,0,0.86
5s2l,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VZS](https://www.rcsb.org/ligand/VZS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2l,nsp3,SARS-CoV-2,0,1.04
5s2m,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VZY](https://www.rcsb.org/ligand/VZY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2m,nsp3,SARS-CoV-2,0,0.83
5s2n,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [GWY](https://www.rcsb.org/ligand/GWY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2n,nsp3,SARS-CoV-2,0,1.1
5s2o,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [NXS](https://www.rcsb.org/ligand/NXS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2o,nsp3,SARS-CoV-2,0,0.9
5s2p,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W04](https://www.rcsb.org/ligand/W04).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2p,nsp3,SARS-CoV-2,0,0.9
5s2q,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0A](https://www.rcsb.org/ligand/W0A).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2q,nsp3,SARS-CoV-2,0,1.14
5s2r,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [K41](https://www.rcsb.org/ligand/K41).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2r,nsp3,SARS-CoV-2,0,1.02
5s2s,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [GWV](https://www.rcsb.org/ligand/GWV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2s,nsp3,SARS-CoV-2,0,0.79
5s2t,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0D](https://www.rcsb.org/ligand/W0D).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2t,nsp3,SARS-CoV-2,0,1.16
5s2u,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [VXD](https://www.rcsb.org/ligand/VXD).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2u,nsp3,SARS-CoV-2,0,0.86
5s2v,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0G](https://www.rcsb.org/ligand/W0G).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2v,nsp3,SARS-CoV-2,0,1.03
5s2w,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [GWP](https://www.rcsb.org/ligand/GWP).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2w,nsp3,SARS-CoV-2,0,0.93
5s2x,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0J](https://www.rcsb.org/ligand/W0J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2x,nsp3,SARS-CoV-2,0,0.9
5s2y,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0M](https://www.rcsb.org/ligand/W0M).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2y,nsp3,SARS-CoV-2,0,1.06
5s2z,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [T6J](https://www.rcsb.org/ligand/T6J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s2z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s2z,nsp3,SARS-CoV-2,0,1.17
5s30,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0P](https://www.rcsb.org/ligand/W0P).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s30,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s30,nsp3,SARS-CoV-2,0,0.91
5s31,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0S](https://www.rcsb.org/ligand/W0S).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s31,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s31,nsp3,SARS-CoV-2,0,0.97
5s32,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0V](https://www.rcsb.org/ligand/W0V).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s32,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s32,nsp3,SARS-CoV-2,0,1.1
5s33,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [K2G](https://www.rcsb.org/ligand/K2G).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s33,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s33,nsp3,SARS-CoV-2,0,0.9
5s34,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [GOV](https://www.rcsb.org/ligand/GOV).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s34,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s34,nsp3,SARS-CoV-2,0,0.64
5s35,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [B1A](https://www.rcsb.org/ligand/B1A).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s35,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s35,nsp3,SARS-CoV-2,0,1.01
5s36,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [7ZC](https://www.rcsb.org/ligand/7ZC).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s36,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s36,nsp3,SARS-CoV-2,0,0.86
5s37,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [NZ1](https://www.rcsb.org/ligand/NZ1).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s37,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s37,nsp3,SARS-CoV-2,0,1.02
5s38,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [S7J](https://www.rcsb.org/ligand/S7J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s38,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s38,nsp3,SARS-CoV-2,0,1.08
5s39,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W0Y](https://www.rcsb.org/ligand/W0Y).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s39,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s39,nsp3,SARS-CoV-2,0,1.01
5s3a,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W17](https://www.rcsb.org/ligand/W17).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3a,nsp3,SARS-CoV-2,0,1.06
5s3b,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1A](https://www.rcsb.org/ligand/W1A).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3b,nsp3,SARS-CoV-2,0,1.01
5s3c,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1D](https://www.rcsb.org/ligand/W1D).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3c,nsp3,SARS-CoV-2,0,1.33
5s3d,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [JFP](https://www.rcsb.org/ligand/JFP).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3d,nsp3,SARS-CoV-2,0,1.36
5s3e,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [WSY](https://www.rcsb.org/ligand/WSY).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3e,nsp3,SARS-CoV-2,0,0.96
5s3f,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1J](https://www.rcsb.org/ligand/W1J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3f,nsp3,SARS-CoV-2,0,0.91
5s3g,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [JHS](https://www.rcsb.org/ligand/JHS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3g,nsp3,SARS-CoV-2,0,0.91
5s3h,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1M](https://www.rcsb.org/ligand/W1M).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3h,nsp3,SARS-CoV-2,0,1.07
5s3i,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1P](https://www.rcsb.org/ligand/W1P).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3i,nsp3,SARS-CoV-2,0,1.11
5s3j,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1S](https://www.rcsb.org/ligand/W1S).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3j,nsp3,SARS-CoV-2,0,0.79
5s3k,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [RZS](https://www.rcsb.org/ligand/RZS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3k,nsp3,SARS-CoV-2,0,1.0
5s3l,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [JH4](https://www.rcsb.org/ligand/JH4).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3l,nsp3,SARS-CoV-2,0,1.01
5s3m,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [S2S](https://www.rcsb.org/ligand/S2S).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3m,nsp3,SARS-CoV-2,0,0.98
5s3n,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1V](https://www.rcsb.org/ligand/W1V).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3n,nsp3,SARS-CoV-2,0,0.97
5s3o,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W1Y](https://www.rcsb.org/ligand/W1Y).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3o,nsp3,SARS-CoV-2,0,1.06
5s3p,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W21](https://www.rcsb.org/ligand/W21).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3p,nsp3,SARS-CoV-2,0,0.83
5s3q,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2A](https://www.rcsb.org/ligand/W2A).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3q,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3q,nsp3,SARS-CoV-2,0,0.9
5s3r,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W24](https://www.rcsb.org/ligand/W24).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3r,nsp3,SARS-CoV-2,0,0.79
5s3s,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W27](https://www.rcsb.org/ligand/W27).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3s,nsp3,SARS-CoV-2,0,1.04
5s3t,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2G](https://www.rcsb.org/ligand/W2G).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3t,nsp3,SARS-CoV-2,0,1.0
5s3u,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2J](https://www.rcsb.org/ligand/W2J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3u,nsp3,SARS-CoV-2,0,1.05
5s3v,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2M](https://www.rcsb.org/ligand/W2M).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3v,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3v,nsp3,SARS-CoV-2,0,1.01
5s3w,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2S](https://www.rcsb.org/ligand/W2S).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3w,nsp3,SARS-CoV-2,0,0.91
5s3x,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2V](https://www.rcsb.org/ligand/W2V).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3x,nsp3,SARS-CoV-2,0,0.83
5s3y,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W2Y](https://www.rcsb.org/ligand/W2Y).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3y,nsp3,SARS-CoV-2,0,0.97
5s3z,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W34](https://www.rcsb.org/ligand/W34).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s3z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s3z,nsp3,SARS-CoV-2,0,0.93
5s40,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [HHQ](https://www.rcsb.org/ligand/HHQ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s40,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s40,nsp3,SARS-CoV-2,0,1.07
5s41,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [HGQ](https://www.rcsb.org/ligand/HGQ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s41,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s41,nsp3,SARS-CoV-2,0,1.16
5s42,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [HH8](https://www.rcsb.org/ligand/HH8).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s42,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s42,nsp3,SARS-CoV-2,0,0.96
5s43,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [UUJ](https://www.rcsb.org/ligand/UUJ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s43,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s43,nsp3,SARS-CoV-2,0,0.83
5s44,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3A](https://www.rcsb.org/ligand/W3A).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s44,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s44,nsp3,SARS-CoV-2,0,0.93
5s45,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3D](https://www.rcsb.org/ligand/W3D).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s45,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s45,nsp3,SARS-CoV-2,0,0.94
5s46,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [HYN](https://www.rcsb.org/ligand/HYN).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s46,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s46,nsp3,SARS-CoV-2,0,1.14
5s47,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [BAQ](https://www.rcsb.org/ligand/BAQ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s47,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s47,nsp3,SARS-CoV-2,0,0.91
5s48,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [HRZ](https://www.rcsb.org/ligand/HRZ).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s48,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s48,nsp3,SARS-CoV-2,0,1.0
5s49,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [3TR](https://www.rcsb.org/ligand/3TR).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s49,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s49,nsp3,SARS-CoV-2,0,1.19
5s4a,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [4AP](https://www.rcsb.org/ligand/4AP).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4a,nsp3,SARS-CoV-2,0,0.78
5s4b,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3G](https://www.rcsb.org/ligand/W3G).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4b,nsp3,SARS-CoV-2,0,0.98
5s4c,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3J](https://www.rcsb.org/ligand/W3J).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4c,nsp3,SARS-CoV-2,0,0.89
5s4d,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [2OP](https://www.rcsb.org/ligand/2OP).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4d,nsp3,SARS-CoV-2,0,1.01
5s4e,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [DMS](https://www.rcsb.org/ligand/DMS).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4e,nsp3,SARS-CoV-2,0,0.93
5s4f,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3P](https://www.rcsb.org/ligand/W3P).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4f,nsp3,SARS-CoV-2,0,1.0
5s4g,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3S](https://www.rcsb.org/ligand/W3S).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4g,nsp3,SARS-CoV-2,0,0.98
5s4h,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3V](https://www.rcsb.org/ligand/W3V).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4h,nsp3,SARS-CoV-2,0,0.88
5s4i,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W3Y](https://www.rcsb.org/ligand/W3Y).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4i,nsp3,SARS-CoV-2,0,0.97
5s4j,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W41](https://www.rcsb.org/ligand/W41).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4j,nsp3,SARS-CoV-2,0,1.07
5s4k,Part of PanDDA analysis group deposition. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [W44](https://www.rcsb.org/ligand/W44).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s4k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s4k,nsp3,SARS-CoV-2,0,0.84
5s73,Part of PanDDA analysis group deposition of ground-state model. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen with EU-OPENSCREEN fragment library. The potential binding ligand(s): [HOH](https://www.rcsb.org/ligand/HOH).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s73,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s73,nsp3,SARS-CoV-2,0,1.19
5s74,Part of PanDDA analysis group deposition of ground-state model. SARS-CoV-2 Nsp3 macrodomain crystallographic fragment screen. The potential binding ligand(s): [EDO](https://www.rcsb.org/ligand/EDO).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/5s74,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/5s74,nsp3,SARS-CoV-2,0,1.25
6z5t,"The nsp3 macrodomain in complex with ADP-ribose. A further ligand is a sodium ion, the resolution of the structure is 1.57 Å.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6z5t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6z5t,nsp3,SARS-CoV-2,0,1.34
6z6i,"The nsp3 macrodomain in complex with ADP-HPD. The ligands are 5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-DIHYDROXYPYRROLIDIN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]ADENOSINE, 3[N-MORPHOLINO]PROPANE SULFONIC ACID, glycerol, 1,2-ethanediol and sodium ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6z6i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6z6i,nsp3,SARS-CoV-2,0,1.5
6z72,"The nsp3 macrodomain in complex with ADP-HPM. Further ligands are D-malate, 1,2-ethanediol and sodium ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/6z72,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/6z72,nsp3,SARS-CoV-2,0,1.29
7bf3,"The crystal structure of the nsp3 macrodomain in complex with adenosine. Further ligands are 1,2-ethanediol and magnesion ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7bf3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7bf3,nsp3,SARS-CoV-2,0,1.03
7bf4,"The crystal structure of the nsp3 macrodomain in complex with GMP. A further ligand is 1,2-ethanediol and the data has a resolution of 1.55 Å.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7bf4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7bf4,nsp3,SARS-CoV-2,0,1.2
7bf5,"The crystal structure of the nsp3 macrodomain in complex with ADP-ribose-phosphate (ADP-ribose-2'-phosphate, ADPRP). Further ligands are 1,2-ethanediol and magnesium ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7bf5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7bf5,nsp3,SARS-CoV-2,0,1.17
7bf6,"The crystal structure of the nsp3 macrodomain in complex with the remdesivir metabolite GS-441524. A further ligand is 1,2-ETHANEDIOL.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7bf6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7bf6,nsp3,SARS-CoV-2,0,0.96
7e35,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7e35,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7e35,nsp3,SARS-CoV-2,0,1.88
7kqo,The X-ray crystal structure of the nsp3 macrodomain in P43 crystal form with a resolution of 0.85 Å.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kqo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kqo,nsp3,SARS-CoV-2,0,1.26
7kqp,The X-ray crystal structure of the nsp3 macrodomain in P43 crystal form and in complex with ADP-ribose. The structure has a resolution of 0.88 Å.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kqp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kqp,nsp3,SARS-CoV-2,0,1.13
7kqw,"The crystal structure of the nsp3 macrodomain in C2 crystal form, methylated. The X-ray structure has one modified residue and a resolution of 0.93 Å.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kqw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kqw,nsp3,SARS-CoV-2,0,1.28
7kr0,The crystal structure of the nsp3 macrodomain in C2 crystal form at 100 K. The structure has a resolution of 0.77 Å.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kr0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kr0,nsp3,SARS-CoV-2,0,1.26
7kr1,The crystal structure of the nsp3 macrodomain in C2 crystal form at 310 K. It has a resolution of 1.55 Å.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kr1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kr1,nsp3,SARS-CoV-2,0,1.38
7krx,"The crystal structure of the nsp3 papain-like protease with a C111S mutant in complex with PLP_Snyder441. Further ligands are zinc, acetate and chloride ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7krx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7krx,nsp3,SARS-CoV-2,0,1.9
7kxb,"The crystal structure of the nsp3 macrodomain in complex with PARG329. The ligands are N-{3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]propyl}-N'-[2-(morpholin-4-yl)ethyl]thiourea, three sulfate ions and BETA-MERCAPTOETHANOL.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7kxb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7kxb,nsp3,SARS-CoV-2,0,1.34
7lbr,"The X-ray structure of the nsp3 papain-like protease (PLpro) bound to inhibitor XR8-89. Its ligands are zinc ions, sulfate ions, glycerol and 5-[(azetidin-3-yl)amino]-N-[(1R)-1-{3-[5-({[(1S,3R)-3-hydroxycyclopentyl]amino}methyl)thiophen-2-yl]phenyl}ethyl]-2-methylbenzamide.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7lbr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7lbr,nsp3,SARS-CoV-2,0,1.15
7lbs,"The nsp3 papain-like protease (PLpro) bound to inhibitor XR8-24. Further ligands are glycerol, boric acid, zinc and sulfate ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7lbs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7lbs,nsp3,SARS-CoV-2,0,1.93
7lg7,"The crystal structure of the nsp3 macrodomain in complex with PARG345. As ligands it has four SO4 and 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7lg7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7lg7,nsp3,SARS-CoV-2,0,1.09
7lgo,The crystal structure of the nsp3 nucleic acid binding domain (NAB).,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7lgo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7lgo,nsp3,SARS-CoV-2,0,2.27
7llf,"The nsp3 papain-like protease (PLpro) bound to the inhibitor XR8-83. Further ligands are glycerol, boric acid, zinc and sulfate ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7llf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7llf,nsp3,SARS-CoV-2,0,1.59
7llz,The nsp3 papain-like protease (PLpro) bound to the inhibitor XR8-69. Further ligands are sulfate and zinc ions.,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7llz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7llz,nsp3,SARS-CoV-2,0,1.55
7los,"The crystal structure of the nsp3 papain-like protease (PLpro) bound to the inhibitor XR8-65. Further ligands are sulfate, zinc and chloride ions.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7los,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7los,nsp3,SARS-CoV-2,0,2.1
7nfv,"The structure of the nsp3 papain-like protease (PLpro). Its ligands are phosphate, zinc and chloride ions and glycerol. The structure has a resolution of 1.42 Å.",X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7nfv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7nfv,nsp3,SARS-CoV-2,0,
7de1,C-terminal dimerisation domain of SARS-CoV-2 nucleocapsid protein in dimerized form. It was made via X-ray diffraction.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7de1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7de1,nucleocapsid_protein,SARS-CoV-2,0,1.49
7kgo,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N351-359. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgo,nucleocapsid_protein,SARS-CoV-2,0,1.17
7kgp,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N316-324. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgp,nucleocapsid_protein,SARS-CoV-2,0,1.24
7kgq,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N222-230. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgq,nucleocapsid_protein,SARS-CoV-2,0,1.13
7kgr,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N159-167. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgr,nucleocapsid_protein,SARS-CoV-2,0,0.99
7kgs,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N138-146. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgs,nucleocapsid_protein,SARS-CoV-2,0,0.96
7kgt,Human leukocyte antigen HLA-A*0201 in complex with SARS-CoV-2 N226-234. HLA-A*0201 consists of a MHC-class-I antigen and a Beta-2-microglobulin. The peptide is derived from the nucleocapsid protein of SARS-CoV-2 and bound between the alpha-helices. The structure was solved via X-ray diffraction to determine if and how nucleocapsid derived SARS-CoV-2 peptides trigger immune responses by CD8+ T-cells.,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7kgt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7kgt,nucleocapsid_protein,SARS-CoV-2,0,1.27
7ltu,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7ltu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7ltu,nucleocapsid_protein,SARS-CoV-2,0,1.27
7lux,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7lux,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7lux,nucleocapsid_protein,SARS-CoV-2,0,0.5
7luz,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7luz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7luz,nucleocapsid_protein,SARS-CoV-2,0,0.5
7lv2,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7lv2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7lv2,nucleocapsid_protein,SARS-CoV-2,0,0.5
7ci3,,X-RAY DIFFRACTION,pdb/orf7a/SARS-CoV-2/7ci3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf7a/SARS-CoV-2/7ci3,orf7a,SARS-CoV-2,1,1.39
7jn5,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/7jn5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7jn5,surface_glycoprotein,SARS-CoV,0,1.81
6zlr,"Crystal structure of SARS-CoV-2 RBD in complex with CR3022 Fab, soaking competent crystal. Hetero trimer, spike with three chains and Fab with heavy and light chain with three chains each. This crystal form shows the accessible space surrounding he target area.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6zlr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6zlr,surface_glycoprotein,SARS-CoV-2,0,
7b3o,"Crystal structure of SARS-CoV-2 RBD in complex with the antibody STE90-C11 Fab. Hetero trimer, spike with one chain and antibody with one heavy and one light chain. Antibody binds at the same region as ACE2 to the RBD and the binding is not blocked by known RBD mutations.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7b3o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b3o,surface_glycoprotein,SARS-CoV-2,0,1.06
7beh,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7beh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7beh,surface_glycoprotein,SARS-CoV-2,0,1.5
7bei,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bei,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bei,surface_glycoprotein,SARS-CoV-2,0,1.56
7bej,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bej,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bej,surface_glycoprotein,SARS-CoV-2,0,1.34
7bek,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bek,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bek,surface_glycoprotein,SARS-CoV-2,0,1.22
7bel,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bel,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bel,surface_glycoprotein,SARS-CoV-2,0,1.81
7bem,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bem,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bem,surface_glycoprotein,SARS-CoV-2,0,1.56
7ben,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ben,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ben,surface_glycoprotein,SARS-CoV-2,0,1.54
7beo,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7beo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7beo,surface_glycoprotein,SARS-CoV-2,0,1.47
7bep,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bep,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bep,surface_glycoprotein,SARS-CoV-2,0,1.68
7c8j,"Structure of COVID-19 virus spike receptor binding domain (RBD) to bat ACE2. It shows a binding mode similar to that of hACE2, the interacting network involving Y41 and E42 of bACE2-Rm showed substantial differences to that of hACE2. The Y41H mutant, attenuates the binding capacity of bACE2-Rm, indicating the central roles of Y41 in the interaction network",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7c8j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c8j,surface_glycoprotein,SARS-CoV-2,0,1.37
7cm4,"Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59, receptor binding domain (RBD) of the viral spike protein via antibody library constructed from peripheral blood mononuclear cells, CT-P59 mAb potently neutralizes SARS-CoV-2 isolates including the D614G variant.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cm4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cm4,surface_glycoprotein,SARS-CoV-2,0,1.51
7d2z,Structure of sy-body SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD). From synthetic construct of Severe acute respiratory syndrome coronavirus 2. ,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7d2z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d2z,surface_glycoprotein,SARS-CoV-2,0,1.53
7d30,"Crystal structure of SARS-CoV-2 RBD in complex with the sybody MR17-SR31 fusion. Hetero dimer, sybody with one chain and spike with one chain.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7d30,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d30,surface_glycoprotein,SARS-CoV-2,0,1.45
7dmu,"Crystal structure of SARS-CoV-2 spike protein receptor binding domain in complex with the high affinity ACE2 mutant 3N39. Hetero dimer, spike protein and ACE2 have two chains each. Modified ACE2 fuses to the human IgG1-Fc region which stabilizes the structure and neutralizes SARS-CoV-2 Infections.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7dmu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dmu,surface_glycoprotein,SARS-CoV-2,0,1.66
7dpm,Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab. From X-ray diffraction at resolution of 3.30 Å.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7dpm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dpm,surface_glycoprotein,SARS-CoV-2,0,1.77
7eam,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7eam,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eam,surface_glycoprotein,SARS-CoV-2,0,1.39
7jvb,"Crystal structure of the RBD-Nb20 complex to study neutralization potency against SC2. All three CDRs of Nb20 interact with the RBD by binding to its large extended external loop with two short b strands. RBD forms hydrogen bonds and ionic interactions with Nb20 which constitutes a major polar interaction network at the RBD and Nb20 interface. In addition, packing of CDR2 against RBD to form hydrophobic interactions at the interface occurs and cation p of Nb20 interacts with RBD side chain",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7jvb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7jvb,surface_glycoprotein,SARS-CoV-2,0,2.16
7kfv,"Crystal structure of SARS-CoV-2 spike protein in complex with Fab C1A-B12. Hetero trimer, spike with three chains and Fab with heavy and light chain with three chains each. Two conformations for the Fab were observed, it can either contact the side chain of RBD Q493 or the backbone carbonyl of RBD S494.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kfv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kfv,surface_glycoprotein,SARS-CoV-2,0,1.31
7kfw,Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab). X-ray crystal structures of four Fab variants bound to the RBD to explain the basis for changes in RBD affinity.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kfw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kfw,surface_glycoprotein,SARS-CoV-2,0,1.94
7kfx,"Crystal structure of SARS-CoV-2 spike protein bound to human antibody C1A-C2 Fab. Hetero trimer, spike with one chain and antibody with one heavy and light chain each. C1A-C2 contains mutations which increase affinity for the RBD and provides new contacts with the RBD Q474 and K458.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kfx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kfx,surface_glycoprotein,SARS-CoV-2,0,1.48
7kfy,Crystal structures of four Fab variants bound to the Receptor binding domain (RBD). The structures explain the basis for changes in RBD affinity. A germline revertant antibody binds tightly to the SC2 RBD and neutralizes SC2. The study clarifies the molecular basis for a heavily germline-biased human antibody response to SC2.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kfy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kfy,surface_glycoprotein,SARS-CoV-2,0,1.3
7kgj,"Crystal structure of a SARS-CoV-2 spike protein receptor binding domain in complex with the Synthetic Nanobody Sb45. Hetero dimer, Spike and Nanobody with one chain each. Sb45 bind the RBD at the ACE2 interface, positioning their CDR2 and CDR3 loops diametrically.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kgj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kgj,surface_glycoprotein,SARS-CoV-2,0,1.64
7kgk,"Crystal structure of SARS-CoV-2 spike protein receptor binding domain in complex with the synthetic nanobody Sb16. Hetero dimer, spike with one chain and nanobody with one chain. Sb16 reveals a large CDR2 shift when binding the RBD.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kgk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kgk,surface_glycoprotein,SARS-CoV-2,0,2.39
7klg,"SARS-CoV-2 RBD in complex with Fab 15033. Fab 15033 recognize a patch of surface-exposed non-polar residues on the RBD using several non-polar residues in both their heavy and light chain CDRs. In the RBD-15033 complex, Fab 15033 residues bind with RBD residues via Van der Waals interactions as well as a weak hydrogen bond. It follows that direct steric hindrance explains the ability of 15033 to block the RBD-ACE2 interaction.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7klg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7klg,surface_glycoprotein,SARS-CoV-2,0,1.54
7klh,"SARS-CoV-2 RBD in complex with Fab 15033-7, protein engineering and modular design principles that have led to the development of synthetic bivalent and tetravalent nAbs against SARS-CoV-2.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7klh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7klh,surface_glycoprotein,SARS-CoV-2,0,1.32
7klw,"Crystal structure of SARS-CoV-2 spike RBD in complex with the synthetic nanobodies SB45 and SB68. Hetero trimer, spike with one chain and nanobodies with one chain each. SB 45 and SB 68 interacting at two different faces of the RBD.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7klw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7klw,surface_glycoprotein,SARS-CoV-2,0,2.26
7kmg,This X-ray structure shows the SARS-CoV-2 spike RBD bound to LY-CoV555 neutralizing antibody.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kmg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmg,surface_glycoprotein,SARS-CoV-2,0,1.33
7kmh,"Crystal structure of SARS-CoV-2 spike protein in complex with the neutralizing antibody LY-CoV488. Hetero trimer, antiboy with one heavy and one light chain, spike protein with one chain. Literature is about the LY-CoV555 antibody the LyCoV488 isnt mentioned in the literature.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kmh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmh,surface_glycoprotein,SARS-CoV-2,0,1.03
7kmi,"Crystal structure of the SARS-CoV-2 neutralizing antibody LY-CoV481 bound to the spike protein S1. Hetero dimer, antibody with one heavy and light chain, S1 with one chain.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kmi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kmi,surface_glycoprotein,SARS-CoV-2,0,1.05
7kn5,Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U. Two out of four neutralizing nanobodies that target the receptor-binding domain of the SARS-CoV-2 spike protein.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kn5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kn5,surface_glycoprotein,SARS-CoV-2,0,1.34
7kn6,This X-Ray structure shows the SARS-CoV-2 receptor binding domain oft the spike complexed with nanobody VHH V and antibody Fab CC12.3. Nanobodies have size and cost advantages over conventional antibodies. This structure shows an in vitro generated multivalent neutralizing nanobody that targets the receptor-binding domain of the SARS-CoV-2 spike protein.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kn6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kn6,surface_glycoprotein,SARS-CoV-2,0,1.5
7kn7,Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3. Two out of four neutralizing nanobodies that target the receptor-binding domain of the SARS-CoV-2 spike protein.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kn7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kn7,surface_glycoprotein,SARS-CoV-2,0,1.45
7kzb,"Crystal structure of SARS-CoV-2 spike protein bound to the antibodies CR3014-C8 and CR3022-B6. Hetero pentamer, spike with one chain, Each antibody has one heavy and one light chain. Antibodies have identical heavy chain bud different light chain, they are binding two completely different epitopes.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kzb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kzb,surface_glycoprotein,SARS-CoV-2,0,2.98
7l0n,X-ray structure of circulating SARS-CoV-2 spike N439K variants. These may maintain fitness while evading antibody-mediated immunity.,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l0n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l0n,surface_glycoprotein,SARS-CoV-2,0,1.58
7l2c,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l2c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l2c,surface_glycoprotein,SARS-CoV-2,0,1.64
7l5b,"Crystal structure of SARS-CoV-2 spike protein receptor binding domain in complex with the neutralizing antibody 2-15. Hetero trimer, spike protein with one chain, antibody with one light and one heavy chain. Antibody utilized VH1-2 encoded motifs to recognize the RBD.",X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l5b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l5b,surface_glycoprotein,SARS-CoV-2,0,2.08
7lop,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7lop,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lop,surface_glycoprotein,SARS-CoV-2,0,1.35
7neg,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7neg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7neg,surface_glycoprotein,SARS-CoV-2,0,1.51
7neh,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7neh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7neh,surface_glycoprotein,SARS-CoV-2,0,1.43
7n0i,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7n0i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7n0i,nucleocapsid_protein,SARS-CoV-2,0,4.35
7f2e,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7f2e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7f2e,nucleocapsid_protein,SARS-CoV-2,0,5.9
7n0r,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7n0r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7n0r,nucleocapsid_protein,SARS-CoV-2,0,3.54
7n3c,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7n3c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7n3c,nucleocapsid_protein,SARS-CoV-2,0,3.36
7n3d,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7n3d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7n3d,nucleocapsid_protein,SARS-CoV-2,0,2.13
7vnu,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7vnu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7vnu,nucleocapsid_protein,SARS-CoV-2,0,3.55
7cr5,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7cr5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7cr5,nucleocapsid_protein,SARS-CoV-2,0,1.16
7r98,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7r98,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7r98,nucleocapsid_protein,SARS-CoV-2,0,7.04
7f2b,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7f2b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7f2b,nucleocapsid_protein,SARS-CoV-2,0,4.94
7lw4,,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7lw4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7lw4,methyltransferase-nsp10,SARS-CoV-2,0,2.53
7lw3,,X-RAY DIFFRACTION,pdb/methyltransferase-nsp10/SARS-CoV-2/7lw3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/methyltransferase-nsp10/SARS-CoV-2/7lw3,methyltransferase-nsp10,SARS-CoV-2,0,6.24
7exm,,X-RAY DIFFRACTION,pdb/nsp2/SARS-CoV-2/7exm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp2/SARS-CoV-2/7exm,nsp2,SARS-CoV-2,0,1.52
7ntk,,X-RAY DIFFRACTION,pdb/protein_e/SARS-CoV-2/7ntk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/protein_e/SARS-CoV-2/7ntk,protein_e,SARS-CoV-2,0,1.59
7dcd,,X-RAY DIFFRACTION,pdb/nsp7-nsp8/SARS-CoV-2/7dcd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp7-nsp8/SARS-CoV-2/7dcd,nsp7-nsp8,SARS-CoV-2,0,2.76
7nng,,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/7nng,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/7nng,helicase,SARS-CoV-2,0,1.92
7nn0,,X-RAY DIFFRACTION,pdb/helicase/SARS-CoV-2/7nn0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/helicase/SARS-CoV-2/7nn0,helicase,SARS-CoV-2,0,2.05
7sdr,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7sdr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7sdr,nsp3,SARS-CoV-2,0,1.67
7m1y,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7m1y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7m1y,nsp3,SARS-CoV-2,0,1.68
7d7k,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7d7k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7d7k,nsp3,SARS-CoV-2,0,1.58
7rbs,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7rbs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7rbs,nsp3,SARS-CoV-2,0,1.83
7oft,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7oft,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7oft,nsp3,SARS-CoV-2,0,2.57
7d7l,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7d7l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7d7l,nsp3,SARS-CoV-2,0,1.42
7ofs,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7ofs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7ofs,nsp3,SARS-CoV-2,0,2.96
7sqe,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7sqe,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7sqe,nsp3,SARS-CoV-2,0,1.45
7sgu,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7sgu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7sgu,nsp3,SARS-CoV-2,0,1.37
7rqg,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7rqg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7rqg,nsp3,SARS-CoV-2,0,3.79
7rbr,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7rbr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7rbr,nsp3,SARS-CoV-2,0,3.68
7sgw,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7sgw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7sgw,nsp3,SARS-CoV-2,0,2.17
7rzc,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7rzc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7rzc,nsp3,SARS-CoV-2,0,3.08
7sgv,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7sgv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7sgv,nsp3,SARS-CoV-2,0,1.61
7ofu,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7ofu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7ofu,nsp3,SARS-CoV-2,0,
7lfv,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/7lfv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/7lfv,nsp3,SARS-CoV,0,6.44
7lfu,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV/7lfu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV/7lfu,nsp3,SARS-CoV,0,5.39
7mlx,,X-RAY DIFFRACTION,pdb/rna/SARS-CoV-2/7mlx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7mlx,rna,SARS-CoV-2,0,2.23
7lyj,,X-RAY DIFFRACTION,pdb/rna/SARS-CoV-2/7lyj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7lyj,rna,SARS-CoV-2,0,1.39
7mky,,X-RAY DIFFRACTION,pdb/rna/SARS-CoV-2/7mky,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/rna/SARS-CoV-2/7mky,rna,SARS-CoV-2,0,1.72
7dhg,,X-RAY DIFFRACTION,pdb/orf9b/SARS-CoV-2/7dhg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf9b/SARS-CoV-2/7dhg,orf9b,SARS-CoV-2,0,4.35
5sa7,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa7,endornase,SARS-CoV-2,0,
5sab,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sab,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sab,endornase,SARS-CoV-2,0,
5sa9,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa9,endornase,SARS-CoV-2,0,
5saa,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5saa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5saa,endornase,SARS-CoV-2,0,
7n83,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7n83,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n83,endornase,SARS-CoV-2,0,2.31
7n7u,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7n7u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n7u,endornase,SARS-CoV-2,0,7.05
5sah,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sah,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sah,endornase,SARS-CoV-2,0,
5sae,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sae,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sae,endornase,SARS-CoV-2,0,
7n7r,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7n7r,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n7r,endornase,SARS-CoV-2,0,3.98
5saf,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5saf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5saf,endornase,SARS-CoV-2,0,
5sa4,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa4,endornase,SARS-CoV-2,0,
5sa8,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa8,endornase,SARS-CoV-2,0,
5sa6,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa6,endornase,SARS-CoV-2,0,
5sad,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sad,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sad,endornase,SARS-CoV-2,0,
7n7w,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7n7w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n7w,endornase,SARS-CoV-2,0,4.8
5sag,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sag,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sag,endornase,SARS-CoV-2,0,
5sac,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sac,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sac,endornase,SARS-CoV-2,0,
7n7y,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/7n7y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/7n7y,endornase,SARS-CoV-2,0,2.98
5sai,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sai,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sai,endornase,SARS-CoV-2,0,
5sa5,,X-RAY DIFFRACTION,pdb/endornase/SARS-CoV-2/5sa5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/endornase/SARS-CoV-2/5sa5,endornase,SARS-CoV-2,0,
7diy,,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV-2/7diy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7diy,exonuclease-nsp10,SARS-CoV-2,0,9.61
7mc6,,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV-2/7mc6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7mc6,exonuclease-nsp10,SARS-CoV-2,0,1.55
7mc5,,X-RAY DIFFRACTION,pdb/exonuclease-nsp10/SARS-CoV-2/7mc5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease-nsp10/SARS-CoV-2/7mc5,exonuclease-nsp10,SARS-CoV-2,0,3.87
7p3d,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7p3d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7p3d,surface_glycoprotein,SARS-CoV-2,0,4.98
7n1f,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n1f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1f,surface_glycoprotein,SARS-CoV-2,0,7.68
7ekc,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ekc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ekc,surface_glycoprotein,SARS-CoV-2,0,4.8
7rtd,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7rtd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rtd,surface_glycoprotein,SARS-CoV-2,0,2.8
7m53,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m53,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m53,surface_glycoprotein,SARS-CoV-2,0,4.4
7mmo,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mmo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mmo,surface_glycoprotein,SARS-CoV-2,0,1.31
7nx9,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nx9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nx9,surface_glycoprotein,SARS-CoV-2,0,1.31
7vnb,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7vnb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vnb,surface_glycoprotein,SARS-CoV-2,0,4.31
7nxc,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nxc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nxc,surface_glycoprotein,SARS-CoV-2,0,1.83
7e3o,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e3o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3o,surface_glycoprotein,SARS-CoV-2,0,7.27
7mzg,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzg,surface_glycoprotein,SARS-CoV-2,0,2.59
7mzn,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzn,surface_glycoprotein,SARS-CoV-2,0,3.61
7eke,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7eke,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eke,surface_glycoprotein,SARS-CoV-2,0,3.33
7mzk,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzk,surface_glycoprotein,SARS-CoV-2,0,9.4
7oay,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7oay,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oay,surface_glycoprotein,SARS-CoV-2,0,
7djz,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7djz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7djz,surface_glycoprotein,SARS-CoV-2,0,3.72
7nx8,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nx8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nx8,surface_glycoprotein,SARS-CoV-2,0,1.47
7r6x,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7r6x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r6x,surface_glycoprotein,SARS-CoV-2,0,6.1
7cho,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cho,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cho,surface_glycoprotein,SARS-CoV-2,0,6.6
7e7y,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e7y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e7y,surface_glycoprotein,SARS-CoV-2,0,5.51
7r6w,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7r6w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r6w,surface_glycoprotein,SARS-CoV-2,0,0.98
7ora,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ora,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ora,surface_glycoprotein,SARS-CoV-2,0,3.74
7m3i,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m3i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m3i,3c_like_proteinase,SARS-CoV-2,0,5.06
7e86,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e86,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e86,surface_glycoprotein,SARS-CoV-2,0,7.15
7r8l,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7r8l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7r8l,surface_glycoprotein,SARS-CoV-2,0,5.23
7e88,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e88,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e88,surface_glycoprotein,SARS-CoV-2,0,12.23
7n6d,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n6d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n6d,surface_glycoprotein,SARS-CoV-2,0,3.47
7rtr,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7rtr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rtr,surface_glycoprotein,SARS-CoV-2,0,3.05
7cyv,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cyv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cyv,surface_glycoprotein,SARS-CoV-2,0,11.54
7b27,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7b27,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b27,surface_glycoprotein,SARS-CoV-2,0,
7bnv,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7bnv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7bnv,surface_glycoprotein,SARS-CoV-2,0,5.57
7kn3,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kn3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kn3,surface_glycoprotein,SARS-CoV-2,0,2.46
7mzl,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzl,surface_glycoprotein,SARS-CoV-2,0,3.68
7m8u,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m8u,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m8u,surface_glycoprotein,SARS-CoV-2,0,1.78
7chp,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7chp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chp,surface_glycoprotein,SARS-CoV-2,0,2.76
7c53,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7c53,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7c53,surface_glycoprotein,SARS-CoV-2,0,4.34
7mf1,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mf1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mf1,surface_glycoprotein,SARS-CoV-2,0,3.98
7nxb,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nxb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nxb,surface_glycoprotein,SARS-CoV-2,0,1.49
7mzm,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzm,surface_glycoprotein,SARS-CoV-2,0,8.16
7m8t,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m8t,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m8t,surface_glycoprotein,SARS-CoV-2,0,2.51
7km5,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7km5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7km5,surface_glycoprotein,SARS-CoV-2,0,5.67
7d6i,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7d6i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7d6i,surface_glycoprotein,SARS-CoV-2,0,9.06
7or9,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7or9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7or9,surface_glycoprotein,SARS-CoV-2,0,3.24
7rnj,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7rnj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rnj,surface_glycoprotein,SARS-CoV-2,0,3.32
7kn4,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7kn4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7kn4,surface_glycoprotein,SARS-CoV-2,0,5.74
7mzf,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzf,surface_glycoprotein,SARS-CoV-2,0,9.09
7efr,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7efr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7efr,surface_glycoprotein,SARS-CoV-2,0,7.77
7n1b,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n1b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1b,surface_glycoprotein,SARS-CoV-2,0,10.95
7deu,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7deu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7deu,surface_glycoprotein,SARS-CoV-2,0,1.56
7cot,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7cot,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7cot,surface_glycoprotein,SARS-CoV-2,0,5.74
7lo4,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7lo4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lo4,surface_glycoprotein,SARS-CoV-2,0,1.28
7e5y,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e5y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e5y,surface_glycoprotein,SARS-CoV-2,0,18.98
7nxa,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nxa,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nxa,surface_glycoprotein,SARS-CoV-2,0,1.5
6x45,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/6x45,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/6x45,surface_glycoprotein,SARS-CoV-2,0,2.52
7rku,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7rku,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rku,surface_glycoprotein,SARS-CoV-2,0,9.23
7nx6,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nx6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nx6,surface_glycoprotein,SARS-CoV-2,0,1.42
7oau,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7oau,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oau,surface_glycoprotein,SARS-CoV-2,0,
7l7d,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l7d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l7d,surface_glycoprotein,SARS-CoV-2,0,2.12
7n4i,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n4i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n4i,surface_glycoprotein,SARS-CoV-2,0,6.43
7ean,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ean,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ean,surface_glycoprotein,SARS-CoV-2,0,1.32
7m7w,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m7w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m7w,surface_glycoprotein,SARS-CoV-2,0,3.11
7lm8,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7lm8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lm8,surface_glycoprotein,SARS-CoV-2,0,1.26
7f4w,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7f4w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7f4w,surface_glycoprotein,SARS-CoV-2,0,12.01
7b62,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7b62,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b62,surface_glycoprotein,SARS-CoV-2,0,5.5
7ekh,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ekh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ekh,surface_glycoprotein,SARS-CoV-2,0,4.28
7n4l,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n4l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n4l,surface_glycoprotein,SARS-CoV-2,0,13.26
7e7x,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e7x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e7x,surface_glycoprotein,SARS-CoV-2,0,7.73
7mfu,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mfu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mfu,surface_glycoprotein,SARS-CoV-2,0,1.8
7s4s,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7s4s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s4s,surface_glycoprotein,SARS-CoV-2,0,3.42
7deo,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7deo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7deo,surface_glycoprotein,SARS-CoV-2,0,1.42
7eu2,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7eu2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7eu2,surface_glycoprotein,SARS-CoV-2,0,10.82
7dk0,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7dk0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk0,surface_glycoprotein,SARS-CoV-2,0,5.31
7s0b,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7s0b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s0b,surface_glycoprotein,SARS-CoV-2,0,10.7
7vmu,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7vmu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7vmu,surface_glycoprotein,SARS-CoV-2,0,9.31
7orb,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7orb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7orb,surface_glycoprotein,SARS-CoV-2,0,4.6
7mzj,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzj,surface_glycoprotein,SARS-CoV-2,0,9.61
7l7e,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l7e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l7e,surface_glycoprotein,SARS-CoV-2,0,4.56
7e3j,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e3j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e3j,surface_glycoprotein,SARS-CoV-2,0,1.6
7det,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7det,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7det,surface_glycoprotein,SARS-CoV-2,0,1.53
7mzi,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzi,surface_glycoprotein,SARS-CoV-2,0,7.94
7ldj,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ldj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ldj,surface_glycoprotein,SARS-CoV-2,0,5.57
7n1a,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n1a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1a,surface_glycoprotein,SARS-CoV-2,0,7.59
7m8s,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m8s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m8s,surface_glycoprotein,SARS-CoV-2,0,2.03
7n4m,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n4m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n4m,surface_glycoprotein,SARS-CoV-2,0,6.28
7efp,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7efp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7efp,surface_glycoprotein,SARS-CoV-2,0,10.63
7n4j,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n4j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n4j,surface_glycoprotein,SARS-CoV-2,0,4.89
7m6d,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7m6d,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7m6d,surface_glycoprotein,SARS-CoV-2,0,11.66
7olz,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7olz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7olz,surface_glycoprotein,SARS-CoV-2,0,2.62
7e5o,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e5o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e5o,surface_glycoprotein,SARS-CoV-2,0,4.01
7ekf,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ekf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ekf,surface_glycoprotein,SARS-CoV-2,0,4.56
7oap,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7oap,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oap,surface_glycoprotein,SARS-CoV-2,0,
7ekg,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ekg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ekg,surface_glycoprotein,SARS-CoV-2,0,4.56
7l4z,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7l4z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7l4z,surface_glycoprotein,SARS-CoV-2,0,9.03
7e8m,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7e8m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7e8m,surface_glycoprotein,SARS-CoV-2,0,2.15
7ly3,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ly3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ly3,surface_glycoprotein,SARS-CoV-2,0,3.83
7mzh,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7mzh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7mzh,surface_glycoprotein,SARS-CoV-2,0,3.75
7n3i,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n3i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n3i,surface_glycoprotein,SARS-CoV-2,0,3.85
7nx7,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nx7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nx7,surface_glycoprotein,SARS-CoV-2,0,1.49
7b0b,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7b0b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7b0b,surface_glycoprotein,SARS-CoV-2,0,12.57
7oaq,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7oaq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oaq,surface_glycoprotein,SARS-CoV-2,0,
7n6e,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n6e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n6e,surface_glycoprotein,SARS-CoV-2,0,5.41
7np1,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7np1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7np1,surface_glycoprotein,SARS-CoV-2,0,6.93
7dhx,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7dhx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dhx,surface_glycoprotein,SARS-CoV-2,0,4.95
7lq7,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7lq7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7lq7,surface_glycoprotein,SARS-CoV-2,0,6.76
7chs,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7chs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7chs,surface_glycoprotein,SARS-CoV-2,0,5.92
7ek6,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ek6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ek6,surface_glycoprotein,SARS-CoV-2,0,6.82
7s3n,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7s3n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7s3n,surface_glycoprotein,SARS-CoV-2,0,6.63
7n1e,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7n1e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7n1e,surface_glycoprotein,SARS-CoV-2,0,8.88
7oao,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7oao,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7oao,surface_glycoprotein,SARS-CoV-2,0,
7rks,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/7rks,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7rks,surface_glycoprotein,SARS-CoV,0,7.77
7lm9,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/7lm9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7lm9,surface_glycoprotein,SARS-CoV,0,4.04
7drv,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV/7drv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV/7drv,surface_glycoprotein,SARS-CoV,0,6.93
7orv,,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7orv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7orv,nsp10,SARS-CoV-2,0,1.62
7orw,,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7orw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7orw,nsp10,SARS-CoV-2,0,0.54
7orr,,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7orr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7orr,nsp10,SARS-CoV-2,0,1.06
7oru,,X-RAY DIFFRACTION,pdb/nsp10/SARS-CoV-2/7oru,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp10/SARS-CoV-2/7oru,nsp10,SARS-CoV-2,0,1.08
7kri,,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/7kri,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/7kri,nsp9,SARS-CoV-2,0,4.4
7bwq,,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/7bwq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/7bwq,nsp9,SARS-CoV-2,0,18.54
7n3k,,X-RAY DIFFRACTION,pdb/nsp9/SARS-CoV-2/7n3k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp9/SARS-CoV-2/7n3k,nsp9,SARS-CoV-2,0,12.9
6iex,,X-RAY DIFFRACTION,pdb/not_assigned/SARS-CoV/6iex,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/not_assigned/SARS-CoV/6iex,not_assigned,SARS-CoV,0,8.15
7p3e,,X-RAY DIFFRACTION,pdb/not_assigned/SARS-CoV/7p3e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/not_assigned/SARS-CoV/7p3e,not_assigned,SARS-CoV,0,6.04
7ntj,,X-RAY DIFFRACTION,pdb/not_assigned/SARS-CoV/7ntj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/not_assigned/SARS-CoV/7ntj,not_assigned,SARS-CoV,0,0.71
7eq4,,X-RAY DIFFRACTION,pdb/leader_protein/SARS-CoV-2/7eq4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/leader_protein/SARS-CoV-2/7eq4,leader_protein,SARS-CoV-2,0,2.27
7rm2,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rm2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rm2,3c_like_proteinase,SARS-CoV-2,0,0.62
7nt3,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nt3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nt3,3c_like_proteinase,SARS-CoV-2,0,5.45
7lmf,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lmf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lmf,3c_like_proteinase,SARS-CoV-2,0,3.95
7rme,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rme,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rme,3c_like_proteinase,SARS-CoV-2,0,2.32
7rfw,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rfw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rfw,3c_like_proteinase,SARS-CoV-2,0,2.76
7lke,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lke,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lke,3c_like_proteinase,SARS-CoV-2,0,1.66
7m8o,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8o,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8o,3c_like_proteinase,SARS-CoV-2,0,13.95
7cuu,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cuu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cuu,3c_like_proteinase,SARS-CoV-2,0,4.86
7l8j,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l8j,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l8j,3c_like_proteinase,SARS-CoV-2,0,4.72
7k0e,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7k0e,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7k0e,3c_like_proteinase,SARS-CoV-2,0,1.9
7m04,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m04,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m04,3c_like_proteinase,SARS-CoV-2,0,1.13
7mpb,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mpb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mpb,3c_like_proteinase,SARS-CoV-2,0,6.37
7dhj,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dhj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dhj,3c_like_proteinase,SARS-CoV-2,0,3.87
7ltn,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ltn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ltn,3c_like_proteinase,SARS-CoV-2,0,4.87
7dgf,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dgf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dgf,3c_like_proteinase,SARS-CoV-2,0,5.15
7s3k,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7s3k,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7s3k,3c_like_proteinase,SARS-CoV-2,0,1.05
7cut,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cut,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cut,3c_like_proteinase,SARS-CoV-2,0,6.57
7vh8,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vh8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vh8,3c_like_proteinase,SARS-CoV-2,0,4.61
7lzt,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzt,3c_like_proteinase,SARS-CoV-2,0,1.03
7nkt,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nkt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nkt,3c_like_proteinase,SARS-CoV-2,0,
7bal,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bal,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bal,3c_like_proteinase,SARS-CoV-2,0,4.99
7m01,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m01,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m01,3c_like_proteinase,SARS-CoV-2,0,1.08
7lct,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lct,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lct,3c_like_proteinase,SARS-CoV-2,0,6.12
7rbz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rbz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rbz,3c_like_proteinase,SARS-CoV-2,0,3.16
7mhi,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhi,3c_like_proteinase,SARS-CoV-2,0,2.73
7m8n,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8n,3c_like_proteinase,SARS-CoV-2,0,9.28
7nuk,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nuk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nuk,3c_like_proteinase,SARS-CoV-2,0,2.9
7mng,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mng,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mng,3c_like_proteinase,SARS-CoV-2,0,12.47
7faz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7faz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7faz,3c_like_proteinase,SARS-CoV-2,0,4.58
7p35,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7p35,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7p35,3c_like_proteinase,SARS-CoV-2,0,
7ng3,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ng3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ng3,3c_like_proteinase,SARS-CoV-2,0,1.25
7dg6,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dg6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dg6,3c_like_proteinase,SARS-CoV-2,0,2.38
7n44,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7n44,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7n44,3c_like_proteinase,SARS-CoV-2,0,5.71
7ein,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ein,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ein,3c_like_proteinase,SARS-CoV-2,0,3.34
7ca8,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ca8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ca8,3c_like_proteinase,SARS-CoV-2,0,1.78
7mhn,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhn,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhn,3c_like_proteinase,SARS-CoV-2,0,19.78
7n5z,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7n5z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7n5z,3c_like_proteinase,SARS-CoV-2,0,2.54
7nt2,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nt2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nt2,3c_like_proteinase,SARS-CoV-2,0,5.09
7ntv,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ntv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ntv,3c_like_proteinase,SARS-CoV-2,0,3.48
7ddc,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ddc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ddc,3c_like_proteinase,SARS-CoV-2,0,4.09
7dgb,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dgb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dgb,3c_like_proteinase,SARS-CoV-2,0,4.91
7mhj,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhj,3c_like_proteinase,SARS-CoV-2,0,2.52
7mbg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mbg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mbg,3c_like_proteinase,SARS-CoV-2,0,1.49
7rc0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rc0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rc0,3c_like_proteinase,SARS-CoV-2,0,3.19
7mhg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhg,3c_like_proteinase,SARS-CoV-2,0,3.64
7rmt,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rmt,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rmt,3c_like_proteinase,SARS-CoV-2,0,0.42
7m8m,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8m,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8m,3c_like_proteinase,SARS-CoV-2,0,7.24
7lzx,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzx,3c_like_proteinase,SARS-CoV-2,0,1.07
7s4b,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7s4b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7s4b,3c_like_proteinase,SARS-CoV-2,0,0.0
7fay,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7fay,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7fay,3c_like_proteinase,SARS-CoV-2,0,2.55
7mhh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhh,3c_like_proteinase,SARS-CoV-2,0,3.15
7rfr,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rfr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rfr,3c_like_proteinase,SARS-CoV-2,0,3.58
7dpv,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dpv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dpv,3c_like_proteinase,SARS-CoV-2,0,1.84
7s3s,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7s3s,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7s3s,3c_like_proteinase,SARS-CoV-2,0,0.21
7lcs,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lcs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lcs,3c_like_proteinase,SARS-CoV-2,0,7.21
7bak,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7bak,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7bak,3c_like_proteinase,SARS-CoV-2,0,2.84
7r7h,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7r7h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7r7h,3c_like_proteinase,SARS-CoV-2,0,7.42
7cb7,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cb7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cb7,3c_like_proteinase,SARS-CoV-2,0,4.89
7m00,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m00,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m00,3c_like_proteinase,SARS-CoV-2,0,1.29
7lco,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lco,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lco,3c_like_proteinase,SARS-CoV-2,0,6.96
7lzw,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzw,3c_like_proteinase,SARS-CoV-2,0,1.26
7dk1,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dk1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dk1,3c_like_proteinase,SARS-CoV-2,0,1.88
7jp0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7jp0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7jp0,3c_like_proteinase,SARS-CoV-2,0,7.55
7m8p,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8p,3c_like_proteinase,SARS-CoV-2,0,8.12
7dau,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dau,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dau,3c_like_proteinase,SARS-CoV-2,0,3.91
7lzy,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzy,3c_like_proteinase,SARS-CoV-2,0,1.11
7dpp,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dpp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dpp,3c_like_proteinase,SARS-CoV-2,0,1.36
7si9,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7si9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7si9,3c_like_proteinase,SARS-CoV-2,0,1.46
7lme,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lme,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lme,3c_like_proteinase,SARS-CoV-2,0,3.87
7mhl,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhl,3c_like_proteinase,SARS-CoV-2,0,
7p51,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7p51,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7p51,3c_like_proteinase,SARS-CoV-2,0,3.54
7aeg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aeg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aeg,3c_like_proteinase,SARS-CoV-2,0,2.27
7lzu,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzu,3c_like_proteinase,SARS-CoV-2,0,0.99
7rls,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rls,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rls,3c_like_proteinase,SARS-CoV-2,0,2.73
7n6n,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7n6n,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7n6n,3c_like_proteinase,SARS-CoV-2,0,10.84
7nt1,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nt1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nt1,3c_like_proteinase,SARS-CoV-2,0,4.24
7rn1,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rn1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rn1,3c_like_proteinase,SARS-CoV-2,0,5.71
7lkd,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lkd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lkd,3c_like_proteinase,SARS-CoV-2,0,1.34
7nf5,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nf5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nf5,3c_like_proteinase,SARS-CoV-2,0,1.02
7dat,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dat,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dat,3c_like_proteinase,SARS-CoV-2,0,3.25
7mhk,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhk,3c_like_proteinase,SARS-CoV-2,0,2.52
7e18,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7e18,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7e18,3c_like_proteinase,SARS-CoV-2,0,2.39
7mgr,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mgr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mgr,3c_like_proteinase,SARS-CoV-2,0,5.04
7mho,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mho,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mho,3c_like_proteinase,SARS-CoV-2,0,14.68
7mgs,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mgs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mgs,3c_like_proteinase,SARS-CoV-2,0,2.93
7m03,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m03,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m03,3c_like_proteinase,SARS-CoV-2,0,1.28
7rmb,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rmb,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rmb,3c_like_proteinase,SARS-CoV-2,0,0.84
7m8z,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8z,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8z,3c_like_proteinase,SARS-CoV-2,0,6.99
7baj,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7baj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7baj,3c_like_proteinase,SARS-CoV-2,0,3.23
7m8x,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8x,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8x,3c_like_proteinase,SARS-CoV-2,0,7.6
7lmc,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lmc,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lmc,3c_like_proteinase,SARS-CoV-2,0,2.81
7dgh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dgh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dgh,3c_like_proteinase,SARS-CoV-2,0,6.99
7mhp,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhp,3c_like_proteinase,SARS-CoV-2,0,18.59
7dgg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dgg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dgg,3c_like_proteinase,SARS-CoV-2,0,5.04
7m90,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m90,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m90,3c_like_proteinase,SARS-CoV-2,0,8.61
7dav,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dav,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dav,3c_like_proteinase,SARS-CoV-2,0,4.56
7ldl,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ldl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ldl,3c_like_proteinase,SARS-CoV-2,0,7.92
7aeh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7aeh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7aeh,3c_like_proteinase,SARS-CoV-2,0,3.46
7e19,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7e19,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7e19,3c_like_proteinase,SARS-CoV-2,0,1.5
7dpu,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dpu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dpu,3c_like_proteinase,SARS-CoV-2,0,0.87
7ng6,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7ng6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7ng6,3c_like_proteinase,SARS-CoV-2,0,1.45
7d64,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7d64,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7d64,3c_like_proteinase,SARS-CoV-2,0,8.92
7m8y,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m8y,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m8y,3c_like_proteinase,SARS-CoV-2,0,8.12
7rnk,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rnk,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rnk,3c_like_proteinase,SARS-CoV-2,0,1.05
7mhm,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhm,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhm,3c_like_proteinase,SARS-CoV-2,0,
7m2p,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m2p,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m2p,3c_like_proteinase,SARS-CoV-2,0,5.83
7rfu,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rfu,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rfu,3c_like_proteinase,SARS-CoV-2,0,4.98
7cam,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7cam,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7cam,3c_like_proteinase,SARS-CoV-2,0,10.62
7lzv,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzv,3c_like_proteinase,SARS-CoV-2,0,1.15
7nts,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nts,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nts,3c_like_proteinase,SARS-CoV-2,0,3.3
7lmd,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lmd,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lmd,3c_like_proteinase,SARS-CoV-2,0,3.66
7dgi,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dgi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dgi,3c_like_proteinase,SARS-CoV-2,0,5.3
7djr,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7djr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7djr,3c_like_proteinase,SARS-CoV-2,0,4.64
7mrr,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mrr,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mrr,3c_like_proteinase,SARS-CoV-2,0,4.32
7n89,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7n89,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7n89,3c_like_proteinase,SARS-CoV-2,0,1.87
7rmz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rmz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rmz,3c_like_proteinase,SARS-CoV-2,0,1.04
7rn0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rn0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rn0,3c_like_proteinase,SARS-CoV-2,0,8.76
7rn4,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rn4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rn4,3c_like_proteinase,SARS-CoV-2,0,2.51
7mhf,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhf,3c_like_proteinase,SARS-CoV-2,0,4.62
7l8i,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7l8i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7l8i,3c_like_proteinase,SARS-CoV-2,0,3.41
7lzz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7lzz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7lzz,3c_like_proteinase,SARS-CoV-2,0,1.16
7m91,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m91,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m91,3c_like_proteinase,SARS-CoV-2,0,5.36
7n8c,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7n8c,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7n8c,3c_like_proteinase,SARS-CoV-2,0,2.12
7nw2,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nw2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nw2,3c_like_proteinase,SARS-CoV-2,0,
7rnh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rnh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rnh,3c_like_proteinase,SARS-CoV-2,0,2.11
7m02,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7m02,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7m02,3c_like_proteinase,SARS-CoV-2,0,0.96
7mbi,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mbi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mbi,3c_like_proteinase,SARS-CoV-2,0,7.17
7rfs,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7rfs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7rfs,3c_like_proteinase,SARS-CoV-2,0,4.03
7mhq,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mhq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mhq,3c_like_proteinase,SARS-CoV-2,0,
7lcq,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lcq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lcq,3c_like_proteinase,SARS-CoV,0,12.5
7k0h,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7k0h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7k0h,3c_like_proteinase,SARS-CoV,0,2.8
7k0g,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7k0g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7k0g,3c_like_proteinase,SARS-CoV,0,2.5
7eo8,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7eo8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7eo8,3c_like_proteinase,SARS-CoV,0,7.64
7lcp,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lcp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lcp,3c_like_proteinase,SARS-CoV,0,12.85
7lmh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lmh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lmh,3c_like_proteinase,SARS-CoV,0,
7lmg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lmg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lmg,3c_like_proteinase,SARS-CoV,0,
7lmi,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lmi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lmi,3c_like_proteinase,SARS-CoV,0,
7dqz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7dqz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7dqz,3c_like_proteinase,SARS-CoV,0,4.94
7rc1,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7rc1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7rc1,3c_like_proteinase,SARS-CoV,0,6.92
7lmj,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV/7lmj,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV/7lmj,3c_like_proteinase,SARS-CoV,0,
7qip,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7qip,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7qip,nucleocapsid_protein,SARS-CoV-2,0,
7qik,,X-RAY DIFFRACTION,pdb/nucleocapsid_protein/SARS-CoV-2/7qik,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nucleocapsid_protein/SARS-CoV-2/7qik,nucleocapsid_protein,SARS-CoV-2,0,
7vph,,X-RAY DIFFRACTION,pdb/orf6/SARS-CoV-2/7vph,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf6/SARS-CoV-2/7vph,orf6,SARS-CoV-2,0,12.03
7vpg,,X-RAY DIFFRACTION,pdb/orf6/SARS-CoV/7vpg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf6/SARS-CoV/7vpg,orf6,SARS-CoV,0,5.34
7qg7,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7qg7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7qg7,nsp3,SARS-CoV-2,0,3.49
7t9w,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7t9w,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7t9w,nsp3,SARS-CoV-2,0,4.83
7thh,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7thh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7thh,nsp3,SARS-CoV-2,0,2.17
7ti9,,X-RAY DIFFRACTION,pdb/nsp3/SARS-CoV-2/7ti9,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/nsp3/SARS-CoV-2/7ti9,nsp3,SARS-CoV-2,0,
7f5f,,X-RAY DIFFRACTION,pdb/orf8/SARS-CoV-2/7f5f,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf8/SARS-CoV-2/7f5f,orf8,SARS-CoV-2,0,0.0
7qnx,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7qnx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7qnx,surface_glycoprotein,SARS-CoV-2,0,3.69
7ps5,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps5,surface_glycoprotein,SARS-CoV-2,0,4.48
7nab,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7nab,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7nab,surface_glycoprotein,SARS-CoV-2,0,3.39
7ps2,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps2,surface_glycoprotein,SARS-CoV-2,0,7.44
7qnw,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7qnw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7qnw,surface_glycoprotein,SARS-CoV-2,0,4.81
7ps0,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps0,surface_glycoprotein,SARS-CoV-2,0,5.23
7q0i,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7q0i,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q0i,surface_glycoprotein,SARS-CoV-2,0,
7sn0,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7sn0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sn0,surface_glycoprotein,SARS-CoV-2,0,
7rpv,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7rpv,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7rpv,surface_glycoprotein,SARS-CoV-2,0,9.67
7msq,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7msq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7msq,surface_glycoprotein,SARS-CoV-2,0,3.86
7pry,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7pry,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7pry,surface_glycoprotein,SARS-CoV-2,0,5.49
7wbq,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7wbq,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wbq,surface_glycoprotein,SARS-CoV-2,0,5.0
7ps6,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps6,surface_glycoprotein,SARS-CoV-2,0,2.64
7sjs,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7sjs,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7sjs,surface_glycoprotein,SARS-CoV-2,0,3.16
7ps7,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps7,surface_glycoprotein,SARS-CoV-2,0,10.99
7qny,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7qny,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7qny,surface_glycoprotein,SARS-CoV-2,0,3.89
7spp,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7spp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7spp,surface_glycoprotein,SARS-CoV-2,0,2.7
7ps4,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps4,surface_glycoprotein,SARS-CoV-2,0,2.85
7q0h,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7q0h,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q0h,surface_glycoprotein,SARS-CoV-2,0,6.01
7wbp,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7wbp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7wbp,surface_glycoprotein,SARS-CoV-2,0,2.82
7ps1,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ps1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ps1,surface_glycoprotein,SARS-CoV-2,0,1.79
7dk2,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7dk2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7dk2,surface_glycoprotein,SARS-CoV-2,0,6.37
7q0g,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7q0g,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7q0g,surface_glycoprotein,SARS-CoV-2,0,2.83
7spo,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7spo,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7spo,surface_glycoprotein,SARS-CoV-2,0,3.15
7prz,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7prz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7prz,surface_glycoprotein,SARS-CoV-2,0,5.54
7ejl,,X-RAY DIFFRACTION,pdb/surface_glycoprotein/SARS-CoV-2/7ejl,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/surface_glycoprotein/SARS-CoV-2/7ejl,surface_glycoprotein,SARS-CoV-2,0,
6w37,,X-RAY DIFFRACTION,pdb/orf7a/SARS-CoV-2/6w37,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/orf7a/SARS-CoV-2/6w37,orf7a,SARS-CoV-2,0,0.99
7qgi,,X-RAY DIFFRACTION,pdb/exonuclease/SARS-CoV-2/7qgi,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/exonuclease/SARS-CoV-2/7qgi,exonuclease,SARS-CoV-2,0,
7f8l,,X-RAY DIFFRACTION,pdb/not_assigned/SARS-CoV/7f8l,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/not_assigned/SARS-CoV/7f8l,not_assigned,SARS-CoV,0,5.53
7t48,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t48,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t48,3c_like_proteinase,SARS-CoV-2,0,2.0
7tll,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7tll,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7tll,3c_like_proteinase,SARS-CoV-2,0,
7dvy,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dvy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dvy,3c_like_proteinase,SARS-CoV-2,0,3.57
7t49,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t49,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t49,3c_like_proteinase,SARS-CoV-2,0,2.26
7vjy,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vjy,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vjy,3c_like_proteinase,SARS-CoV-2,0,
7vk4,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk4,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk4,3c_like_proteinase,SARS-CoV-2,0,
7t4b,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t4b,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t4b,3c_like_proteinase,SARS-CoV-2,0,2.9
7mlg,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mlg,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mlg,3c_like_proteinase,SARS-CoV-2,0,3.64
7vk8,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk8,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk8,3c_like_proteinase,SARS-CoV-2,0,
7vk7,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk7,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk7,3c_like_proteinase,SARS-CoV-2,0,
7t4a,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t4a,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t4a,3c_like_proteinase,SARS-CoV-2,0,2.17
7vjx,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vjx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vjx,3c_like_proteinase,SARS-CoV-2,0,
7vk6,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk6,3c_like_proteinase,SARS-CoV-2,0,
7nxh,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nxh,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nxh,3c_like_proteinase,SARS-CoV-2,0,
7nwx,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7nwx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7nwx,3c_like_proteinase,SARS-CoV-2,0,
7t43,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t43,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t43,3c_like_proteinase,SARS-CoV-2,0,2.07
7vjw,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vjw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vjw,3c_like_proteinase,SARS-CoV-2,0,
7vjz,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vjz,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vjz,3c_like_proteinase,SARS-CoV-2,0,
7vk3,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk3,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk3,3c_like_proteinase,SARS-CoV-2,0,
7te0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7te0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7te0,3c_like_proteinase,SARS-CoV-2,0,4.03
7vk0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk0,3c_like_proteinase,SARS-CoV-2,0,
7dw0,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dw0,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dw0,3c_like_proteinase,SARS-CoV-2,0,4.65
7dvx,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dvx,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dvx,3c_like_proteinase,SARS-CoV-2,0,3.7
7vk2,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk2,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk2,3c_like_proteinase,SARS-CoV-2,0,
7t44,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t44,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t44,3c_like_proteinase,SARS-CoV-2,0,2.62
7mlf,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7mlf,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7mlf,3c_like_proteinase,SARS-CoV-2,0,1.5
7dvp,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dvp,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dvp,3c_like_proteinase,SARS-CoV-2,0,2.07
7dvw,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dvw,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dvw,3c_like_proteinase,SARS-CoV-2,0,2.08
7vk5,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk5,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk5,3c_like_proteinase,SARS-CoV-2,0,
7t46,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t46,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t46,3c_like_proteinase,SARS-CoV-2,0,2.99
7vk1,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7vk1,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7vk1,3c_like_proteinase,SARS-CoV-2,0,
7dw6,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7dw6,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7dw6,3c_like_proteinase,SARS-CoV-2,0,3.33
7t45,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t45,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t45,3c_like_proteinase,SARS-CoV-2,0,2.83
7t42,,X-RAY DIFFRACTION,pdb/3c_like_proteinase/SARS-CoV-2/7t42,https://github.com/thorn-lab/coronavirus_structural_task_force/tree/master/pdb/3c_like_proteinase/SARS-CoV-2/7t42,3c_like_proteinase,SARS-CoV-2,0,2.18
